{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "709aa4df",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['40668915', '40668537', '40668244', '40668119', '40668093', '40667967', '40667723', '40667431', '40667220', '40665411', '40665407', '40665383', '40665361', '40665105', '40665053', '40664887', '40664716', '40664706', '40664435', '40664333']\n"
     ]
    }
   ],
   "source": [
    "import requests\n",
    "\n",
    "term = \"asthma\"\n",
    "esearch_url = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi\"\n",
    "params = {\n",
    "    \"db\": \"pubmed\",\n",
    "    \"term\": term,\n",
    "    \"retmode\": \"json\"\n",
    "}\n",
    "\n",
    "esearch_response = requests.get(esearch_url, params=params)\n",
    "pmid_list = esearch_response.json()[\"esearchresult\"][\"idlist\"]\n",
    "print(pmid_list)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "2cfafd1a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<?xml version=\"1.0\" ?>\n",
      "<!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2025//EN\" \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd\">\n",
      "<PubmedArticleSet>\n",
      "<PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">40668915</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">2375-2548</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>11</Volume><Issue>29</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>18</Day></PubDate></JournalIssue><Title>Science advances</Title><ISOAbbreviation>Sci Adv</ISOAbbreviation></Journal><ArticleTitle>Atopy-related immune profiles are subject to genetic influence as evaluated using school-aged twin pairs.</ArticleTitle><Pagination><StartPage>eads8033</StartPage><MedlinePgn>eads8033</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1126/sciadv.ads8033</ELocationID><Abstract><AbstractText>The interaction of genetic and environmental contributions to immunological traits and their association with atopic disease remain unclear. Flow cytometry and in vitro cytokine responses were used to characterize immune profiles from 93 school-aged twin pairs. Using an established twin pair analytical strategy, the genetic and environmental influences on immunological traits were evaluated, along with their association with atopy. Our findings suggest strong genetic influence on several traits, particularly B cell abundance. In contrast, cytokine responses from in vitro stimulations appeared mainly shaped by environmental exposures. Regarding associations with atopy, greater abundance of both B cells and basophils were observed in atopic individuals as well as increased expression of the immunoglobulin E (IgE) receptor. Genetic influence appeared central to regulating IgE receptor expression on basophils, whereas expression on dendritic cells instead appeared sensitive to environmental exposures. Identifying environmentally regulated immune traits may facilitate the development of targeted therapies to limit the impact of atopic disease in the future.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Leffler</LastName><ForeName>Jonatan</ForeName><Initials>J</Initials><Identifier Source=\"ORCID\">0000-0001-5674-8462</Identifier><AffiliationInfo><Affiliation>Wal-yan Respiratory Research Centre, The Kids Research Institute Australia, University of Western Australia, Perth, WA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Read</LastName><ForeName>James F</ForeName><Initials>JF</Initials><Identifier Source=\"ORCID\">0000-0003-2962-6835</Identifier><AffiliationInfo><Affiliation>The Kids Research Institute Australia, University of Western Australia, Perth, WA, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Asthma and Airway Disease Research Centre, University of Arizona, Tucson, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Mok</LastName><ForeName>Danny</ForeName><Initials>D</Initials><Identifier Source=\"ORCID\">0000-0001-7425-6891</Identifier><AffiliationInfo><Affiliation>The Kids Research Institute Australia, University of Western Australia, Perth, WA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Serralha</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source=\"ORCID\">0000-0002-0121-2879</Identifier><AffiliationInfo><Affiliation>The Kids Research Institute Australia, University of Western Australia, Perth, WA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Bosco</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><Identifier Source=\"ORCID\">0000-0002-4335-615X</Identifier><AffiliationInfo><Affiliation>Asthma and Airway Disease Research Centre, University of Arizona, Tucson, AZ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunobiology, The University of Arizona College of Medicine, Tucson, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Holt</LastName><ForeName>Patrick G</ForeName><Initials>PG</Initials><AffiliationInfo><Affiliation>Wal-yan Respiratory Research Centre, The Kids Research Institute Australia, University of Western Australia, Perth, WA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Saffery</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Murdoch Children's Research Institute, Parkville, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Strickland</LastName><ForeName>Deborah H</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Wal-yan Respiratory Research Centre, The Kids Research Institute Australia, University of Western Australia, Perth, WA, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Graduate Research, Edith Cowan University, Perth, WA, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D018486\">Twin Study</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2025</Year><Month>07</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Sci Adv</MedlineTA><NlmUniqueID>101653440</NlmUniqueID><ISSNLinking>2375-2548</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D016207\">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D017455\">Receptors, IgE</NameOfSubstance></Chemical><Chemical><RegistryNumber>37341-29-0</RegistryNumber><NameOfSubstance UI=\"D007073\">Immunoglobulin E</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D005260\" MajorTopicYN=\"N\">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008297\" MajorTopicYN=\"N\">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D002648\" MajorTopicYN=\"N\">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000293\" MajorTopicYN=\"N\">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006969\" MajorTopicYN=\"Y\">Hypersensitivity, Immediate</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000276\" MajorTopicYN=\"N\">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D016207\" MajorTopicYN=\"N\">Cytokines</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D001491\" MajorTopicYN=\"N\">Basophils</DescriptorName><QualifierName UI=\"Q000276\" MajorTopicYN=\"N\">immunology</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D017455\" MajorTopicYN=\"N\">Receptors, IgE</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D007073\" MajorTopicYN=\"N\">Immunoglobulin E</DescriptorName><QualifierName UI=\"Q000276\" MajorTopicYN=\"N\">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D001402\" MajorTopicYN=\"N\">B-Lymphocytes</DescriptorName><QualifierName UI=\"Q000276\" MajorTopicYN=\"N\">immunology</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D059647\" MajorTopicYN=\"N\">Gene-Environment Interaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D003713\" MajorTopicYN=\"N\">Dendritic Cells</DescriptorName><QualifierName UI=\"Q000276\" MajorTopicYN=\"N\">immunology</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D014429\" MajorTopicYN=\"N\">Twins, Dizygotic</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>18</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>18</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>14</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">40668915</ArticleId><ArticleId IdType=\"doi\">10.1126/sciadv.ads8033</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">40668537</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">2210-7711</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2025</Year><Month>Jul</Month><Day>16</Day></PubDate></JournalIssue><Title>International journal of clinical pharmacy</Title><ISOAbbreviation>Int J Clin Pharm</ISOAbbreviation></Journal><ArticleTitle>Patients' perspectives on medication adherence feedback interventions for managing long-term medications: a systematic review of qualitative evidence.</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1007/s11096-025-01958-4</ELocationID><Abstract><AbstractText Label=\"INTRODUCTION\" NlmCategory=\"BACKGROUND\">Optimising medication usage is a worldwide challenge. While numerous feedback interventions have been developed to address this issue, understanding patients' perspectives on the use of such interventions to optimise adherence provides opportunities for successful development and implementation.</AbstractText><AbstractText Label=\"AIM\" NlmCategory=\"OBJECTIVE\">To synthesise qualitative evidence on patients' views on medication adherence feedback interventions to support adherence behaviour.</AbstractText><AbstractText Label=\"METHOD\" NlmCategory=\"METHODS\">CINAHL, EMBASE, MEDLINE, PsycINFO, and PubMed were systematically searched from database inception to February 2023 with searches updated to February 2025. Additionally, Google Scholar was used to identify any potentially relevant grey literature or supplementary sources. Eligible studies included qualitative or mixed-methods research that explored adult patients' perspectives on medication adherence feedback interventions for long-term conditions, specifically those aimed at self-management within community settings. The review was conducted according to ENTREQ and reported following PRISMA guidelines. Study quality was appraised using the Mixed Methods Appraisal Tool (MMAT). Data were extracted and analysed using thematic synthesis, with findings presented narratively.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">Of the 1270 studies screened, 11 met the inclusion criteria and evaluated participants' views on therapeutic drug monitoring and digital adherence interventions across conditions including asthma, human immunodeficiency virus (HIV), coronary heart disease, hypertension, type 2 diabetes, and opioid use disorder. Three themes were identified; balancing support and autonomy in feedback interventions, maintaining patient-provider relationship and enhancing engagement through tailored design. Interventions were considered acceptable when they were easy to use, offered users control over personal data, incorporated audio-visual cues, and provided emotional or motivational support. Trust and shared decision-making between patients and providers facilitated uptake, while tailored interventions were considered essential for supporting engagement.</AbstractText><AbstractText Label=\"CONCLUSION\" NlmCategory=\"CONCLUSIONS\">Medication adherence feedback interventions are acceptable, however further improvements will enhance user engagement and optimise adherence. Future research should prioritise co-designed interventions that address user needs, improve patient-provider communication, deliver accurate adherence feedback, and support cost-effective scalability.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Kobson</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Edinburgh Napier University, Edinburgh, United Kingdom of Great Britain and Northern Ireland. b.kobson@napier.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hanley</LastName><ForeName>Janet</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Edinburgh Napier University, Edinburgh, United Kingdom of Great Britain and Northern Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Mair</LastName><ForeName>Alpana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Edinburgh Napier University, Edinburgh, United Kingdom of Great Britain and Northern Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Dima</LastName><ForeName>Alexandra L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Avedis Donabedian Research Institute (FAD) - Universitat Aut&#xf2;noma de Barcelona (UAB), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Avaluaci&#xf3; de tecnologies sanit&#xe0;ries en atenci&#xf3; prim&#xe0;ria i salut mental (PRISMA), Institut de Recerca Sant Joan de D&#xe9;u (IRSJD) - Consortium \"Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red\" Epidemiology and Public Health (CIBERESP), Esplugues de Llobregat, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Rea</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Edinburgh Napier University, Edinburgh, United Kingdom of Great Britain and Northern Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Paterson</LastName><ForeName>Ruth E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Edinburgh Napier University, Edinburgh, United Kingdom of Great Britain and Northern Ireland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2025</Year><Month>07</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int J Clin Pharm</MedlineTA><NlmUniqueID>101554912</NlmUniqueID></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Feedback interventions</Keyword><Keyword MajorTopicYN=\"N\">Long-term medication</Keyword><Keyword MajorTopicYN=\"N\">Medication adherence</Keyword><Keyword MajorTopicYN=\"N\">Patient perspectives</Keyword></KeywordList><CoiStatement>Declarations. Competing interests: The authors declare no competing interests. Ethics approval: Not required.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2025</Year><Month>4</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2025</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>12</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>12</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>11</Hour><Minute>19</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">40668537</ArticleId><ArticleId IdType=\"doi\">10.1007/s11096-025-01958-4</ArticleId><ArticleId IdType=\"pii\">10.1007/s11096-025-01958-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pi&#xf1;a IL, Di Palo KE, Brown MT, et al. Medication adherence: importance, issues and policy: a policy statement from the American heart association. Prog Cardiovasc Dis. 2021;64:111&#x2013;20. https://doi.org/10.1016/j.pcad.2020.08.003 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.pcad.2020.08.003</ArticleId><ArticleId IdType=\"pubmed\">32800791</ArticleId></ArticleIdList></Reference><Reference><Citation>Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691&#x2013;705. https://doi.org/10.1111/j.1365-2125.2012.04167.x .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1365-2125.2012.04167.x</ArticleId><ArticleId IdType=\"pubmed\">22486599</ArticleId><ArticleId IdType=\"pmc\">3403197</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkhart PV, Sabate E. Adherence to long-term therapies: evidence for action. J Nurs Scholarsh. 2003;35(3):207. https://doi.org/10.1111/j.1547-5069.2003.tb00001.x .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1547-5069.2003.tb00001.x</ArticleId><ArticleId IdType=\"pubmed\">14562485</ArticleId></ArticleIdList></Reference><Reference><Citation>Haynes RB, Ackloo E, Sahota N, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;16(2):CD000011. https://doi.org/10.1002/14651858.CD000011.pub3 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/14651858.CD000011.pub3</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmood S, Jalal Z, Hadi MA, et al. Prevalence of non-adherence to antihypertensive medication in Asia: a systematic review and meta-analysis. Int J Clin Pharm. 2021;43(3):486&#x2013;501. https://doi.org/10.1007/s11096-021-01236-z .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11096-021-01236-z</ArticleId><ArticleId IdType=\"pubmed\">33515135</ArticleId></ArticleIdList></Reference><Reference><Citation>Egede LE, Gebregziabher M, Echols C, et al. Longitudinal effects of medication nonadherence on glycemic control. Ann Pharmacother. 2014;48(5):562&#x2013;70. https://doi.org/10.1177/1060028014526362 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/1060028014526362</ArticleId><ArticleId IdType=\"pubmed\">24586059</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho PPM, Magid DJ, Shetterly SM, et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J. 2008;155(4):772&#x2013;9. https://doi.org/10.1016/j.ahj.2007.12.011 .</Citation></Reference><Reference><Citation>Mehran RP, Baber UMD, Steg PGP, et al. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. Lancet (Br Ed). 2013;382(9906):1714&#x2013;22. https://doi.org/10.1016/S0140-6736(13)61720-1 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0140-6736(13)61720-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Du L, Cheng Z, Zhang Y, et al. The impact of medication adherence on clinical outcomes of coronary artery disease: a meta-analysis. Eur J Prev Cardiol. 2017;24(9):962&#x2013;70. https://doi.org/10.1177/2047487317695628 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/2047487317695628</ArticleId><ArticleId IdType=\"pubmed\">28436725</ArticleId></ArticleIdList></Reference><Reference><Citation>Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27(5):1218&#x2013;24. https://doi.org/10.2337/diacare.27.5.1218 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2337/diacare.27.5.1218</ArticleId><ArticleId IdType=\"pubmed\">15111553</ArticleId></ArticleIdList></Reference><Reference><Citation>Boehme P, Wienand P, Herrmann M, et al. New digital adherence devices could prevent millions of strokes from atrial fibrillation by the end of the next century. Med Hypotheses. 2017;108:46&#x2013;50. https://doi.org/10.1016/j.mehy.2017.07.034 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.mehy.2017.07.034</ArticleId><ArticleId IdType=\"pubmed\">29055399</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson LJ, Nuckols TK, Coles C, et al. A systematic overview of systematic reviews evaluating medication adherence interventions. Am J Health Syst Pharm. 2020;77(2):138&#x2013;47. https://doi.org/10.1093/ajhp/zxz284 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/ajhp/zxz284</ArticleId><ArticleId IdType=\"pubmed\">31901098</ArticleId><ArticleId IdType=\"pmc\">6946938</ArticleId></ArticleIdList></Reference><Reference><Citation>Redfern J, Coorey G, Mulley J, et al. A digital health intervention for cardiovascular disease management in primary care (CONNECT) randomized controlled trial. NPJ Digit Med. 2020;3(1):117. https://doi.org/10.1038/s41746-020-00325-z .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41746-020-00325-z</ArticleId><ArticleId IdType=\"pubmed\">32964140</ArticleId><ArticleId IdType=\"pmc\">7484809</ArticleId></ArticleIdList></Reference><Reference><Citation>Pouls BPH, Vriezekolk JE, Bekker CL, et al. Effect of interactive ehealth interventions on improving medication adherence in adults with long-term medication: systematic review. J Med Internet Res. 2021;23(1):e18901. https://doi.org/10.2196/18901 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2196/18901</ArticleId><ArticleId IdType=\"pubmed\">33416501</ArticleId><ArticleId IdType=\"pmc\">7822716</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieuwlaat R, Wilczynski N, Navarro T, et al. Interventions for enhancing medication adherence (review). Cochrane Database Syst Rev. 2014;2014(11):CD000011. https://doi.org/10.1002/14651858.CD000011.pub4 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/14651858.CD000011.pub4</ArticleId><ArticleId IdType=\"pubmed\">25412402</ArticleId><ArticleId IdType=\"pmc\">7263418</ArticleId></ArticleIdList></Reference><Reference><Citation>Farmer AJ, McSharry J, Rowbotham S, et al. Effects of interventions promoting monitoring of medication use and brief messaging on medication adherence for people with Type 2 diabetes: a systematic review of randomized trials. Diabet Med. 2016;33(5):565&#x2013;79. https://doi.org/10.1111/dme.12987 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/dme.12987</ArticleId><ArticleId IdType=\"pubmed\">26470750</ArticleId></ArticleIdList></Reference><Reference><Citation>van Heuckelum M, van den Ende CH, Houterman AE, et al. The effect of electronic monitoring feedback on medication adherence and clinical outcomes: a systematic review. PLoS ONE. 2017;12(10):e0185453. https://doi.org/10.1371/journal.pone.0185453 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0185453</ArticleId><ArticleId IdType=\"pubmed\">28991903</ArticleId><ArticleId IdType=\"pmc\">5633170</ArticleId></ArticleIdList></Reference><Reference><Citation>Seewoodharry MDM, Maconachie GDEP, Gillies CLP, et al. The Effects of feedback on adherence to treatment: a systematic review and meta-analysis of RCTs. Am J Prev Med. 2017;53(2):232&#x2013;40. https://doi.org/10.1016/j.amepre.2017.03.005 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.amepre.2017.03.005</ArticleId><ArticleId IdType=\"pubmed\">28456347</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandura A. Health promotion by social cognitive means. Health Educ Behav. 2004;31(2):143&#x2013;64. https://doi.org/10.1177/1090198104263660 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/1090198104263660</ArticleId><ArticleId IdType=\"pubmed\">15090118</ArticleId></ArticleIdList></Reference><Reference><Citation>Granja C, Janssen W, Johansen MA. Factors determining the success and failure of eHealth interventions: systematic review of the literature. J Med Internet Res. 2018;20(5):e10235. https://doi.org/10.2196/10235 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2196/10235</ArticleId><ArticleId IdType=\"pubmed\">29716883</ArticleId><ArticleId IdType=\"pmc\">5954232</ArticleId></ArticleIdList></Reference><Reference><Citation>Arshed M, Mahmud AB, Minhat HS, et al. Effectiveness of mHealth interventions in medication adherence among patients with cardiovascular diseases: a systematic review. Diseases. 2023;11(1):41. https://doi.org/10.3390/diseases11010041 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/diseases11010041</ArticleId><ArticleId IdType=\"pubmed\">36975590</ArticleId><ArticleId IdType=\"pmc\">10047328</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosworth HB, Granger BB, Mendys P, et al. Medication adherence: a call for action. Am Heart J. 2011;162(3):412&#x2013;24. https://doi.org/10.1016/j.ahj.2011.06.007 .</Citation></Reference><Reference><Citation>Chang L, Wanner KJ, Kovalsky D, et al. &#x201c;It&#x2019;s really overwhelming&#x201d;: patient perspectives on care coordination. J Am Board Family Med. 2018;31(5):682. https://doi.org/10.3122/jabfm.2018.05.180034 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3122/jabfm.2018.05.180034</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruppar T. Pilot study of a feedback intervention to improve medication adherence in older adults with hypertension. Eur J Cardiovasc Nurs. 2010;9:S26. https://doi.org/10.1016/S1474-5151(2810)2960095-3 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S1474-5151(2810)2960095-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Hebing R, Bos W, Nurmohamed M, et al. Effectiveness of electronic drug monitoring feedback in order to increase adherence in RA patients starting with a biological DMARD. Arthritis Rheumatol. 2020;72(SUPPL 10):1563&#x2013;5. https://doi.org/10.1002/art.41538 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/art.41538</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy A, Huseman TL, Canamucio A, et al. Patient and partner feedback reports to improve statin medication adherence: a randomized control trial. J Gen Intern Med. 2017;32(3):256&#x2013;61. https://doi.org/10.1007/s11606-016-3858-0 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11606-016-3858-0</ArticleId><ArticleId IdType=\"pubmed\">27612487</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabin LL, DeSilva MB, Hamer DH, et al. Using electronic drug monitor feedback to improve adherence to antiretroviral therapy among HIV-positive patients in China. AIDS Behav. 2010;14(3):580&#x2013;9. https://doi.org/10.1007/s10461-009-9615-1 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10461-009-9615-1</ArticleId><ArticleId IdType=\"pubmed\">19771504</ArticleId></ArticleIdList></Reference><Reference><Citation>Coulter A, Oldham J. Person-centred care: what is it and how do we get there? Future Hosp J. 2016;3(2):114&#x2013;6. https://doi.org/10.7861/futurehosp.3-2-114 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.7861/futurehosp.3-2-114</ArticleId><ArticleId IdType=\"pubmed\">31098200</ArticleId><ArticleId IdType=\"pmc\">6465833</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas J, Harden A. Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med Res Methodol. 2008;8(1):45. https://doi.org/10.1186/1471-2288-8-45 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1471-2288-8-45</ArticleId><ArticleId IdType=\"pubmed\">18616818</ArticleId><ArticleId IdType=\"pmc\">2478656</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Online). 2021;372:n71. https://doi.org/10.1136/bmj.n71 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/bmj.n71</ArticleId><ArticleId IdType=\"pubmed\">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong A, Flemming K, McInnes E, et al. Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ. BMC Med Res Methodol. 2012;12(1):181. https://doi.org/10.1186/1471-2288-12-181 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1471-2288-12-181</ArticleId><ArticleId IdType=\"pubmed\">23185978</ArticleId><ArticleId IdType=\"pmc\">3552766</ArticleId></ArticleIdList></Reference><Reference><Citation>British Library. EThOS: Electronic Theses Online Service. 2023. https://www.bl.uk/ . Accessed 13 Feb 2023.</Citation></Reference><Reference><Citation>Hong QN, F&#xe0;bregues S, Bartlett G, et al. The mixed methods appraisal tool (MMAT) version 2018 for information professionals and researchers. Educ Inf. 2018;34:285&#x2013;91. https://doi.org/10.3233/efi-180221 .</Citation></Reference><Reference><Citation>Nelson LA, Mulvaney SA, Johnson KB, et al. mHealth intervention elements and user characteristics determine utility: a mixed-methods analysis. Diabetes Technol Ther. 2017;19(1):9&#x2013;17. https://doi.org/10.1089/dia.2016.0294 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1089/dia.2016.0294</ArticleId><ArticleId IdType=\"pubmed\">28099052</ArticleId><ArticleId IdType=\"pmc\">5248539</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuipers E, Poot CC, Wensing M, et al. Self-management maintenance inhalation therapy with eHealth (SELFIE): observational study on the use of an electronic monitoring device in respiratory patient care and research. J Med Internet Res. 2019;21(5):e13551. https://doi.org/10.2196/13551 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2196/13551</ArticleId><ArticleId IdType=\"pubmed\">31148542</ArticleId><ArticleId IdType=\"pmc\">6658221</ArticleId></ArticleIdList></Reference><Reference><Citation>Pack AP, Golin CE, Hill LM, et al. Patient and clinician perspectives on optimizing graphical displays of longitudinal medication adherence data. Patient Educ Couns. 2019;102(6):1090&#x2013;7. https://doi.org/10.1016/j.pec.2018.12.029 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.pec.2018.12.029</ArticleId><ArticleId IdType=\"pubmed\">30626550</ArticleId><ArticleId IdType=\"pmc\">6525638</ArticleId></ArticleIdList></Reference><Reference><Citation>Schesing KB, Chia R, Elwood B et al. Assessment of patient and provider attitudes towards therapeutic drug monitoring to improve medication adherence in low-income patients with hypertension: a qualitative study. BMJ open. 2020;10(11):e039940-e. https://doi.org/10.1136/bmjopen-2020-039940 .</Citation></Reference><Reference><Citation>Faisal S, Ivo J, McDougall A, et al. Stakeholder feedback of electronic medication adherence products: qualitative analysis. J Med Internet Res. 2020;22(12):e18074. https://doi.org/10.2196/18074 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2196/18074</ArticleId><ArticleId IdType=\"pubmed\">33258778</ArticleId><ArticleId IdType=\"pmc\">7738262</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill LM, Golin CE, Pack A, et al. Using real-time adherence feedback to enhance communication about adherence to antiretroviral therapy: patient and clinician perspectives. J Assoc Nurses AIDS Care: JANAC. 2020;31(1):25&#x2013;34. https://doi.org/10.1097/JNC.0000000000000089 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/JNC.0000000000000089</ArticleId><ArticleId IdType=\"pubmed\">31033629</ArticleId></ArticleIdList></Reference><Reference><Citation>Park LG, Ng F, Shim K, et al. Perceptions and experiences of using mobile technology for medication adherence among older adults with coronary heart disease: a qualitative study. Digit Health. 2020;6:2055207620926844. https://doi.org/10.1177/2055207620926844 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1177/2055207620926844</ArticleId><ArticleId IdType=\"pubmed\">32489672</ArticleId><ArticleId IdType=\"pmc\">7241207</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngowi K, Pima F, Mmbaga BT, et al. &#x201c;I wish to continue receiving the reminder short messaging service&#x201d;: a mixed methods study on the acceptability of digital adherence tools among adults living with hiv on antiretroviral treatment in Tanzania. Patient Prefer Adherence. 2021;15:559&#x2013;68. https://doi.org/10.2147/PPA.S290079 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2147/PPA.S290079</ArticleId><ArticleId IdType=\"pubmed\">33727801</ArticleId><ArticleId IdType=\"pmc\">7955743</ArticleId></ArticleIdList></Reference><Reference><Citation>Adejumo I, Patel M, McKeever TM, et al. Qualitative study of user perspectives and experiences of digital inhaler technology. NPJ Primary Care Respir Med. 2022;32(1):57. https://doi.org/10.1038/s41533-022-00320-9 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41533-022-00320-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Emmenis M, Jamison J, Kassavou A, et al. Patient and practitioner views on a combined face-to-face and digital intervention to support medication adherence in hypertension: a qualitative study within primary care. BMJ Open. 2022;12(2):e053183. https://doi.org/10.1136/bmjopen-2021-053183 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/bmjopen-2021-053183</ArticleId><ArticleId IdType=\"pubmed\">35228280</ArticleId><ArticleId IdType=\"pmc\">8886486</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith CL, Keever A, Bowden T, et al. Patient feedback on a mobile medication adherence app for buprenorphine and naloxone: closed and open-ended survey on feasibility and acceptability. JMIR Form Res. 2023;7: e40437. https://doi.org/10.2196/40437 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2196/40437</ArticleId><ArticleId IdType=\"pubmed\">37074780</ArticleId><ArticleId IdType=\"pmc\">10157459</ArticleId></ArticleIdList></Reference><Reference><Citation>Galvin HK, DeMuro PR. Developments in privacy and data ownership in mobile health technologies, 2016&#x2013;2019. Yearb Med Inform. 2020;29(1):032&#x2013;43. https://doi.org/10.1055/s-0040-1701987 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1055/s-0040-1701987</ArticleId></ArticleIdList></Reference><Reference><Citation>Caine K, Hanania R. Patients want granular privacy control over health information in electronic medical records. J Am Med Inform Assoc: JAMIA. 2013;20(1):7&#x2013;15. https://doi.org/10.1136/amiajnl-2012-001023 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/amiajnl-2012-001023</ArticleId><ArticleId IdType=\"pubmed\">23184192</ArticleId></ArticleIdList></Reference><Reference><Citation>Wetzels M, Broers E, Peters P, et al. Patient perspectives on health data privacy and management: &#x201c;where is my data and whose is it?&#x201d; Int J Telemed Appl. 2018;2018:3838747&#x2013;56. https://doi.org/10.1155/2018/3838747 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2018/3838747</ArticleId><ArticleId IdType=\"pubmed\">30631347</ArticleId><ArticleId IdType=\"pmc\">6304538</ArticleId></ArticleIdList></Reference><Reference><Citation>Solem IKL, Varsi C, Eide H, et al. A user-centered approach to an evidence-based electronic health pain management intervention for people with chronic pain: design and development of EPIO. J Med Internet Res. 2020;22(1):e15889. https://doi.org/10.2196/15889 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2196/15889</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SK, Park SY, Hwang HR, et al. Effectiveness of mobile health intervention in medication adherence: a systematic review and meta-analysis. J Med Syst. 2025;49(1):13. https://doi.org/10.1007/s10916-024-02135-2 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10916-024-02135-2</ArticleId><ArticleId IdType=\"pubmed\">39821698</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkins L, Francis J, Islam R, et al. A guide to using the theoretical domains framework of behaviour change to investigate implementation problems. Implement Sci: IS. 2017;12(1):77. https://doi.org/10.1186/s13012-017-0605-9 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s13012-017-0605-9</ArticleId><ArticleId IdType=\"pubmed\">28637486</ArticleId><ArticleId IdType=\"pmc\">5480145</ArticleId></ArticleIdList></Reference><Reference><Citation>Li E, Lounsbury O, Clarke J, et al. Patient and caregiver perceptions of electronic health records interoperability in the NHS and its impact on care quality: a focus group study. BMC Med Inform Decis Mak. 2024;24(1):370&#x2013;412. https://doi.org/10.1186/s12911-024-02789-5 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12911-024-02789-5</ArticleId><ArticleId IdType=\"pubmed\">39627780</ArticleId><ArticleId IdType=\"pmc\">11616290</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharkiya SH. Quality communication can improve patient-centred health outcomes among older patients: a rapid review. BMC Health Serv Res. 2023;23(1):1&#x2013;886. https://doi.org/10.1186/s12913-023-09869-8 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12913-023-09869-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Galmarini E, Marciano L, Schulz PJ. The effectiveness of visual-based interventions on health literacy in health care: a systematic review and meta-analysis. BMC Health Serv Res. 2024;24(1):718. https://doi.org/10.1186/s12913-024-11138-1 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12913-024-11138-1</ArticleId><ArticleId IdType=\"pubmed\">38862966</ArticleId><ArticleId IdType=\"pmc\">11165863</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Y, Zheng P, Deng H, et al. Design features for improving mobile health intervention user engagement: systematic review and thematic analysis. J Med Internet Res. 2020;22(12):e21687. https://doi.org/10.2196/21687 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2196/21687</ArticleId><ArticleId IdType=\"pubmed\">33295292</ArticleId><ArticleId IdType=\"pmc\">7758171</ArticleId></ArticleIdList></Reference><Reference><Citation>Skivington K, Matthews L, Simpson SA, et al. A new framework for developing and evaluating complex interventions: update of medical research council guidance. BMJ (Online). 2021;374:n2061. https://doi.org/10.1136/bmj.n2061 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/bmj.n2061</ArticleId><ArticleId IdType=\"pubmed\">34593508</ArticleId><ArticleId IdType=\"pmc\">8482308</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinnicombe S, Bianchim MS, Noyes J. A review of reviews exploring patient and public involvement in population health research and development of tools containing best practice guidance. BMC Public Health. 2023;23(1):1271. https://doi.org/10.1186/s12889-023-15937-9 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12889-023-15937-9</ArticleId><ArticleId IdType=\"pubmed\">37391764</ArticleId><ArticleId IdType=\"pmc\">10311710</ArticleId></ArticleIdList></Reference><Reference><Citation>Ocloo J, Garfield S, Franklin BD, et al. Exploring the theory, barriers and enablers for patient and public involvement across health, social care and patient safety: a systematic review of reviews. Health Res Policy Syst. 2021;19(1):8. https://doi.org/10.1186/s12961-020-00644-3 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12961-020-00644-3</ArticleId><ArticleId IdType=\"pubmed\">33472647</ArticleId><ArticleId IdType=\"pmc\">7816359</ArticleId></ArticleIdList></Reference><Reference><Citation>Brett J, Staniszewska S, Simera I, et al. Reaching consensus on reporting patient and public involvement (PPI) in research: methods and lessons learned from the development of reporting guidelines. BMJ Open. 2017;7(10):e016948. https://doi.org/10.1136/bmjopen-2017-016948 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/bmjopen-2017-016948</ArticleId><ArticleId IdType=\"pubmed\">29061613</ArticleId><ArticleId IdType=\"pmc\">5665282</ArticleId></ArticleIdList></Reference><Reference><Citation>Fylan B, Tomlinson J, Raynor DK, et al. Using experience-based co-design with patients, carers and healthcare professionals to develop theory-based interventions for safer medicines use. Res Social Adm Pharm. 2021;17(12):2127&#x2013;35. https://doi.org/10.1016/j.sapharm.2021.06.004 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.sapharm.2021.06.004</ArticleId><ArticleId IdType=\"pubmed\">34187746</ArticleId></ArticleIdList></Reference><Reference><Citation>Mair JL, Salamanca-Sanabria A, Augsburger M, et al. Effective behavior change techniques in digital health interventions for the prevention or management of noncommunicable diseases: an umbrella review. Ann Behav Med. 2023;57(10):817&#x2013;35. https://doi.org/10.1093/abm/kaad041 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/abm/kaad041</ArticleId><ArticleId IdType=\"pubmed\">37625030</ArticleId><ArticleId IdType=\"pmc\">10498822</ArticleId></ArticleIdList></Reference><Reference><Citation>Patton DE, Hughes CM, Cadogan CA, et al. Theory-based interventions to improve medication adherence in older adults prescribed polypharmacy: a systematic review. Drugs Aging. 2016;34(2):97&#x2013;113. https://doi.org/10.1007/s40266-016-0426-6 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s40266-016-0426-6</ArticleId><ArticleId IdType=\"pmc\">5290062</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">40668244</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1438-8359</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2025</Year><Month>Jul</Month><Day>16</Day></PubDate></JournalIssue><Title>Journal of anesthesia</Title><ISOAbbreviation>J Anesth</ISOAbbreviation></Journal><ArticleTitle>Postoperative pulmonary complications of desflurane- versus sevoflurane-based general anesthesia in patients with chronic obstructive pulmonary disease or asthma undergoing gastrointestinal cancer surgery: a nationwide retrospective cohort study.</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1007/s00540-025-03548-0</ELocationID><Abstract><AbstractText Label=\"PURPOSE\" NlmCategory=\"OBJECTIVE\">Desflurane and sevoflurane are widely used for general anesthesia; however, it remains uncertain if sevoflurane might be preferable for patients with chronic respiratory inflammatory diseases. This study compared postoperative outcomes of desflurane and sevoflurane following gastrointestinal cancer surgery in patients with chronic obstructive pulmonary disease (COPD) or asthma.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"METHODS\">We conducted a retrospective cohort study using the Japanese Diagnosis Procedure Combination database (April 2011-March 2022), identifying patients with COPD or asthma who underwent gastrointestinal cancer surgery. The primary outcome was postoperative pulmonary complications, including pneumonia, respiratory failure, mechanical ventilation&#x2009;&gt;&#x2009;24&#xa0;h, and unplanned reintubation within 7&#xa0;days after surgery. Secondary outcomes were in-hospital mortality and postoperative stay. We conducted propensity score overlap weighting and instrumental variable analyses adjusted for confounders.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">We identified 24,243 COPD and 16,199 asthma patients. Propensity score overlap weighting showed no significant association between desflurane and increased postoperative pulmonary complications in COPD [adjusted risk difference (aRD) -&#x2009;0.57%; 99% confidence interval (CI), -&#x2009;1.8% to 0.60%] or asthma (aRD, -&#x2009;0.62%; 99% CI, -&#x2009;1.8% to 0.59%). In-hospital mortality did not differ significantly between groups in COPD (aRD, -&#x2009;0.24%; 99% CI, -&#x2009;0.76% to 0.29%) or asthma (aRD, 0.07%; 99% CI, -&#x2009;0.45% to 0.59%). The postoperative stay also showed no significant association between the desflurane and sevoflurane groups.</AbstractText><AbstractText Label=\"CONCLUSIONS\" NlmCategory=\"CONCLUSIONS\">Desflurane-based anesthesia was not associated with increased postoperative pulmonary complications and mortality compared to sevoflurane in patients with chronic respiratory diseases undergoing gastrointestinal cancer surgery. However, further studies using reliable diagnostic criteria to assess COPD or asthma are warranted.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Makito</LastName><ForeName>Kanako</ForeName><Initials>K</Initials><Identifier Source=\"ORCID\">0000-0003-4165-7917</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics, School of Public Health, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. canakana87@m.u-tokyo.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Matsuo</LastName><ForeName>Yuichiro</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Matsui</LastName><ForeName>Hiroki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Fushimi</LastName><ForeName>Kiyohide</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Health Policy and Informatics, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, S1560/S1568 M&amp;D Tower 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Yasunaga</LastName><ForeName>Hideo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>24AA2003</GrantID><Agency>Ministry of Health, Labour and Welfare</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2025</Year><Month>07</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>J Anesth</MedlineTA><NlmUniqueID>8905667</NlmUniqueID><ISSNLinking>0913-8668</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Asthma</Keyword><Keyword MajorTopicYN=\"N\">Chronic obstructive pulmonary disease</Keyword><Keyword MajorTopicYN=\"N\">Postoperative pulmonary complications</Keyword><Keyword MajorTopicYN=\"N\">Volatile anesthetics</Keyword></KeywordList><CoiStatement>Declarations. Conflict of interest: The authors have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2025</Year><Month>5</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2025</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>12</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>12</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>11</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">40668244</ArticleId><ArticleId IdType=\"doi\">10.1007/s00540-025-03548-0</ArticleId><ArticleId IdType=\"pii\">10.1007/s00540-025-03548-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nyktari V, Papaioannou A, Volakakis N, Lappa A, Margaritsanaki P, Askitopoulou H. Respiratory resistance during anaesthesia with isoflurane, sevoflurane, and desflurane: a randomized clinical trial. Br J Anaesth. 2011;107(3):454&#x2013;61.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21665899</ArticleId></ArticleIdList></Reference><Reference><Citation>Dikmen Y, Eminoglu E, Salihoglu Z, Demiroluk S. Pulmonary mechanics during isoflurane, sevoflurane and desflurane anaesthesia. Anaesthesia. 2003;58(8):745&#x2013;8.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12859465</ArticleId></ArticleIdList></Reference><Reference><Citation>Goff MJ, Arain SR, Ficke DJ, Uhrich TD, Ebert TJ. Absence of bronchodilation during desflurane anesthesia: a comparison to sevoflurane and thiopental. Anesthesiology. 2000;93(2):404&#x2013;8.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10910489</ArticleId></ArticleIdList></Reference><Reference><Citation>McKay RE, Malhotra A, Cakmakkaya OS, Hall KT, McKay WR, Apfel CC. Effect of increased body mass index and anaesthetic duration on recovery of protective airway reflexes after sevoflurane vs desflurane. Br J Anaesth. 2010;104(2):175&#x2013;82.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20037150</ArticleId></ArticleIdList></Reference><Reference><Citation>Dexter F, Bayman EO, Epstein RH. Statistical modeling of average and variability of time to extubation for meta-analysis comparing desflurane to sevoflurane. Anesth Analg. 2010;110(2):570&#x2013;80.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19820242</ArticleId></ArticleIdList></Reference><Reference><Citation>Schilling T, Kozian A, Senturk M, Huth C, Reinhold A, Hedenstierna G, Hachenberg T.&#xa0;Effects of volatile and intravenous anesthesia on the alveolar and systemic inflammatory response in thoracic surgical patients. Anesthesiology. 2011;115(1):65&#x2013;74.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21399490</ArticleId></ArticleIdList></Reference><Reference><Citation>De Hert SG, Turani F, Mathur S, Stowe DF. Cardioprotection with volatile anesthetics: mechanisms and clinical implications. Anesth Analg. 2005;100(6):1584&#x2013;93.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15920178</ArticleId></ArticleIdList></Reference><Reference><Citation>De Hert S, Vlasselaers D, Barb&#xe9; R, Ory JP, Dekegel D, Donnadonni R, Demeere JL, Mulier J, Wouters P. A comparison of volatile and non volatile agents for cardioprotection during on-pump coronary surgery. Anaesthesia. 2009;64(9):953&#x2013;60.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19686479</ArticleId></ArticleIdList></Reference><Reference><Citation>Li XF, Hu JR, Wu Y, Chen Y, Zhang MQ, Yu H. Comparative effect of propofol and volatile anesthetics on postoperative pulmonary complications after lung resection surgery: a randomized clinical trial. Anesth Analg. 2021;133(4):949&#x2013;57.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33410611</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen WS, Chiang MH, Hung KC,&#xa0;Lin KL, Wang CH, Poon YY, Luo SD, Wu SC. Adverse respiratory events with sevoflurane compared with desflurane in ambulatory surgery: a systematic review and meta-analysis. Eur J Anaesthesiol. 2020;37(12):1093&#x2013;104.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33109925</ArticleId><ArticleId IdType=\"pmc\">7752224</ArticleId></ArticleIdList></Reference><Reference><Citation>Zucco L, Santer P, Levy N, Hammer M, Grabitz SD, Nabel S, Ramachandran SK. A comparison of postoperative respiratory complications associated with the use of desflurane and sevoflurane: a single-centre cohort study. Anaesthesia. 2021;76(1):36&#x2013;44.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32743803</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasunaga H. Updated information on the diagnosis procedure combination data. Ann Clin Epidemiol. 2024;6(4):106&#x2013;10.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">39726797</ArticleId><ArticleId IdType=\"pmc\">11668689</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J. 1965;14:61&#x2013;5.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">14258950</ArticleId></ArticleIdList></Reference><Reference><Citation>Grabitz SD, Farhan HN, Ruscic KJ, Timm FP, Shin CH, Thevathasan T, Staehr-Rye AK, Kurth T, Eikermann M. Dose-dependent protective effect of inhalational anesthetics against postoperative respiratory complications: a prospective analysis of data on file from three hospitals in New England. Crit Care Med. 2017;45(1):e30&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27635768</ArticleId></ArticleIdList></Reference><Reference><Citation>Grosse-Sundrup M, Henneman JP, Sandberg WS, Bateman BT, Uribe JV, Nguyen NT, Ehrenfeld JM, Martinez EA, Kurth T, Eikermann M.&#xa0;Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study. BMJ. 2012;345:e6329.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23077290</ArticleId><ArticleId IdType=\"pmc\">3473088</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva JM Jr, de Oliveira AM, Nogueira FA, Vianna PM, Pereira Filho MC, Dias LF, Maia VP, Neucamp Cde S, Amendola CP, Carmona MJ, Malbouisson LM. The effect of excess fluid balance on the mortality rate of surgical patients: a multicenter prospective study. Crit Care. 2013;17(6):1&#x2013;7.</Citation></Reference><Reference><Citation>Numata T, Nakayama K, Fujii S, Yumino Y, Saito N, Yoshida M, Kurita Y, Kobayashi K, Ito S, Utsumi H, Yanagisawa H, Hashimoto M, Wakui H, Minagawa S, Ishikawa T, Hara H, Araya J, Kaneko Y, Kuwano K . Risk factors of postoperative pulmonary complications in patients with asthma and COPD. BMC Pulm Med. 2018;18(1):4.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29316890</ArticleId><ArticleId IdType=\"pmc\">5761153</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, Januel JM, Sundararajan V.&#xa0;Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676&#x2013;82.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21330339</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas LE, Li F, Pencina MJ. Overlap weighting: a propensity score method that mimics attributes of a randomized clinical trial. JAMA. 2020;323(23):2417&#x2013;8.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32369102</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin DB, Schenker N. Multiple imputation in health-care databases: an overview and some applications. Stat Med. 1991;10(4):585&#x2013;98.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">2057657</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen TQ, Stuart EA. Multiple imputation for propensity score analysis with covariates missing at random: some clarity on within and across methods. Am J Epidemiol. 2024;193(10):1470&#x2013;6.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">38863120</ArticleId><ArticleId IdType=\"pmc\">11458199</ArticleId></ArticleIdList></Reference><Reference><Citation>Baiocchi M, Cheng J, Small DS. Instrumental variable methods for causal inference. Stat Med. 2014;33(13):2297&#x2013;2340. Published corrections: Stat Med. 2014;33(27):4859&#x2013;4860; Stat Med. 2019;38(20):3960; Stat Med. 2020;39(20):2693.</Citation></Reference><Reference><Citation>Hern&#xe1;n MA, Robins JM. Instruments for causal inference: an epidemiologist's dream? Epidemiology. 2006;17(4):360&#x2013;372. Published correction: Epidemiology. 2014;25(1):164.</Citation></Reference><Reference><Citation>Terza JV, Basu A, Rathouz PJ. Two-stage residual inclusion estimation: addressing endogeneity in health econometric modeling. J Health Econ. 2008;27(3):531&#x2013;43.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18192044</ArticleId></ArticleIdList></Reference><Reference><Citation>Staiger D, Stock JH. Instrumental variables regression with weak instruments. Econometrica. 1997;65:557&#x2013;86.</Citation></Reference><Reference><Citation>Fisher BW, Majumdar SR, McAlister FA. Predicting pulmonary complications after non-thoracic surgery: a systematic review of blinded studies. Am J Med. 2002;112(3):219&#x2013;25.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11893349</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekine Y, Yamada Y, Chiyo M, Iwata T, Nakajima T, Yasufuku K, Suzuki M, Fujisawa T.&#xa0;Association of chronic obstructive pulmonary disease and tumor recurrence in patients with stage IA lung cancer after complete resection. Ann Thorac Surg. 2007;84(3):946&#x2013;50.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17720404</ArticleId></ArticleIdList></Reference><Reference><Citation>Canet J, Gallart L, Gomar C, Paluzie G, Vall&#xe8;s J, Castillo J, Sabat&#xe9; S, Mazo V, Briones Z, Sanchis J. Prediction of postoperative pulmonary complications in a population-based surgical cohort. Anesthesiology. 2010;113(6):1338&#x2013;50.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21045639</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Yamakage M, Namiki A. Inhibitory effects of volatile anesthetics on K+ and Cl- channel currents in porcine tracheal and bronchial smooth muscle. Anesthesiology. 2002;96(2):458&#x2013;66.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11818782</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamakage M, Iwasaki S, Namiki A. Guideline-oriented perioperative management of patients with bronchial asthma and chronic obstructive pulmonary disease. J Anesth. 2008;22(4):412&#x2013;28.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19011781</ArticleId></ArticleIdList></Reference><Reference><Citation>Volta CA, Alvisi V, Petrini S, Zardi S, Marangoni E, Ragazzi R, Capuzzo M, Alvisi R. The effect of volatile anesthetics on respiratory system resistance in patients with chronic obstructive pulmonary disease. Anesth Analg. 2005;100(2):348&#x2013;53.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15673854</ArticleId></ArticleIdList></Reference><Reference><Citation>Klock PA Jr, Czeslick EG, Klafta JM, Ovassapian A, Moss J. The effect of sevoflurane and desflurane on upper airway reactivity. Anesthesiology. 2001;94(6):963&#x2013;7. https://doi.org/10.1097/00000542-200106000-00008 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/00000542-200106000-00008</ArticleId><ArticleId IdType=\"pubmed\">11465621</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskovic A, Lumb AB. Postoperative pulmonary complications. Br J Anaesth. 2017;118(3):317&#x2013;34.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28186222</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith PR, Baig MA, Brito V, Bader F, Bergman MI, Alfonso A. Postoperative pulmonary complications after laparotomy. Respiration. 2010;80(4):269&#x2013;74.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19864881</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawrence VA, Hilsenbeck SG, Mulrow CD, Dhanda R, Sapp J, Page CP. Incidence and hospital stay for cardiac and pulmonary complications after abdominal surgery. J Gen Intern Med. 1995;10(12):671&#x2013;8.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8770719</ArticleId></ArticleIdList></Reference><Reference><Citation>Khuri SF, Henderson WG, DePalma RG, Mosca C, Healey NA, Kumbhani DJ. Determinants of long-term survival after major surgery and the adverse effect of postoperative complications. Ann Surg. 2005;242(3):326&#x2013;43.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16135919</ArticleId><ArticleId IdType=\"pmc\">1357741</ArticleId></ArticleIdList></Reference><Reference><Citation>White SM, Shelton CL, Gelb AW, Lawson C, McGain F, Muret J, Sherman JD. Principles of environmentally-sustainable anaesthesia: a global consensus statement from the World Federation of Societies of Anaesthesiologists. Anaesthesia. 2022;77:201&#x2013;12.</Citation></Reference><Reference><Citation>MacNeill AJ, Lillywhite R, Brown CJ. The impact of surgery on global climate: a carbon footprinting study of operating theatres in three health systems. Lancet Planet Health. 2017;1:e381&#x2013;8.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29851650</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulbaek Andersen MP, Nielsen OJ, Sherman JD. Assessing the potential climate impact of anaesthetic gases. Lancet Planet Health. 2023;7:e622&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37438003</ArticleId></ArticleIdList></Reference><Reference><Citation>McGain F, Muret J, Lawson C, Sherman JD. Environmental sustainability in anaesthesia and critical care. Br J Anaesth. 2020;125:680&#x2013;92.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32798068</ArticleId></ArticleIdList></Reference><Reference><Citation>Martens EP, Pestman WR, de Boer A, Belitser SV, Klungel OH. Instrumental variables: application and limitations. Epidemiology. 2006;17(3):260&#x2013;7.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16617274</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">40668119</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">2150-1327</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>16</Volume><PubDate><Year>2025</Year><Season>Jan-Dec</Season></PubDate></JournalIssue><Title>Journal of primary care &amp; community health</Title><ISOAbbreviation>J Prim Care Community Health</ISOAbbreviation></Journal><ArticleTitle>Quality of Care of Adult Patients With Allergic Diseases in Urban, Rural, and Remote Primary Care Sites in the Philippines.</ArticleTitle><Pagination><StartPage>21501319251353599</StartPage><MedlinePgn>21501319251353599</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1177/21501319251353599</ELocationID><Abstract><AbstractText Label=\"INTRODUCTION\" NlmCategory=\"BACKGROUND\">This study determined the clinic prevalence and compared the quality of care of allergic diseases in urban, rural, and remote primary care sites.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"METHODS\">This was a retrospective review of electronic health records of all adult patients who consulted in the 3 sites from May 2019 to April 2022. Data of adult patients with allergic diseases was extracted from the 3 EHR systems operating across the participating sites using standardized Structured Query Language queries across the 3 systems. We computed the prevalence of allergic diseases among adults who consulted in primary care health facilities by dividing the number of patients diagnosed to have an allergic disease over the total number of adult patients who consulted within the 3-year study period. We compared the quality of care of patients across the 3 sites based on clinical practice guidelines using Chi-square test, Fisher's exact test, or 1-way analysis of variance, as appropriate.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">The prevalence of allergic disease among adults who consulted in primary care health facilities was 1.3% for the urban site, 2.2% for the rural site, and 2.1% for the remote site. The most common allergic disease was asthma (59.0%). First-line medications based on recommendations in clinical practice guidelines were prescribed more often in the urban site, including inhaled corticosteroids with long-acting beta-agonists for asthma patients (<i>P</i>&#x2009;&lt;&#x2009;.001) and topical corticosteroids for atopic dermatitis (<i>P</i>&#x2009;&lt;&#x2009;.001). In contrast, there was more frequent prescription of medications that were not recommended in clinical practice guidelines in the rural and remote sites.</AbstractText><AbstractText Label=\"CONCLUSION\" NlmCategory=\"CONCLUSIONS\">Health inequity was observed in this study, with results demonstrating that the rural and remote sites had greater allergic disease prevalence, greater underutilization of first-line medications, and more frequent overutilization of non-essential medications.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Tan-Lim</LastName><ForeName>Carol Stephanie C</ForeName><Initials>CSC</Initials><Identifier Source=\"ORCID\">0000-0001-8815-4191</Identifier><AffiliationInfo><Affiliation>Department of Clinical Epidemiology, College of Medicine, University of the Philippines Manila, Philippines.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Program on Health Systems Development - Philippine Primary Care Studies, Center for Integrative and Development Studies, University of the Philippines Diliman, Quezon City, Metro Manila, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Falcon</LastName><ForeName>Robbi Miguel G</ForeName><Initials>RMG</Initials><AffiliationInfo><Affiliation>College of Medicine, University of the Philippines Manila, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Feliciano</LastName><ForeName>Jeremiah F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>College of Medicine, University of the Philippines Manila, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Fong</LastName><ForeName>Michael B</ForeName><Initials>MB</Initials><Identifier Source=\"ORCID\">0009-0006-5744-1554</Identifier><AffiliationInfo><Affiliation>Program on Health Systems Development - Philippine Primary Care Studies, Center for Integrative and Development Studies, University of the Philippines Diliman, Quezon City, Metro Manila, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Javelosa</LastName><ForeName>Mark Anthony U</ForeName><Initials>MAU</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology, College of Medicine, University of the Philippines Manila, Philippines.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Program on Health Systems Development - Philippine Primary Care Studies, Center for Integrative and Development Studies, University of the Philippines Diliman, Quezon City, Metro Manila, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Dans</LastName><ForeName>Leonila F</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>Program on Health Systems Development - Philippine Primary Care Studies, Center for Integrative and Development Studies, University of the Philippines Diliman, Quezon City, Metro Manila, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Isip-Tan</LastName><ForeName>Iris Thiele C</ForeName><Initials>ITC</Initials><AffiliationInfo><Affiliation>Program on Health Systems Development - Philippine Primary Care Studies, Center for Integrative and Development Studies, University of the Philippines Diliman, Quezon City, Metro Manila, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Sanchez</LastName><ForeName>Josephine T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Program on Health Systems Development - Philippine Primary Care Studies, Center for Integrative and Development Studies, University of the Philippines Diliman, Quezon City, Metro Manila, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Rey</LastName><ForeName>Mia P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Program on Health Systems Development - Philippine Primary Care Studies, Center for Integrative and Development Studies, University of the Philippines Diliman, Quezon City, Metro Manila, Philippines.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Accounting and Finance, Cesar E A Virata School of Business, University of the Philippines Diliman, Quezon City, Metro Manila, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Dans</LastName><ForeName>Antonio Miguel L</ForeName><Initials>AML</Initials><AffiliationInfo><Affiliation>Program on Health Systems Development - Philippine Primary Care Studies, Center for Integrative and Development Studies, University of the Philippines Diliman, Quezon City, Metro Manila, Philippines.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine, University of the Philippines Manila, Philippines.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2025</Year><Month>07</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Prim Care Community Health</MedlineTA><NlmUniqueID>101518419</NlmUniqueID><ISSNLinking>2150-1319</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011320\" MajorTopicYN=\"Y\">Primary Health Care</DescriptorName><QualifierName UI=\"Q000706\" MajorTopicYN=\"N\">statistics &amp; numerical data</QualifierName><QualifierName UI=\"Q000592\" MajorTopicYN=\"N\">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000328\" MajorTopicYN=\"N\">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D012189\" MajorTopicYN=\"N\">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006967\" MajorTopicYN=\"Y\">Hypersensitivity</DescriptorName><QualifierName UI=\"Q000453\" MajorTopicYN=\"N\">epidemiology</QualifierName><QualifierName UI=\"Q000628\" MajorTopicYN=\"N\">therapy</QualifierName><QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D005260\" MajorTopicYN=\"N\">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008297\" MajorTopicYN=\"N\">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D010679\" MajorTopicYN=\"N\" Type=\"Geographic\">Philippines</DescriptorName><QualifierName UI=\"Q000453\" MajorTopicYN=\"N\">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D008875\" MajorTopicYN=\"N\">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011787\" MajorTopicYN=\"Y\">Quality of Health Care</DescriptorName><QualifierName UI=\"Q000706\" MajorTopicYN=\"N\">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D015995\" MajorTopicYN=\"N\">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D012424\" MajorTopicYN=\"N\">Rural Population</DescriptorName><QualifierName UI=\"Q000706\" MajorTopicYN=\"N\">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D014505\" MajorTopicYN=\"N\">Urban Population</DescriptorName><QualifierName UI=\"Q000706\" MajorTopicYN=\"N\">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D019035\" MajorTopicYN=\"Y\">Rural Health Services</DescriptorName><QualifierName UI=\"Q000592\" MajorTopicYN=\"N\">standards</QualifierName><QualifierName UI=\"Q000706\" MajorTopicYN=\"N\">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D001249\" MajorTopicYN=\"N\">Asthma</DescriptorName><QualifierName UI=\"Q000453\" MajorTopicYN=\"N\">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D057286\" MajorTopicYN=\"N\">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D055815\" MajorTopicYN=\"N\">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000368\" MajorTopicYN=\"N\">Aged</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">allergy</Keyword><Keyword MajorTopicYN=\"N\">asthma</Keyword><Keyword MajorTopicYN=\"N\">health equity</Keyword><Keyword MajorTopicYN=\"N\">prevalence</Keyword><Keyword MajorTopicYN=\"N\">primary care</Keyword></KeywordList><CoiStatement>Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>12</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>12</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>10</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">40668119</ArticleId><ArticleId IdType=\"doi\">10.1177/21501319251353599</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">40668093</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel=\"Print\"><Journal><ISSN IssnType=\"Electronic\">1537-6613</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>232</Volume><Issue>Supplement_1</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>16</Day></PubDate></JournalIssue><Title>The Journal of infectious diseases</Title><ISOAbbreviation>J Infect Dis</ISOAbbreviation></Journal><ArticleTitle>The Impact of Chronic Medical Conditions on the Risk of Human Metapneumovirus Hospitalizations in New Zealand Adults, 2012-2015.</ArticleTitle><Pagination><StartPage>S59</StartPage><EndPage>S68</EndPage><MedlinePgn>S59-S68</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1093/infdis/jiaf226</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\" NlmCategory=\"BACKGROUND\">Unlike influenza, information on the risk of human metapneumovirus (HMPV) infections in adults with chronic medical conditions (CMCs) is less robust.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"METHODS\">The SHIVERS project (Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance) performed a population-based surveillance of acute respiratory illness hospitalizations in Auckland, New Zealand, from 2012 to 2015. In this analysis, we linked these surveillance data to population-based administrative data to estimate the age- and ethnicity-adjusted risk of HMPV-associated hospitalization during the study period among adults by certain CMCs: chronic obstructive pulmonary disease, asthma, congestive heart failure, coronary artery disease, cerebrovascular accidents, diabetes mellitus, and end-stage renal disease.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">Overall, HMPV hospitalization rates were significantly higher across all ages and ethnic groups among adults with CMCs than those without any condition. In imputed analysis, the CMC with the highest risk of HMPV hospitalization across age groups was congestive heart failure (incidence rate ratio [IRR] range, 7.0-23.0), followed by coronary artery disease (IRR range, 4.2-9.1) and chronic obstructive pulmonary disease (IRR range, 6.7-11.9) in adults aged &#x2265;50 years. The CMC with the highest risk of HMPV hospitalization was congestive heart failure in M&#x101;ori/Pacific adults and chronic obstructive pulmonary disease in non-M&#x101;ori/Pacific adults. Adults with &#x2265;2 CMCs had a higher risk than those without CMCs; the risk varied by age group and ethnicity.</AbstractText><AbstractText Label=\"CONCLUSIONS\" NlmCategory=\"CONCLUSIONS\">Adults with specific or &#x2265;2 CMCs are at increased risk of HMPV hospitalizations. Age and ethnicity affect this relationship for some CMCs but not all. Such populations may benefit from future HMPV prevention strategies.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2025. Published by Oxford University Press on behalf of Infectious Diseases Society of America.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Aminisani</LastName><ForeName>Nayyereh</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Wallaceville Science Centre, Institute of Environmental Science and Research.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Wood</LastName><ForeName>Timothy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Wallaceville Science Centre, Institute of Environmental Science and Research.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Waite</LastName><ForeName>Ben</ForeName><Initials>B</Initials><Identifier Source=\"ORCID\">0000-0003-0909-8078</Identifier><AffiliationInfo><Affiliation>Wallaceville Science Centre, Institute of Environmental Science and Research.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Seeds</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Wallaceville Science Centre, Institute of Environmental Science and Research.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Jelley</LastName><ForeName>Lauren</ForeName><Initials>L</Initials><Identifier Source=\"ORCID\">0000-0001-5993-6266</Identifier><AffiliationInfo><Affiliation>Wallaceville Science Centre, Institute of Environmental Science and Research.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Wong</LastName><ForeName>Conroy</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Te Whatu Ora, Health NZ Counties Manukau, Auckland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, University of Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Sue Huang</LastName><ForeName>Q</ForeName><Initials>Q</Initials><Identifier Source=\"ORCID\">0000-0002-3923-5195</Identifier><AffiliationInfo><Affiliation>Wallaceville Science Centre, Institute of Environmental Science and Research.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>U01IP000480</GrantID><Acronym>CC</Acronym><Agency>CDC HHS</Agency><Country>United States</Country></Grant><Grant><Agency>New Zealand Ministry of Health</Agency><Country/></Grant><Grant><Agency>Icosavax</Agency><Country/></Grant><Grant><Agency>AstraZeneca Group</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Infect Dis</MedlineTA><NlmUniqueID>0413675</NlmUniqueID><ISSNLinking>0022-1899</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D009520\" MajorTopicYN=\"N\" Type=\"Geographic\">New Zealand</DescriptorName><QualifierName UI=\"Q000453\" MajorTopicYN=\"N\">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D006760\" MajorTopicYN=\"Y\">Hospitalization</DescriptorName><QualifierName UI=\"Q000706\" MajorTopicYN=\"N\">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000328\" MajorTopicYN=\"N\">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008875\" MajorTopicYN=\"N\">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000368\" MajorTopicYN=\"N\">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008297\" MajorTopicYN=\"N\">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D005260\" MajorTopicYN=\"N\">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D002908\" MajorTopicYN=\"N\">Chronic Disease</DescriptorName><QualifierName UI=\"Q000453\" MajorTopicYN=\"N\">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D055815\" MajorTopicYN=\"N\">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D018184\" MajorTopicYN=\"Y\">Paramyxoviridae Infections</DescriptorName><QualifierName UI=\"Q000453\" MajorTopicYN=\"N\">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000293\" MajorTopicYN=\"N\">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D029121\" MajorTopicYN=\"Y\">Metapneumovirus</DescriptorName><QualifierName UI=\"Q000302\" MajorTopicYN=\"N\">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000369\" MajorTopicYN=\"N\">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D012307\" MajorTopicYN=\"N\">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D012141\" MajorTopicYN=\"Y\">Respiratory Tract Infections</DescriptorName><QualifierName UI=\"Q000453\" MajorTopicYN=\"N\">epidemiology</QualifierName><QualifierName UI=\"Q000821\" MajorTopicYN=\"N\">virology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">acute respiratory infection</Keyword><Keyword MajorTopicYN=\"N\">adults</Keyword><Keyword MajorTopicYN=\"N\">chronic medical conditions</Keyword><Keyword MajorTopicYN=\"N\">human metapneumovirus</Keyword><Keyword MajorTopicYN=\"N\">incidence</Keyword></KeywordList><CoiStatement>Potential conflicts of interest . Q. S. H. is currently contracted by Icosavax, a member of the AstraZeneca Group, to conduct data analysis for this article. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>12</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>12</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>9</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">40668093</ArticleId><ArticleId IdType=\"doi\">10.1093/infdis/jiaf226</ArticleId><ArticleId IdType=\"pii\">8203262</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">40667967</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel=\"Electronic-eCollection\"><Journal><ISSN IssnType=\"Electronic\">2965-2774</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>37</Volume><PubDate><Year>2025</Year></PubDate></JournalIssue><Title>Critical care science</Title><ISOAbbreviation>Crit Care Sci</ISOAbbreviation></Journal><ArticleTitle>Inhaled sevoflurane use for myoclonic status secondary to bupropion intoxication.</ArticleTitle><Pagination><StartPage>e20250296</StartPage><MedlinePgn>e20250296</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.62675/2965-2774.20250296</ELocationID><ELocationID EIdType=\"pii\" ValidYN=\"Y\">S2965-27742025000100801</ELocationID><Abstract><AbstractText>A 26-year-old female with a history of depression was admitted after ingesting 7.5g of bupropion. Her clinical status rapidly deteriorated into a coma and myoclonic status, which was complicated by lung aspiration. Initial treatment with high-dose midazolam and later propofol failed to control her myoclonus. Sevoflurane inhalation therapy (6.5 mg/hour) was initiated, and complete resolution of myoclonus was achieved within hours. Propofol was discontinued, and the sevoflurane dose was gradually tapered over 24 hours without myoclonus recurrence. The patient awoke agitated but neurologically intact, was extubated, and fully recovered by Day 10. This case highlights the efficacy of sevoflurane in managing refractory myoclonic status due to bupropion toxicity, especially when electroencephalogram monitoring is unavailable. Sevoflurane rapid titration and elimination allow precise sedation control and safe neurological assessment. Inhaled anesthetics may also be beneficial in other ICU scenarios, including status epilepticus, severe asthma, and hemodynamic instability. This successful outcome demonstrates the potential of sevoflurane as an alternative therapy in critical toxicological emergencies.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Canasiro</LastName><ForeName>Artur Ribeiro</ForeName><Initials>AR</Initials><Identifier Source=\"ORCID\">0009-0006-4682-4111</Identifier><AffiliationInfo><Affiliation>Intensive Care Unit, Hospital das Cl&#xed;nicas, Faculdade de Medicina, Universidade de S&#xe3;o Paulo - S&#xe3;o Paulo (SP), Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Park</LastName><ForeName>Marcelo</ForeName><Initials>M</Initials><Identifier Source=\"ORCID\">0000-0002-4201-2718</Identifier><AffiliationInfo><Affiliation>Intensive Care Unit, Hospital das Cl&#xed;nicas, Faculdade de Medicina, Universidade de S&#xe3;o Paulo - S&#xe3;o Paulo (SP), Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Cardozo Junior</LastName><ForeName>Luis Carlos Maia</ForeName><Initials>LCM</Initials><Identifier Source=\"ORCID\">0000-0002-0459-6564</Identifier><AffiliationInfo><Affiliation>Intensive Care Unit, Hospital das Cl&#xed;nicas, Faculdade de Medicina, Universidade de S&#xe3;o Paulo - S&#xe3;o Paulo (SP), Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Vilar</LastName><ForeName>Giovanna Rego</ForeName><Initials>GR</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Hospital das Cl&#xed;nicas, Faculdade de Medicina, Universidade de S&#xe3;o Paulo - S&#xe3;o Paulo (SP), Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hajjar</LastName><ForeName>Ludhmila Abrah&#xe3;o</ForeName><Initials>LA</Initials><Identifier Source=\"ORCID\">0000-0001-5645-2055</Identifier><AffiliationInfo><Affiliation>Intensive Care Unit, Hospital das Cl&#xed;nicas, Faculdade de Medicina, Universidade de S&#xe3;o Paulo - S&#xe3;o Paulo (SP), Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D002363\">Case Reports</PublicationType><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2025</Year><Month>07</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Crit Care Sci</MedlineTA><NlmUniqueID>9918627781706676</NlmUniqueID><ISSNLinking>2965-2774</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>38LVP0K73A</RegistryNumber><NameOfSubstance UI=\"D000077149\">Sevoflurane</NameOfSubstance></Chemical><Chemical><RegistryNumber>01ZG3TPX31</RegistryNumber><NameOfSubstance UI=\"D016642\">Bupropion</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D018685\">Anesthetics, Inhalation</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D018687\">Antidepressive Agents, Second-Generation</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000077149\" MajorTopicYN=\"Y\">Sevoflurane</DescriptorName><QualifierName UI=\"Q000008\" MajorTopicYN=\"N\">administration &amp; dosage</QualifierName><QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D005260\" MajorTopicYN=\"N\">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000328\" MajorTopicYN=\"N\">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D016642\" MajorTopicYN=\"Y\">Bupropion</DescriptorName><QualifierName UI=\"Q000506\" MajorTopicYN=\"N\">poisoning</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D018685\" MajorTopicYN=\"Y\">Anesthetics, Inhalation</DescriptorName><QualifierName UI=\"Q000008\" MajorTopicYN=\"N\">administration &amp; dosage</QualifierName><QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D009207\" MajorTopicYN=\"Y\">Myoclonus</DescriptorName><QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName><QualifierName UI=\"Q000139\" MajorTopicYN=\"N\">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000280\" MajorTopicYN=\"N\">Administration, Inhalation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D004569\" MajorTopicYN=\"N\">Electroencephalography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D018687\" MajorTopicYN=\"Y\">Antidepressive Agents, Second-Generation</DescriptorName><QualifierName UI=\"Q000506\" MajorTopicYN=\"N\">poisoning</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2024</Year><Month>11</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>12</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>12</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>8</Hour><Minute>54</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">40667967</ArticleId><ArticleId IdType=\"doi\">10.62675/2965-2774.20250296</ArticleId><ArticleId IdType=\"pii\">S2965-27742025000100801</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">40667723</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">2211-5463</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2025</Year><Month>Jul</Month><Day>16</Day></PubDate></JournalIssue><Title>FEBS open bio</Title><ISOAbbreviation>FEBS Open Bio</ISOAbbreviation></Journal><ArticleTitle>Polydatin ameliorates ovalbumin-induced asthma in a rat model through NCOA4-mediated ferroautophagy and ferroptosis pathway.</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1002/2211-5463.70090</ELocationID><Abstract><AbstractText>Asthma is one of the most prevalent chronic diseases worldwide. In this study, we aimed to explore whether polydatin can achieve therapeutic effects in experimental asthma in a rat model by suppressing ferroptosis and its potential mechanism of inhibiting ferroptosis. We established a rat asthma model, and five experimental groups were established: the control group, model group, polydatin group, 3-MA group, and Fer-1 group. We compared general conditions, behavioral changes, Fe<sup>3+</sup>deposition, pathological changes, pulmonary function, serum IgE levels, ferroautophagy-related genes, and ferroptosis-related genes expression among the groups. Following the polydatin intervention, the mental state of the rats stabilized, their fur condition improved, and both food intake and body weight increased. The incubation period of asthma lengthened, and they sneezed and scratched less frequently. Additionally, polydatin reduced serum IgE levels and Fe<sup>3+</sup> deposition, enhanced lung function and pathological alterations, and also downregulated the expression of nuclear receptor coactivator 4 (NCOA4), Bcl-2 homologous domain protein (Beclin1), Fe<sup>2+</sup>, malondialdehyde (MDA), and 4-hydroxynonenal (4-HNE) in lung tissue. Levels of ferritin heavy chain 1 (FTH1), ubiquitin-binding protein p62 (P62), glutathione (GSH), glutathione peroxidase 4 (GPX4), and solute carrier family 7 member 11 (SLC7A11) were all upregulated. In conclusion, in this rat model, polydatin was capable of reducing Fe<sup>2+</sup> overload by inhibiting the NCOA4-mediated ferroautophagy. This, in turn, inhibited ferroptosis in the lung tissues, thereby alleviating asthma symptoms. Further studies, including clinical trials, are required to validate this result.</AbstractText><CopyrightInformation>&#xa9; 2025 The Author(s). FEBS Open Bio published by John Wiley &amp; Sons Ltd on behalf of Federation of European Biochemical Societies.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Li</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>College of Traditional Chinese Medicine, Hebei University of Chinese Medicine, Shijiazhuang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Tang</LastName><ForeName>Yuwei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>College of Traditional Chinese Medicine, Hebei University of Chinese Medicine, Shijiazhuang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Liu</LastName><ForeName>Wenkang</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>College of Traditional Chinese Medicine, Hebei University of Chinese Medicine, Shijiazhuang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Fang</LastName><ForeName>Fang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>College of Traditional Chinese Medicine, Hebei University of Chinese Medicine, Shijiazhuang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hebei Key Laboratory of Integrated Chinese and Western Medicine for Lung Disease Research, Shijiazhuang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Wang</LastName><ForeName>Jiepeng</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>College of Traditional Chinese Medicine, Hebei University of Chinese Medicine, Shijiazhuang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hebei Key Laboratory of Integrated Chinese and Western Medicine for Lung Disease Research, Shijiazhuang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Fang</LastName><ForeName>Chaoyi</ForeName><Initials>C</Initials><Identifier Source=\"ORCID\">0000-0003-3559-3160</Identifier><AffiliationInfo><Affiliation>College of Traditional Chinese Medicine, Hebei University of Chinese Medicine, Shijiazhuang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hebei Key Laboratory of Integrated Chinese and Western Medicine for Lung Disease Research, Shijiazhuang, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>2022082</GrantID><Agency>Research Plan Project of Hebei Provincial Administration of Traditional Chinese Medicine</Agency><Country/></Grant><Grant><GrantID>XCXZZSS2024014</GrantID><Agency>the Innovation Grant Program for Graduate Students of Hebei University of Traditional Chinese Medicine</Agency><Country/></Grant><Grant><GrantID>CXZZBS2024150</GrantID><Agency>Innovation ability training for postgraduates of the Education Department of Hebei Province</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2025</Year><Month>07</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>FEBS Open Bio</MedlineTA><NlmUniqueID>101580716</NlmUniqueID><ISSNLinking>2211-5463</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">asthma</Keyword><Keyword MajorTopicYN=\"N\">ferroautophagy</Keyword><Keyword MajorTopicYN=\"N\">ferroptosis</Keyword><Keyword MajorTopicYN=\"N\">polydatin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"revised\"><Year>2025</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus=\"received\"><Year>2025</Year><Month>2</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2025</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>12</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>12</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>7</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">40667723</ArticleId><ArticleId IdType=\"doi\">10.1002/2211-5463.70090</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Garcia&#x2010;Marcos L (2021) What is asthma? J Clin Med 10, 1282.</Citation></Reference><Reference><Citation>Miller RL, Grayson MH and Strothman K (2021) Advances in asthma: new understandings of asthma's natural history, risk factors, underlying mechanisms, and clinical management. J Allergy Clin Immunol 148, 1430&#x2013;1441.</Citation></Reference><Reference><Citation>Imanirad D and Tabatabaian F (2022) Current biologics in asthma treatment. Semin Respir Crit Care Med 43, 627&#x2013;634.</Citation></Reference><Reference><Citation>Sakagami T (2023) Evolution of asthma treatment goals. Respir Investig 61, 333&#x2013;334.</Citation></Reference><Reference><Citation>Calzetta L, Matera MG, Coppola A and Rogliani P (2021) Prospects for severe asthma treatment. Curr Opin Pharmacol 56, 52&#x2013;60.</Citation></Reference><Reference><Citation>Kaur S and Singh V (2018) Asthma and medicines &#x2010; long&#x2010;term side&#x2010;effects, monitoring and dose titration. Indian J Pediatr 85, 748&#x2013;756.</Citation></Reference><Reference><Citation>Leatherman J (2015) Mechanical ventilation for severe asthma. Chest 147, 1671&#x2013;1680.</Citation></Reference><Reference><Citation>Lommatzsch M and Virchow JC (2014) Severe asthma: definition, diagnosis and treatment. Dtsch Arztebl Int 111, 847&#x2013;855.</Citation></Reference><Reference><Citation>Li M, Li M, Hou Y, He H, Jiang R, Wang C and Sun S (2023) Ferroptosis triggers airway inflammation in asthma. Ther Adv Respir Dis 17, 1611179340.</Citation></Reference><Reference><Citation>Wang H, Jia Y, Gu J, Chen O and Yue S (2023) Ferroptosis&#x2010;related genes are involved in asthma and regulate the immune microenvironment. Front Pharmacol 14, 1087557.</Citation></Reference><Reference><Citation>Liu L, Zhou L, Wang L, Zheng P, Zhang F, Mao Z, Zhang H and Liu H (2023) Programmed cell death in asthma: apoptosis, autophagy, pyroptosis, ferroptosis, and necroptosis. J Inflamm Res 16, 2727&#x2013;2754.</Citation></Reference><Reference><Citation>Song J, Zhang H, Tong Y, Wang Y, Xiang Q, Dai H, Weng C, Wang L, Fan J, Shuai Y et&#xa0;al. (2023) Molecular mechanism of interleukin&#x2010;17A regulating airway epithelial cell ferroptosis based on allergic asthma airway inflammation. Redox Biol 68, 102970.</Citation></Reference><Reference><Citation>Yang N and Shang Y (2022) Ferrostatin&#x2010;1 and 3&#x2010;methyladenine ameliorate ferroptosis in OVA&#x2010;induced asthma model and in IL&#x2010;13&#x2010;challenged BEAS&#x2010;2B cells. Oxid Med Cell Longev 2022, 9657933.</Citation></Reference><Reference><Citation>Tang W, Dong M, Teng F, Cui J, Zhu X, Wang W, Wuniqiemu T, Qin J, Yi L, Wang S et&#xa0;al. (2021) Environmental allergens house dust mite&#x2010;induced asthma is associated with ferroptosis in the lungs. Exp Ther Med 22, 1483.</Citation></Reference><Reference><Citation>Han F, Li S, Yang Y and Bai Z (2021) Interleukin&#x2010;6 promotes ferroptosis in bronchial epithelial cells by inducing reactive oxygen species&#x2010;dependent lipid peroxidation and disrupting iron homeostasis. Bioengineered 12, 5279&#x2013;5288.</Citation></Reference><Reference><Citation>Zhang X, Jin M, Yao X, Liu J, Yang Y, Huang J, Jin G, Liu S and Zhang B (2024) Upregulation of LncRNA WT1&#x2010;AS inhibits tumor growth and promotes autophagy in gastric cancer via suppression of PI3K/Akt/mTOR pathway. Curr Mol Pharmacol 17, e18761429318398.</Citation></Reference><Reference><Citation>Ren Y, Wang R, Weng S, Xu H, Zhang Y, Chen S, Liu S, Ba Y, Zhou Z, Luo P et&#xa0;al. (2023) Multifaceted role of redox pattern in the tumor immune microenvironment regarding autophagy and apoptosis. Mol Cancer 22, 130.</Citation></Reference><Reference><Citation>Gong T, Cao G, Sun D, Ge T and Li P (2024) The roles of mTOR signaling in nasopharyngeal carcinoma: from pathogenesis to therapy. Curr Mol Pharmacol 17, e18761429293675.</Citation></Reference><Reference><Citation>Yang L, Gao ZW, Wu XN, Liu C, Zhang J, Zhang HZ and Dong K (2024) CD73 blockade alleviated hepatic fibrosis via inhibiting hepatic stellate cells proliferation and activation. Curr Mol Pharmacol 17, e220323214863.</Citation></Reference><Reference><Citation>Li X, Dai Z, Wu X, Zhang N, Zhang H, Wang Z, Zhang X, Liang X, Luo P, Zhang J et&#xa0;al. (2022) The comprehensive analysis identified an autophagy signature for the prognosis and the immunotherapy efficiency prediction in lung adenocarcinoma. Front Immunol 13, 749241.</Citation></Reference><Reference><Citation>Liu J, Liu Y, Wang Y, Li C, Xie Y, Klionsky DJ, Kang R and Tang D (2023) TMEM164 is a new determinant of autophagy&#x2010;dependent ferroptosis. Autophagy 19, 945&#x2013;956.</Citation></Reference><Reference><Citation>Chu LK, Cao X, Wan L, Diao Q, Zhu Y, Kan Y, Ye LL, Mao YM and Dong XQ (2023) Autophagy of OTUD5 destabilizes GPX4 to confer ferroptosis&#x2010;dependent kidney injury. Nat Commun 14, 8393.</Citation></Reference><Reference><Citation>Liu L, Du J, Fan H, Yu Y, Luo Y, Gu F, Yu H and Liao X (2024) Blueberry anthocyanins improve liver fibrosis by regulating NCOA4 ubiquitination through TRIM7 to affect ferroptosis of hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 326, G426&#x2013;G437.</Citation></Reference><Reference><Citation>Wu T, Ji M, Li T and Luo L (2025) The molecular and metabolic landscape of ferroptosis in respiratory diseases: pharmacological aspects. J Pharm Anal 15, 101050.</Citation></Reference><Reference><Citation>Wu M, Li X, Wang S, Yang S, Zhao R, Xing Y and Liu L (2020) Polydatin for treating atherosclerotic diseases: a functional and mechanistic overview. Biomed Pharmacother 128, 110308.</Citation></Reference><Reference><Citation>Tang D, Zhang Q, Duan H, Ye X, Liu J, Peng W and Wu C (2022) Polydatin: a critical promising natural agent for liver protection via antioxidative stress. Oxid Med Cell Longev 2022, 9218738.</Citation></Reference><Reference><Citation>Zheng S, Yin J, Wang B, Ye Q, Huang J, Liang X, Wu J, Yue H and Zhang T (2025) Polydatin protects against DSS&#x2010;induced ulcerative colitis via Nrf2/Slc7a11/Gpx4&#x2010;dependent inhibition of ferroptosis signalling activation. Front Pharmacol 15, 1513020.</Citation></Reference><Reference><Citation>Wang C, Li X, Ye T, Gu J, Zheng Z, Chen G, Dong J, Zhou W and Shi J (2025) Polydatin, a derivative of resveratrol, ameliorates busulfan&#x2010;induced oligozoospermia in mice by inhibiting NF&#x2010;&#x3ba;B pathway activation and suppressing ferroptosis. Bioorg Chem 156, 108170.</Citation></Reference><Reference><Citation>Pu F, Chen F, Zhang Z, Shi D, Zhong B, Lv X, Tucker AB, Fan J, Li AJ, Qin K et&#xa0;al. (2022) Ferroptosis as a novel form of regulated cell death: implications in the pathogenesis, oncometabolism and treatment of human cancer. Genes Dis 9, 347&#x2013;357.</Citation></Reference><Reference><Citation>Zhang X, Hou L, Guo Z, Wang G, Xu J, Zheng Z, Sun K and Guo F (2023) Lipid peroxidation in osteoarthritis: focusing on 4&#x2010;hydroxynonenal, malondialdehyde, and ferroptosis. Cell Death Dis 9, 320.</Citation></Reference><Reference><Citation>Forcina GC and Dixon SJ (2019) GPX4 at the crossroads of lipid homeostasis and ferroptosis. Proteomics 19, e1800311.</Citation></Reference><Reference><Citation>Guo C, Peng J, Cheng P, Yang C, Gong S, Zhang L, Zhang T and Peng J (2024) Mechanistic elucidation of ferroptosis and ferritinophagy: implications for advancing our understanding of arthritis. Front Physiol 15, 1290234.</Citation></Reference><Reference><Citation>He F, Zhang P, Liu J, Wang R, Kaufman RJ, Yaden BC and Karin M (2023) ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to&#xa0;block stress&#x2010;related ferroptosis. J Hepatol 79, 362&#x2013;377.</Citation></Reference><Reference><Citation>Koppula P, Zhuang L and Gan B (2021) Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell 12, 599&#x2013;620.</Citation></Reference><Reference><Citation>Chen Q, Zheng W, Guan J, Liu H, Dan Y, Zhu L, Song Y, Zhou Y, Zhao X, Zhang Y et&#xa0;al. (2023) SOCS2&#x2010;enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma. Cell Death Differ 30, 137&#x2013;151.</Citation></Reference><Reference><Citation>Debnath J, Gammoh N and Ryan KM (2023) Autophagy and autophagy&#x2010;related pathways in cancer. Nat Rev Mol Cell Biol 24, 560&#x2013;575.</Citation></Reference><Reference><Citation>Matsuzawa&#x2010;Ishimoto Y, Hwang S and Cadwell K (2018) Autophagy and inflammation. Annu Rev Immunol 36, 73&#x2013;101.</Citation></Reference><Reference><Citation>Lee S, Hwang N, Seok BG, Lee S, Lee SJ and Chung SW (2023) Autophagy mediates an amplification loop during ferroptosis. Cell Death Dis 14, 464.</Citation></Reference><Reference><Citation>Lv X, Li K and Hu Z (2020) Asthma and autophagy. Adv Exp Med Biol 1207, 581&#x2013;584.</Citation></Reference><Reference><Citation>Farooq MB and Walsh GM (2016) Autophagy and asthma. Clin Exp Allergy 46, 7&#x2013;9.</Citation></Reference><Reference><Citation>Jyothula SSSK and Eissa NT (2013) Autophagy and role in asthma. Curr Opin Pulm Med 19, 30&#x2013;35.</Citation></Reference><Reference><Citation>Xu H and Qin Z (2019) Beclin 1, Bcl&#x2010;2 and autophagy. Adv Exp Med Biol 1206, 109&#x2013;126.</Citation></Reference><Reference><Citation>Hill SM, Wrobel L, Ashkenazi A, Fernandez&#x2010;Estevez M, Tan K, Burli RW and Rubinsztein DC (2021) VCP/p97 regulates Beclin&#x2010;1&#x2010;dependent autophagy initiation. Nat Chem Biol 17, 448&#x2013;455.</Citation></Reference><Reference><Citation>Jeong S, Zhang X, Rodriguez&#x2010;Velez A, Evans TD and Razani B (2019) p62/SQSTM1 and selective autophagy in cardiometabolic diseases. Antioxid Redox Signal 31, 458&#x2013;471.</Citation></Reference><Reference><Citation>Huang X, Yao J, Liu L, Chen J, Mei L, Huangfu J, Luo D, Wang X, Lin C, Chen X et&#xa0;al. (2023) S&#x2010;acylation of p62 promotes p62 droplet recruitment into autophagosomes in mammalian autophagy. Mol Cell 83, 3485&#x2013;3501.</Citation></Reference><Reference><Citation>Fang Y, Chen X, Tan Q, Zhou H, Xu J and Gu Q (2021) Inhibiting ferroptosis through disrupting the NCOA4&#x2010;FTH1 interaction: a new mechanism of action. Acs Cent Sci 7, 980&#x2013;989.</Citation></Reference><Reference><Citation>Yang Y, Wu Q, Shan X, Zhou H, Wang J, Hu Y, Chen J and Lv Z (2024) Ginkgolide B attenuates&#xa0;cerebral ischemia&#x2010;reperfusion injury via inhibition of&#xa0;ferroptosis through disrupting NCOA4&#x2010;FTH1 interaction. J Ethnopharmacol 318, 116982.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">40667431</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">2950-3620</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>2</Volume><Issue>2</Issue><PubDate><Year>2025</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Indoor environments</Title><ISOAbbreviation>Indoor Environ</ISOAbbreviation></Journal><ArticleTitle>School-informed risk calculator tool for reducing the spread of respiratory viral infection among school-aged children.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">100090</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.indenv.2025.100090</ELocationID><Abstract><AbstractText>School health staff need decision support for responding to respiratory viral outbreaks. Quantitative microbial risk assessment (QMRA) tools are an inexpensive and fast resource. Our objectives were to engage school districts to inform the development of a risk-based calculator tool, test the tool across hypothetical cases, and elicit feedback among school health staff. We administered an online survey for Kindergarten (K) - Grade 5 teachers, school health professionals, and other school staff to gather data about respiratory viral disease interventions and model parameters. A risk calculator tool was developed in which users choose hypothetical scenarios to estimate infection risk per individual and compare interventions. Three case studies (CS) were explored: CS1 - Rhinovirus transmission in a general education classroom with \"poor\" vs. \"great\" air quality, CS2 - Influenza A virus transmission in a music classroom with vs. without a portable air purifier, CS3 - SARS-CoV-2 transmission in a special education classroom with vs. without open doors/windows. The prototype tool was presented at a national school nursing meeting, and attendees were surveyed on (dis)likes and anticipated tool uses. For the initial survey of Arizona school personnel (n = 132), the top respiratory viral outbreak strategies reported by teachers were hand (94 %) and surface hygiene (85.1 %). For all case studies, infection risks were above thresholds used in other contexts but were comparable to published student respiratory illness incidence data. At the national meeting, school nurses (n = 12) identified potential uses including advocating for interventions to administrators. This work reflects a unique application of community partnership and QMRA to address school health decision support.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Wilson</LastName><ForeName>Amanda M</ForeName><Initials>AM</Initials><Identifier Source=\"ORCID\">0000-0003-3259-8169</Identifier><AffiliationInfo><Affiliation>Department of Community, Environment &amp; Policy, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lowe</LastName><ForeName>Ashley A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Nursing &amp; Health Sciences Division, College of Nursing, University of Arizona, Tucson, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Asthma &amp; Airway Disease Research Center, Tucson, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Amoh-Asante</LastName><ForeName>Nana Adwoa A</ForeName><Initials>NAA</Initials><AffiliationInfo><Affiliation>Department of Community, Environment &amp; Policy, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhan</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Community, Environment &amp; Policy, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ashraf</LastName><ForeName>Ahamed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Community, Environment &amp; Policy, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gerald</LastName><ForeName>Lynn B</ForeName><Initials>LB</Initials><AffiliationInfo><Affiliation>Office of Population Health Sciences, Office of the Vice Chancellor for Health Affairs, University of Illinois Chicago, Chicago, IL, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Breathe Chicago Center, University of Illinois Chicago, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2025</Year><Month>03</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Indoor Environ</MedlineTA><NlmUniqueID>9918917842906676</NlmUniqueID><ISSNLinking>2950-3620</ISSNLinking></MedlineJournalInfo><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Asthma</Keyword><Keyword MajorTopicYN=\"N\">QMRA</Keyword><Keyword MajorTopicYN=\"N\">Risk management</Keyword><Keyword MajorTopicYN=\"N\">School health</Keyword><Keyword MajorTopicYN=\"N\">School nurse</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>11</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>11</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>5</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2025</Year><Month>7</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">40667431</ArticleId><ArticleId IdType=\"pmc\">PMC12263118</ArticleId><ArticleId IdType=\"doi\">10.1016/j.indenv.2025.100090</ArticleId><ArticleId IdType=\"pii\">100090</ArticleId><ArticleId IdType=\"mid\">NIHMS2090460</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>National Center for Education Statistics, &#x201c;School Nurses in U.S. Public Schools.&#x201d; 2020. Accessed: Apr. 24, 2022. [Online]. Available: &#x2329;https://nces.ed.gov/pubs2020/2020086/index.asp&#x232a;.</Citation></Reference><Reference><Citation>Silverman RA, Ito K, Stevenson L, Hastings HM, The relationship of fall school opening and emergency department asthma visits in a large Metropolitan Area, Arch. Pedia Adolesc. Med 159 (9) (2005) 818, 10.1001/archpedi.159.9.818.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/archpedi.159.9.818</ArticleId><ArticleId IdType=\"pubmed\">16143740</ArticleId></ArticleIdList></Reference><Reference><Citation>Falsey AR, Branche AR, Rhinoviruses. International Encyclopedia of Public Health, Elsevier, 2017, pp. 363&#x2013;369, 10.1016/B978-0-12-803678-5.00386-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/B978-0-12-803678-5.00386-6</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Environmental Protection Agency, &#x201c;Take Action to Improve Indoor Air Quality in Schools.&#x201d; 2023. Accessed: Mar. 12, 2024. [Online]. Available: &#x2329;https://www.epa.gov/iaq-schools/take-action-improve-indoor-air-quality-schools#:~:text=According%20to%20the%20U.S.%20Department,it%20is%20not%20properly%20maintained&#x232a;.</Citation></Reference><Reference><Citation>Ma KC, et al. , Increase in acute respiratory illnesses among children and adolescents associated with rhinoviruses and enteroviruses, including enterovirus D68 &#x2014; United States, July&#x2013;September 2022, MMWR Morb. Mortal. Wkly. Rep 71 (40) (2022) 1265&#x2013;1270, 10.15585/mmwr.mm7140e1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.15585/mmwr.mm7140e1</ArticleId><ArticleId IdType=\"pmc\">PMC9541033</ArticleId><ArticleId IdType=\"pubmed\">36201400</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization, &#x201c;Upsurge of respiratory illnesses among children-Northern China.&#x201d; Nov. 23, 2023. Accessed: Mar. 12, 2023. [Online]. Available: &#x2329;https://www.who.int/emergencies/disease-outbreak-news/item/2023-DON494&#x232a;.</Citation></Reference><Reference><Citation>Hassanzad M, et al. , Association of specific viral infections with childhood asthma exacerbations, Interv. Med. Appl. Sci 11 (1) (2018) 17&#x2013;20, 10.1556/1646.10.2018.35.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1556/1646.10.2018.35</ArticleId><ArticleId IdType=\"pmc\">PMC7044566</ArticleId><ArticleId IdType=\"pubmed\">32148899</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurai D, Saraya T, Ishii H, Takizawa H, Virus-induced exacerbations in asthma and COPD, Front. Microbiol 4 (2013), 10.3389/fmicb.2013.00293.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fmicb.2013.00293</ArticleId><ArticleId IdType=\"pmc\">PMC3787546</ArticleId><ArticleId IdType=\"pubmed\">24098299</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson AM, Ravi P, Pargas NT, Gerald LB, Lowe AA, School health systems under strain: an example of COVID-19 experiences &amp; burnout among school health staff in Pima County, Arizona, BMC Public Health 23 (1) (2023) 1626, 10.1186/s12889-023-16532-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12889-023-16532-8</ArticleId><ArticleId IdType=\"pmc\">PMC10463464</ArticleId><ArticleId IdType=\"pubmed\">37626343</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowe AA, Ravi P, Gerald LB, Wilson AM, The changing job of school nurses during the COVID-19 pandemic: a media content analysis of contributions to stress, wxac053, Ann. Work Expo. Health (2022), 10.1093/annweh/wxac053.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/annweh/wxac053</ArticleId><ArticleId IdType=\"pmc\">PMC9494455</ArticleId><ArticleId IdType=\"pubmed\">36111528</ArticleId></ArticleIdList></Reference><Reference><Citation>National Center for Environmental Health, &#x201c;Most Recent National Asthma Data.&#x201d; Centers for Disease Control and Prevention, Dec. 13, 2022. Accessed: Feb. 15, 2023. [Online]. Available: &#x2329;https://www.cdc.gov/asthma/most_recent_national_asthma_data.htm&#x232a;.</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention, &#x201c;CDC Healthy Schools: Asthma.&#x201d; Aug. 18, 2022. Accessed: Jan. 24, 2024. [Online]. Available: &#x2329;https://www.cdc.gov/healthyschools/asthma/index.htm&#x232a;.</Citation></Reference><Reference><Citation>Ahanchian H, Jones CM, Chen Y, Sly PD, Respiratory viral infections in children with asthma: do they matter and can we prevent them? BMC Pedia 12 (1) (2012) 147, 10.1186/1471-2431-12-147.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/1471-2431-12-147</ArticleId><ArticleId IdType=\"pmc\">PMC3471019</ArticleId><ArticleId IdType=\"pubmed\">22974166</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson DJ, Gern JE, Rhinovirus Infections and Their Roles in Asthma: Etiology and Exacerbations, J. Allergy Clin. Immunol.: Pract 10 (3) (2022) 673&#x2013;681, 10.1016/j.jaip.2022.01.006.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jaip.2022.01.006</ArticleId><ArticleId IdType=\"pmc\">PMC10314805</ArticleId><ArticleId IdType=\"pubmed\">35074599</ArticleId></ArticleIdList></Reference><Reference><Citation>Haas CN, Rose JB, Gerba CP, Quantitative Microbial Risk Assessment: Second Edition, Wiley-Blackwell, 2014.</Citation></Reference><Reference><Citation>Xu Y, Cai J, Li S, He Q, Zhu S, Airborne infection risks of SARS-CoV-2 in U.S. schools and impacts of different intervention strategies, Sustain. Cities Soc 74 (2021) 103188, 10.1016/j.scs.2021.103188.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.scs.2021.103188</ArticleId><ArticleId IdType=\"pmc\">PMC8290078</ArticleId><ArticleId IdType=\"pubmed\">34306993</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan K, et al. , A computational framework for transmission risk assessment of aerosolized particles in classrooms, Eng. Comput 40 (1) (2024) 235&#x2013;256, 10.1007/s00366-022-01773-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00366-022-01773-9</ArticleId><ArticleId IdType=\"pmc\">PMC9884603</ArticleId><ArticleId IdType=\"pubmed\">36742376</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirzaie M, Lakzian E, Khan A, Warkiani ME, Mahian O, Ahmadi G, COVID-19 spread in a classroom equipped with partition &#x2013; a CFD approach, J. Hazard. Mater 420 (2021) 126587, 10.1016/j.jhazmat.2021.126587.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jhazmat.2021.126587</ArticleId><ArticleId IdType=\"pmc\">PMC8270738</ArticleId><ArticleId IdType=\"pubmed\">34273880</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvard T.H. Chan School of Public Health, &#x201c;COVID-19 Risk Calculator.&#x201d; 2021. Accessed: Mar. 12, 2024. [Online]. Available: &#x2329;https://covid-19.forhealth.org/covid-19-transmission-calculator/&#x232a;.</Citation></Reference><Reference><Citation>Jimenez JL and Peng Z, &#x201c;COVID-19 Aerosol Transmission Estimator.&#x201d; 2020. Accessed: Mar. 12, 2024. [Online]. Available: &#x2329;https://docs.google.com/spreadsheets/d/16K1OQkLD4BjgBdO8ePj6ytf-RpPMlJ6aXFg3PrIQBbQ/htmlview?pru=AAABc30E5QM*CFtztmRZt3oxrKJp0LzcsQ#gid=519189277&#x232a;.</Citation></Reference><Reference><Citation>Peng Z, et al. , Practical indicators for risk of airborne transmission in shared indoor environments and their application to COVID-19 outbreaks, Environ. Sci. Technol 56 (2) (2022) 1125&#x2013;1137, 10.1021/acs.est.1c06531.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acs.est.1c06531</ArticleId><ArticleId IdType=\"pmc\">PMC7617205</ArticleId><ArticleId IdType=\"pubmed\">34985868</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulledge ST, &#x201c;Duke develops online tool to judge risk of classroom infection,&#x201d; Triangle Business Journal, Aug. 12, 2020. Accessed: Mar. 12, 2024. [Online]. Available: &#x2329;https://www.bizjournals.com/triangle/news/2020/08/12/duke-develops-online-tool-to-judge-risk-of-classro.html&#x232a;.</Citation></Reference><Reference><Citation>Duke University, &#x201c;Covid Exposure Modeler.&#x201d; 2020. Accessed: Mar. 12, 2024. [Online]. Available: &#x2329;https://covid-exposure-modeler-data-devils.cloud.duke.edu/&#x232a;.</Citation></Reference><Reference><Citation>Safeairspaces, &#x201c;SAFEAIRSPACES COVID-19 Aerosol Relative Risk Estimator v2.&#x201d; 2023. Accessed: Jun. 24, 2024. [Online]. Available: &#x2329;https://safeairspaces.com/safeairspaces-estimator&#x232a;.</Citation></Reference><Reference><Citation>Kyng&#xe4;s H, Inductive content analysis, in: Kyng&#xe4;s H, Mikkonen K, K&#xe4;&#xe4;ri&#xe4;inen M (Eds.), The Application of Content Analysis in Nursing Science Research, Springer International Publishing, Cham, 2020, pp. 13&#x2013;21, 10.1007/978-3-030-30199-6_2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/978-3-030-30199-6_2</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson AM, Ogunseye OO, DiGioia O, Gerald LB, Lowe AA, Barriers to COVID-19 Intervention Implementation in K-5 Classrooms: A Survey of Teachers from a District with Mask Mandates despite a Statewide Mask Mandate Ban, IJERPH 19 (14) (2022) 8311, 10.3390/ijerph19148311.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijerph19148311</ArticleId><ArticleId IdType=\"pmc\">PMC9316596</ArticleId><ArticleId IdType=\"pubmed\">35886159</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson AM, et al. , Respirators, face masks, and their risk reductions via multiple transmission routes for first responders within an ambulance, J. Occup. Environ. Hyg 18 (7) (2021) 345&#x2013;360, 10.1080/15459624.2021.1926468.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/15459624.2021.1926468</ArticleId><ArticleId IdType=\"pubmed\">34129448</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones RM, Relative contributions of transmission routes for COVID-19 among healthcare personnel providing patient care, J. Occup. Environ. Hyg 17 (9) (2020) 408&#x2013;415, 10.1080/15459624.2020.1784427.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/15459624.2020.1784427</ArticleId><ArticleId IdType=\"pubmed\">32643585</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung NHL, et al. , Respiratory virus shedding in exhaled breath and efficacy of face masks, Nat. Med 26 (5) (2020) 676&#x2013;680, 10.1038/s41591-020-0843-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41591-020-0843-2</ArticleId><ArticleId IdType=\"pmc\">PMC8238571</ArticleId><ArticleId IdType=\"pubmed\">32371934</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitol AK, Julian TR, Community transmission of SARS-CoV-2 by surfaces: risks and risk reduction strategies, Environ. Sci. Technol. Lett 8 (3) (2021) 263&#x2013;269, 10.1021/acs.estlett.0c00966.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acs.estlett.0c00966</ArticleId><ArticleId IdType=\"pubmed\">37566313</ArticleId></ArticleIdList></Reference><Reference><Citation>Batterman S, Su F-C, Wald A, Watkins F, Godwin C, Thun G, Ventilation rates in recently constructed U.S. school classrooms, Indoor Air 27 (5) (2017) 880&#x2013;890, 10.1111/ina.12384.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/ina.12384</ArticleId><ArticleId IdType=\"pubmed\">28370427</ArticleId></ArticleIdList></Reference><Reference><Citation>ASHRAE Technical Committee 9.7, Educational facilities. Design Guidance for Educational Facilities: Prioritization for Advanced Indoor Air Quality, ASHRAE, 2023.</Citation></Reference><Reference><Citation>Allen J, Spengler J, Jones E, Cedeno-Laurent J, &#x201c;5-step guide to checking ventilation rates in classrooms.&#x201d;, Sch. Health. Org (2020).</Citation></Reference><Reference><Citation>Stilianakis NI, Drossinos Y, Dynamics of infectious disease transmission by inhalable respiratory droplets, J. R. Soc. Interface 7 (50) (2010) 1355&#x2013;1366, 10.1098/rsif.2010.0026.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1098/rsif.2010.0026</ArticleId><ArticleId IdType=\"pmc\">PMC2894888</ArticleId><ArticleId IdType=\"pubmed\">20164087</ArticleId></ArticleIdList></Reference><Reference><Citation>School Outfitters, &#x201c;Structure Series Open Front School Desk w/ Black Book Box &amp; Black Frame.&#x201d; Accessed: Jun. 24, 2024. [Online]. Available: &#x2329;https://www.schooloutfitters.com/catalog/product_info/pfam_id/PFAM54063/products_id/PRO72727?sc_cid=Google_LNT-0027&amp;adtype=pla&amp;kw=&amp;utm_term=&amp;utm_campaign=Product%20Listings%20Core%201%20-%20Target%20ROAS&amp;utm_source=google&amp;utm_medium=cpc&amp;hsa_acc=431056174&#x232a;.</Citation></Reference><Reference><Citation>School Outfitters, &#x201c;Kidney Adjustable-Height Activity Table.&#x201d; Accessed: Jun. 24, 2024. [Online]. Available: &#x2329;https://www.schooloutfitters.com/catalog/product_info/pfam_id/PFAM34905/products_id/PRO46302&#x232a;.</Citation></Reference><Reference><Citation>AuYeung W, Canales RA, Leckie JO, The fraction of total hand surface area involved in young children&#x2019;s outdoor hand-to-object contacts, Environ. Res 108 (3) (2008) 294&#x2013;299, 10.1016/j.envres.2008.07.010.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.envres.2008.07.010</ArticleId><ArticleId IdType=\"pubmed\">18760778</ArticleId></ArticleIdList></Reference><Reference><Citation>Exposure Factors Handbook 2011 Edition.&#x201d; U.S. Environmental Protection Agency, 2011. [Online]. Available: &#x2329;https://cfpub.epa.gov/ncea/risk/recordisplay.cfm?deid=236252&#x232a;.</Citation></Reference><Reference><Citation>Child-Specific Exposure Factors Handbook (2008, Final Report).&#x201d; U.S. Environmental Protection Agency, 2008. Accessed: Feb. 28, 2024. [Online]. Available: &#x2329;https://cfpub.epa.gov/ncea/risk/recordisplay.cfm?deid=199243&#x232a;.</Citation></Reference><Reference><Citation>Beamer PI, Plotkin KR, Gerba CP, Sifuentes LY, Koenig DW, Reynolds KA, Modeling of human viruses on hands and risk of infection in an office workplace using micro-activity data, J. Occup. Environ. Hyg 12 (4) (2015) 266&#x2013;275, 10.1080/15459624.2014.974808.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/15459624.2014.974808</ArticleId><ArticleId IdType=\"pmc\">PMC4455933</ArticleId><ArticleId IdType=\"pubmed\">25436665</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson CE, Boehm AB, Transfer rate of enveloped and nonenveloped viruses between fingerpads and surfaces, Appl. Environ. Microbiol 87 (22) (2021) e01215&#x2013;21, 10.1128/AEM.01215-21.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1128/AEM.01215-21</ArticleId><ArticleId IdType=\"pmc\">PMC8552898</ArticleId><ArticleId IdType=\"pubmed\">34469200</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusin P, Maxwell S, Gerba C, Comparative surface-to-hand and fingertip-to-mouth transfer efficiency of gram-positive bacteria, gram-negative bacteria, and phage, J. Appl. Microbiol 93 (4) (2002) 585&#x2013;592, 10.1046/j.1365-2672.2002.01734.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1046/j.1365-2672.2002.01734.x</ArticleId><ArticleId IdType=\"pubmed\">12234341</ArticleId></ArticleIdList></Reference><Reference><Citation>Abney SE, Wilson AM, Ijaz MK, McKinney J, Reynolds KA, Gerba CP, Minding the matrix: the importance of inoculum suspensions on finger transfer efficiency of virus, J. Appl. Microbiol 135 (5) (2022) 3083&#x2013;3093, 10.1111/jam.15758.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/jam.15758</ArticleId><ArticleId IdType=\"pmc\">PMC9804790</ArticleId><ArticleId IdType=\"pubmed\">35916494</ArticleId></ArticleIdList></Reference><Reference><Citation>Beamer PI, Luik CE, Canales RA, Leckie JO, Quantified outdoor micro-activity data for children aged 7&#x2013;12-years old, J. Expo. Sci. Environ. Epidemiol 22 (1) (2012) 82&#x2013;92, 10.1038/jes.2011.34.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/jes.2011.34</ArticleId><ArticleId IdType=\"pubmed\">21989500</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodge K, Du Puis JL, Maher M, Frey MW, Baytar F, Park H, Cloth face mask fit and function for children part two: Material Selection, Fash. Text 9 (1) (2022) 41, 10.1186/s40691-022-00315-7.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40691-022-00315-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Science M, et al. , Effect of wearing a face mask on hand-to-face contact by children in a simulated school environment: the back-to-school COVID-19 simulation randomized clinical trial, JAMA Pedia 176 (12) (2022) 1169, 10.1001/jamapediatrics.2022.3833.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jamapediatrics.2022.3833</ArticleId><ArticleId IdType=\"pmc\">PMC9593317</ArticleId><ArticleId IdType=\"pubmed\">36279142</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson AM, Verhougstraete MP, Beamer PI, King M-F, Reynolds KA, Gerba CP, Frequency of hand-to-head, -mouth, -eyes, and -nose contacts for adults and children during eating and non-eating macro-activities, J. Expo. Sci. Environ. Epidemiol 31 (1) (2021) 34&#x2013;44, 10.1038/s41370-020-0249-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41370-020-0249-8</ArticleId><ArticleId IdType=\"pmc\">PMC7362609</ArticleId><ArticleId IdType=\"pubmed\">32669669</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber TP, Stilianakis NI, Inactivation of influenza A viruses in the environment and modes of transmission: a critical review, J. Infect 57 (5) (2008) 361&#x2013;373, 10.1016/j.jinf.2008.08.013.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jinf.2008.08.013</ArticleId><ArticleId IdType=\"pmc\">PMC7112701</ArticleId><ArticleId IdType=\"pubmed\">18848358</ArticleId></ArticleIdList></Reference><Reference><Citation>Dabisch P, et al. , The influence of temperature, humidity, and simulated sunlight on the infectivity of SARS-CoV-2 in aerosols, Aerosol Sci. Technol 55 (2) (2021) 142&#x2013;153, 10.1080/02786826.2020.1829536.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/02786826.2020.1829536</ArticleId><ArticleId IdType=\"pmc\">PMC10698725</ArticleId><ArticleId IdType=\"pubmed\">38077296</ArticleId></ArticleIdList></Reference><Reference><Citation>Karim YG, Ijaz MK, Sattar SA, Johnson-Lussenburg CM, Effect of relative humidity on the airborne survival of rhinovirus-14, Can. J. Microbiol 31 (11) (1985) 1058&#x2013;1061, 10.1139/m85-199.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1139/m85-199</ArticleId><ArticleId IdType=\"pubmed\">3004682</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirose R, et al. , Survival of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Influenza Virus on Human Skin: Importance of Hand Hygiene in Coronavirus Disease 2019 (COVID-19), Clin. Infect. Dis 73 (11) (2021) e4329&#x2013;e4335, 10.1093/cid/ciaa1517.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/cid/ciaa1517</ArticleId><ArticleId IdType=\"pmc\">PMC7665347</ArticleId><ArticleId IdType=\"pubmed\">33009907</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendley JO, Wenzel RP, Gwaltney JM, Transmission of rhinovirus colds by self-inoculation, N. Engl. J. Med 288 (26) (1973) 1361&#x2013;1364, 10.1056/NEJM197306282882601.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1056/NEJM197306282882601</ArticleId><ArticleId IdType=\"pubmed\">4350527</ArticleId></ArticleIdList></Reference><Reference><Citation>Kampf G, Efficacy of ethanol against viruses in hand disinfection, J. Hosp. Infect 98 (4) (2018) 331&#x2013;338, 10.1016/j.jhin.2017.08.025.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jhin.2017.08.025</ArticleId><ArticleId IdType=\"pmc\">PMC7132458</ArticleId><ArticleId IdType=\"pubmed\">28882643</ArticleId></ArticleIdList></Reference><Reference><Citation>Bean B, Moore BM, Sterner B, Peterson LR, Gerding DN, Balfour HH, Survival of influenza viruses on environmental surfaces, J. Infect. Dis 146 (1) (1982) 47&#x2013;51, 10.1093/infdis/146.1.47.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/infdis/146.1.47</ArticleId><ArticleId IdType=\"pubmed\">6282993</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J, et al. , Stability of SARS-CoV-2 on inanimate surfaces: a review, Microbiol. Res 272 (2023) 127388, 10.1016/j.micres.2023.127388.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.micres.2023.127388</ArticleId><ArticleId IdType=\"pmc\">PMC10116155</ArticleId><ArticleId IdType=\"pubmed\">37141851</ArticleId></ArticleIdList></Reference><Reference><Citation>Sattar SA, Karim YG, Springthorpe VS, Johnson-Lussenburg CM, Survival of human rhinovirus type 14 dried onto nonporous inanimate surfaces: effect of relative humidity and suspending medium, Can. J. Microbiol 33 (9) (1987) 802&#x2013;806, 10.1139/m87-136.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1139/m87-136</ArticleId><ArticleId IdType=\"pubmed\">2825955</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones RM, Su Y-M, Dose-response models for selected respiratory infectious agents: Bordetella pertussis, group a Streptococcus, rhinovirus and respiratory syncytial virus, BMC Infect. Dis 15 (1) (2015) 90, 10.1186/s12879-015-0832-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12879-015-0832-0</ArticleId><ArticleId IdType=\"pmc\">PMC4345006</ArticleId><ArticleId IdType=\"pubmed\">25880210</ArticleId></ArticleIdList></Reference><Reference><Citation>Haas CN, Action levels for SARS-CoV-2 in air: preliminary approach, Risk Anal. 41 (5) (2021) 705&#x2013;709, 10.1111/risa.13728.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/risa.13728</ArticleId><ArticleId IdType=\"pmc\">PMC8251121</ArticleId><ArticleId IdType=\"pubmed\">33818802</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe T, Bartrand TA, Omura T, Haas CN, Dose-response assessment for influenza A virus based on data sets of infection with its live attenuated reassortants, Risk Anal. 32 (3) (2012) 555&#x2013;565, 10.1111/j.1539-6924.2011.01680.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1539-6924.2011.01680.x</ArticleId><ArticleId IdType=\"pubmed\">21977924</ArticleId></ArticleIdList></Reference><Reference><Citation>Arizona Department of Health Services, &#x201c;Communicable Disease Reporting - Schools &amp; Childcare.&#x201d; 2018. Accessed: Aug. 14, 2024. [Online]. Available: &#x2329;https://www.azdhs.gov/preparedness/epidemiology-disease-control/index.php#reporting-schools&#x232a;.</Citation></Reference><Reference><Citation>Watanabe T, Bartrand TA, Weir MH, Omura T, Haas CN, Development of a dose-response model for SARS coronavirus, Risk Anal. 30 (7) (2010) 1129&#x2013;1138, 10.1111/j.1539-6924.2010.01427.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1539-6924.2010.01427.x</ArticleId><ArticleId IdType=\"pmc\">PMC7169223</ArticleId><ArticleId IdType=\"pubmed\">20497390</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindsley WG, et al. , Distribution of airborne influenza virus and respiratory syncytial virus in an urgent care medical clinic, Clin. Infect. Dis (2010), 10.1086/650457.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1086/650457</ArticleId><ArticleId IdType=\"pubmed\">20100093</ArticleId></ArticleIdList></Reference><Reference><Citation>Gralton J, Tovey ER, McLaws M, Rawlinson WD, Respiratory virus RNA is detectable in airborne and droplet particles, J. Med. Virol 85 (12) (2013) 2151&#x2013;2159, 10.1002/jmv.23698.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jmv.23698</ArticleId><ArticleId IdType=\"pubmed\">23959825</ArticleId></ArticleIdList></Reference><Reference><Citation>Riediker M, Morawska L, Low exhaled breath droplet formation may explain why children are poor SARS-CoV-2 transmitters, Aerosol Air Qual. Res 20 (7) (2020) 1513&#x2013;1515, 10.4209/aaqr.2020.06.0304.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4209/aaqr.2020.06.0304</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton KA, et al. , Research gaps and priorities for quantitative microbial risk assessment (QMRA), Risk Anal. 44 (11) (2024) 2521&#x2013;2536, 10.1111/risa.14318.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/risa.14318</ArticleId><ArticleId IdType=\"pmc\">PMC11560611</ArticleId><ArticleId IdType=\"pubmed\">38772724</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinclair RG, Choi CY, Riley MR, Gerba CP, Pathogen surveillance through monitoring of sewer systems. Advances in Applied Microbiology 65, Elsevier, 2008, pp. 249&#x2013;269, 10.1016/S0065-2164(08)00609-6.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0065-2164(08)00609-6</ArticleId><ArticleId IdType=\"pmc\">PMC7112011</ArticleId><ArticleId IdType=\"pubmed\">19026868</ArticleId></ArticleIdList></Reference><Reference><Citation>McNeill VF, et al. , Room-level ventilation in schools and universities, Atmos. Environ.: X 13 (2022) 100152, 10.1016/j.aeaoa.2022.100152.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.aeaoa.2022.100152</ArticleId><ArticleId IdType=\"pmc\">PMC8789458</ArticleId><ArticleId IdType=\"pubmed\">35098105</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard-Reed C, Wallace LA, Ott WR, The effect of opening windows on air change rates in two homes, J. Air Waste Manag. Assoc 52 (2) (2002) 147&#x2013;159, 10.1080/10473289.2002.10470775.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/10473289.2002.10470775</ArticleId><ArticleId IdType=\"pubmed\">15143789</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari S, et al. , Air change rates and infection risk in school environments: Monitoring naturally ventilated classrooms in a northern Italian urban context, Heliyon 9 (9) (2023) e19120, 10.1016/j.heliyon.2023.e19120.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.heliyon.2023.e19120</ArticleId><ArticleId IdType=\"pmc\">PMC10558299</ArticleId><ArticleId IdType=\"pubmed\">37809762</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Department of Education, &#x201c;Improving Ventilation in Schools, Colleges, and Universities to Prevent COVID-19.&#x201d; Accessed: Jun. 24, 2024. [Online]. Available: &#x2329;https://www.ed.gov/improving-ventilation-schools-colleges-and-universities-prevent-covid-19&#x232a;.</Citation></Reference><Reference><Citation>Das D, Babik KR, Moynihan E, Ramachandran G, Experimental studies of particle removal and probability of COVID-19 infection in passenger railcars, J. Occup. Environ. Hyg 20 (1) (2023) 1&#x2013;13, 10.1080/15459624.2022.2137298.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/15459624.2022.2137298</ArticleId><ArticleId IdType=\"pmc\">PMC10074430</ArticleId><ArticleId IdType=\"pubmed\">36256520</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. EPA, &#x201c;What is a HEPA filter?&#x201d; Mar. 05, 2024. Accessed: Jun. 24, 2024. [Online]. Available: &#x2329;https://www.epa.gov/indoor-air-quality-iaq/what-hepa-filter#:~:text=This%20type%20of%20air%20filter,penetrating%20particle%20size%20&#x232a;(MPPS).</Citation></Reference><Reference><Citation>Dal Porto R, Kunz MN, Pistochini T, Corsi RL, Cappa CD, Characterizing the performance of a do-it-yourself (DIY) box fan air filter, Aerosol Sci. Technol 56 (6) (2022) 564&#x2013;572, 10.1080/02786826.2022.2054674.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/02786826.2022.2054674</ArticleId></ArticleIdList></Reference><Reference><Citation>Arizona Administrative Code, &#x201c;Ariz. Admin. Code &#xa7; 7-6-210. Sections R7&#x2013;6&#x2013;210 - Classroom Square Footage.&#x201d; Feb. 05, 2023. Accessed: Jul. 24, 2024. [Online]. Available: &#x2329;https://casetext.com/regulation/arizona-administrative-code/title-7-education/chapter-6-school-facilities-oversight-board/article-2-minimum-school-facility-guidelines/section-r7-6-210-classroom-square-footage#:~:text=For%20preschool%20children%20with%20d&#x232a;.</Citation></Reference><Reference><Citation>Southern Carolina Department of Education, &#x201c;Best Practices for Instructional Space.&#x201d; 2023. [Online]. Available: &#x2329;https://ed.sc.gov/districts-schools/planning-building/facilities/20&#x232a;.</Citation></Reference><Reference><Citation>Pan J, Harb C, Leng W, Marr LC, Inward and outward effectiveness of cloth masks, a surgical mask, and a face shield, Aerosol Sci. Technol 55 (6) (2021) 718&#x2013;733, 10.1080/02786826.2021.1890687.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/02786826.2021.1890687</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Kelly E, Arora A, Pirog S, Ward J, Clarkson PJ, Comparing the fit of N95, KN95, surgical, and cloth face masks and assessing the accuracy of fit checking, PLoS ONE 16 (1) (2021) e0245688, 10.1371/journal.pone.0245688.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0245688</ArticleId><ArticleId IdType=\"pmc\">PMC7822328</ArticleId><ArticleId IdType=\"pubmed\">33481870</ArticleId></ArticleIdList></Reference><Reference><Citation>Niazi S, Groth R, Morawska L, Spann K, Ristovski Z, Dynamics and viability of airborne respiratory syncytial virus under various indoor air conditions, Environ. Sci. Technol 57 (51) (2023) 21558&#x2013;21569, 10.1021/acs.est.3c03455.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acs.est.3c03455</ArticleId><ArticleId IdType=\"pubmed\">38084588</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas TL, Mustain R, Goldsby RE, Frequency of face touching with and without a mask in pediatric hematology/oncology health care professionals, Pedia Blood Cancer 67 (9) (2020), 10.1002/pbc.28593.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/pbc.28593</ArticleId><ArticleId IdType=\"pmc\">PMC7404441</ArticleId><ArticleId IdType=\"pubmed\">32672907</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. EPA, &#x201c;Pesticide Registration Manual: Chapter 4 - Additional Considerations for Antimicrobial Products.&#x201d; Jun. 20, 2024. Accessed: Jun. 24, 2024. [Online]. Available: &#x2329;https://www.epa.gov/pesticide-registration/pesticide-registration-manual-chapter-4-additional-considerations&#x232a;.</Citation></Reference><Reference><Citation>Leslie RA, Zhou SS, Macinga DR, Inactivation of SARS-CoV-2 by commercially available alcohol-based hand sanitizers, Am. J. Infect. Control 49 (3) (2021) 401&#x2013;402, 10.1016/j.ajic.2020.08.020.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ajic.2020.08.020</ArticleId><ArticleId IdType=\"pmc\">PMC7431409</ArticleId><ArticleId IdType=\"pubmed\">32818578</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirose R, et al. , Situations leading to reduced effectiveness of current hand hygiene against infectious mucus from influenza virus-infected patients, mSphere 4 (5) (2019) e00474&#x2013;19, 10.1128/mSphere.00474-19.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1128/mSphere.00474-19</ArticleId><ArticleId IdType=\"pmc\">PMC6751490</ArticleId><ArticleId IdType=\"pubmed\">31533996</ArticleId></ArticleIdList></Reference><Reference><Citation>Sickbert-Bennett EE, Weber DJ, Gergen-Teague MF, Rutala WA, The effects of test variables on the efficacy of hand hygiene agents, Am. J. Infect. Control 32 (2) (2004) 69&#x2013;83, 10.1016/j.ajic.2003.09.003.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ajic.2003.09.003</ArticleId><ArticleId IdType=\"pubmed\">15057198</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloomfield SF, Aiello AE, Cookson B, O&#x2019;Boyle C, Larson EL, The effectiveness of hand hygiene procedures in reducing the risks of infections in home and community settings including handwashing and alcohol-based hand sanitizers, Am. J. Infect. Control 35 (10) (2007) S27&#x2013;S64, 10.1016/j.ajic.2007.07.001.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ajic.2007.07.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Park GW, Barclay L, Macinga D, Charbonneau D, Pettigrew CA, Vinje J, Comparative efficacy of seven hand sanitizers against Murine Norovirus, Feline Calicivirus, and GII.4 Norovirus, J. Food Prot 73 (12) (2010) 2232&#x2013;2238, 10.4315/0362-028X-73.12.2232.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4315/0362-028X-73.12.2232</ArticleId><ArticleId IdType=\"pubmed\">21219741</ArticleId></ArticleIdList></Reference><Reference><Citation>Julian TR, Canales RA, Leckie JO, Boehm AB, A model of exposure to rotavirus from nondietary ingestion iterated by simulated intermittent contacts, Risk Anal. 29 (5) (2009) 617&#x2013;632, 10.1111/j.1539-6924.2008.01193.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1539-6924.2008.01193.x</ArticleId><ArticleId IdType=\"pubmed\">19187484</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Alessio DJ, Meschievitz CK, Peterson JA, Dick CR, Dick EC, Short-duration exposure and the transmission of rhinoviral colds, J. Infect. Dis 150 (2) (1984) 189&#x2013;194, 10.1093/infdis/150.2.189.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/infdis/150.2.189</ArticleId><ArticleId IdType=\"pubmed\">6088645</ArticleId></ArticleIdList></Reference><Reference><Citation>Arizona Department of Health Services, &#x201c;Outbreak Threshold Guide: Schools/Child Care Establishments/Shelters.&#x201d; Nov. 23, 2011. Accessed: Aug. 29, 2024. [Online]. Available: chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/&#x2329;https://www.azdhs.gov/documents/preparedness/epidemiology-disease-control/disease-investigation-resources/outbreak-threshold-guide-schools.pdf&#x232a;.</Citation></Reference><Reference><Citation>World Health Organization, Guidelines for drinking-water quality: fourth edition incorporating the first and second addenda, + 1st add + 2nd add, World Health Organization, Geneva, 2022, &#x2329;https://apps.who.int/iris/handle/10665/352532&#x232a;. + 1st add + 2nd add.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35417116</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerrity D, Crank K, Steinle-Darling E, Pecson BM, Establishing pathogen log reduction value targets for direct potable reuse in the United States, AWWA Water Sci. 5 (5) (2023) e1353, 10.1002/aws2.1353.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/aws2.1353</ArticleId></ArticleIdList></Reference><Reference><Citation>Slovic P, The Perception of Risk, Taylor &amp; Francis, 2000.</Citation></Reference><Reference><Citation>Roberts S, &#x201c;The Swiss Cheese Model of Pandemic Defense,&#x201d; The New York Times, Dec. 05, 2020. Accessed: Jun. 21, 2022. [Online]. Available: &#x2329;https://www.nytimes.com/2020/12/05/health/coronavirus-swiss-cheese-infection-mackay.html&#x232a;.</Citation></Reference><Reference><Citation>Berendes D, Andujar A, Barrios LC, Hill V, Associations among school absenteeism, gastrointestinal and respiratory illness, and income &#x2014; United States, 2010&#x2013;2016, MMWR Morb. Mortal. Wkly. Rep 68 (53) (2020) 1201&#x2013;1205, 10.15585/mmwr.mm6853a1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.15585/mmwr.mm6853a1</ArticleId><ArticleId IdType=\"pmc\">PMC6973341</ArticleId><ArticleId IdType=\"pubmed\">31945036</ArticleId></ArticleIdList></Reference><Reference><Citation>Sexton JD, Wilson AM, Sassi HP, Reynolds KA, Tracking and controlling soft surface contamination in health care settings, Am. J. Infect. Control 46 (1) (2018) 39&#x2013;43, 10.1016/j.ajic.2017.08.002.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ajic.2017.08.002</ArticleId><ArticleId IdType=\"pubmed\">28916372</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson AM, Jones RM, Exploring spatial averaging of contamination in fomite microbial transfer models and implications for dose, J. Expo. Sci. Environ. Epidemiol (2021), 10.1038/s41370-021-00398-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/s41370-021-00398-2</ArticleId><ArticleId IdType=\"pmc\">PMC8571976</ArticleId><ArticleId IdType=\"pubmed\">34743183</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention, &#x201c;SARS-CoV-2 and Surface (Fomite) Transmission for Indoor Community Environments.&#x201d; Apr. 05, 2021. Accessed: Jul. 26, 2021. [Online]. Available: &#x2329;https://www.cdc.gov/coronavirus/2019-ncov/more/science-and-research/surface-transmission.html&#x232a;.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34009771</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrup L, Krogfelt KA, Hansen KS, Madsen AM, Transmission route of rhinovirus - the causative agent for common cold. A systematic review, Am. J. Infect. Control 51 (8) (2023) 938&#x2013;957, 10.1016/j.ajic.2022.12.005.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.ajic.2022.12.005</ArticleId><ArticleId IdType=\"pubmed\">36535318</ArticleId></ArticleIdList></Reference><Reference><Citation>Mubareka S, Lowen AC, Steel J, Coates AL, Garc&#xed;a-Sastre A, Palese P, Transmission of influenza virus via aerosols and fomites in the guinea pig model, J. Infect. Dis 199 (6) (2009) 858&#x2013;865, 10.1086/597073.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1086/597073</ArticleId><ArticleId IdType=\"pmc\">PMC4180291</ArticleId><ArticleId IdType=\"pubmed\">19434931</ArticleId></ArticleIdList></Reference><Reference><Citation>Leal Neto O, et al. , Combining wearable devices and mobile surveys to study child and youth development in Malawi: implementation study of a multimodal approach, JMIR Public Health Surveill. 7 (3) (2021) e23154, 10.2196/23154.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2196/23154</ArticleId><ArticleId IdType=\"pmc\">PMC7980111</ArticleId><ArticleId IdType=\"pubmed\">33536159</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"PubMed-not-MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">40667220</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">2692-8205</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2025</Year><Month>Jun</Month><Day>18</Day></PubDate></JournalIssue><Title>bioRxiv : the preprint server for biology</Title><ISOAbbreviation>bioRxiv</ISOAbbreviation></Journal><ArticleTitle>Immune pathways and perinatal environmental exposures contribute to epigenetic gestational age prediction and acceleration.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">2025.06.13.659090</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1101/2025.06.13.659090</ELocationID><Abstract><AbstractText>DNA methylation (DNAm), capturing biological gestational age (GA) and epigenetic gestational age acceleration (EGAA), can be modified by environmental exposures. The Asthma&amp;Allergy array is a new DNAm array developed with content focused on asthma and allergy loci. The association between content on the Asthma&amp;Allergy array and chronological GA and EGAA has not been evaluated alone or in the context of perinatal exposures. We performed an epigenome wide association study(EWAS) based on chronological GA at single CpG sites and regions. We further constructed a multi-CpG site methylation model to predict chronological GA in cord blood from 391 newborn children from a Detroit-based birth cohort. Associations between perinatal environmental factors with GA, epigenetic gestational age (EGA), and EGAA were assessed. We identified 2,435 CpG sites associated with chronological GA. HLA class II ( <i>HLA-DRB1,HLA-DQB1,HLA-DRB6</i> ) were the most significantly associated with chronological GA. Our multi-CpG site model attained predictive accuracy (cross-validated Pearson's correlation=0.75) comparable to other EGA methods. Using genes implicated in region-based analyses (n=395 regions), the pathways most significantly enriched with chronological GA-associated CpGs included T helper 1(Th1) and 2(Th2) activation, macrophage classical activation, and IL10 signaling, which were also enriched in at least one of the other published epigenetic clocks. In multi-exposure models, prenatal indoor pet exposure and unplanned C-section were associated with EGA deceleration, while infant's first-born status was associated with EGAA. Our findings highlight enrichment for T cell modulated pathways and antigen presentation as biological processes enriched in chronological GA, as well as novel perinatal factors that may impact EGAA.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Eapen</LastName><ForeName>Amy A</ForeName><Initials>AA</Initials><Identifier Source=\"ORCID\">0000-0003-1629-1511</Identifier></Author><Author ValidYN=\"Y\"><LastName>Loveless</LastName><ForeName>Ian M</ForeName><Initials>IM</Initials></Author><Author ValidYN=\"Y\"><LastName>Pan</LastName><ForeName>Mingming</ForeName><Initials>M</Initials></Author><Author ValidYN=\"Y\"><LastName>Liang</LastName><ForeName>Xiaoyu</ForeName><Initials>X</Initials></Author><Author ValidYN=\"Y\"><LastName>Urquhart</LastName><ForeName>Audrey</ForeName><Initials>A</Initials></Author><Author ValidYN=\"Y\"><LastName>Straughen</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Author><Author ValidYN=\"Y\"><LastName>Cassidy-Bushrow</LastName><ForeName>Andrea E</ForeName><Initials>AE</Initials></Author><Author ValidYN=\"Y\"><LastName>Sitarik</LastName><ForeName>Alexandra R</ForeName><Initials>AR</Initials></Author><Author ValidYN=\"Y\"><LastName>Simmerman</LastName><ForeName>Neil</ForeName><Initials>N</Initials></Author><Author ValidYN=\"Y\"><LastName>Thompson</LastName><ForeName>Emma E</ForeName><Initials>EE</Initials></Author><Author ValidYN=\"Y\"><LastName>Kottyan</LastName><ForeName>Leah</ForeName><Initials>L</Initials><Identifier Source=\"ORCID\">0000-0003-3979-2220</Identifier></Author><Author ValidYN=\"Y\"><LastName>Ober</LastName><ForeName>Carole</ForeName><Initials>C</Initials></Author><Author ValidYN=\"Y\"><LastName>Johnson</LastName><ForeName>Christine C</ForeName><Initials>CC</Initials></Author><Author ValidYN=\"Y\"><LastName>Zoratti</LastName><ForeName>Edward</ForeName><Initials>E</Initials></Author><Author ValidYN=\"Y\"><LastName>Levin</LastName><ForeName>Albert M</ForeName><Initials>AM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D000076942\">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2025</Year><Month>06</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>bioRxiv</MedlineTA><NlmUniqueID>101680187</NlmUniqueID><ISSNLinking>2692-8205</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"medline\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>5</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2025</Year><Month>7</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">40667220</ArticleId><ArticleId IdType=\"pmc\">PMC12262535</ArticleId><ArticleId IdType=\"doi\">10.1101/2025.06.13.659090</ArticleId><ArticleId IdType=\"pii\">2025.06.13.659090</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"In-Process\" Owner=\"NLM\"><PMID Version=\"1\">40665411</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>15</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1479-5876</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of translational medicine</Title><ISOAbbreviation>J Transl Med</ISOAbbreviation></Journal><ArticleTitle>Meta-analysis of microarray data to identify potential signature genes and MiRNAs associated with the pathogenesis of asthma.</ArticleTitle><Pagination><StartPage>796</StartPage><MedlinePgn>796</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1186/s12967-025-06646-5</ELocationID><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Vafadar</LastName><ForeName>Asma</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Alashti</LastName><ForeName>Shayan Khalili</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Khazayel</LastName><ForeName>Saeed</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Research and Technology, Kermanshah University of Medical Sciences, Kermanshah, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Babadi</LastName><ForeName>Sepideh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Eghtesadi</LastName><ForeName>Melika</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Younesi</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Savardashtaki</LastName><ForeName>Amir</ForeName><Initials>A</Initials><Identifier Source=\"ORCID\">0000-0003-1700-9426</Identifier><AffiliationInfo><Affiliation>Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran. dashtaki63@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infertility Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. dashtaki63@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Negahdaripour</LastName><ForeName>Manica</ForeName><Initials>M</Initials><Identifier Source=\"ORCID\">0000-0002-4265-1499</Identifier><AffiliationInfo><Affiliation>Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. manica.negahdaripour@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran. manica.negahdaripour@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Artificial Intelligence, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. manica.negahdaripour@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>31955</GrantID><Agency>Vice-Chancellor for Research, Shiraz University of Medical Sciences</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2025</Year><Month>07</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Transl Med</MedlineTA><NlmUniqueID>101190741</NlmUniqueID><ISSNLinking>1479-5876</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Asthma</Keyword><Keyword MajorTopicYN=\"N\">Bioinformatics</Keyword><Keyword MajorTopicYN=\"N\">Gene expression</Keyword><Keyword MajorTopicYN=\"N\">Hub genes</Keyword><Keyword MajorTopicYN=\"N\">Immune pathway</Keyword><Keyword MajorTopicYN=\"N\">MiRNA</Keyword><Keyword MajorTopicYN=\"N\">Microarray meta-analysis</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2025</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2025</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>0</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>0</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2025</Year><Month>7</Month><Day>15</Day><Hour>23</Hour><Minute>56</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">40665411</ArticleId><ArticleId IdType=\"doi\">10.1186/s12967-025-06646-5</ArticleId><ArticleId IdType=\"pii\">10.1186/s12967-025-06646-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Reddel HK, Bacharier LB, Bateman ED, Brightling CE, Brusselle GG, Buhl R, et al. Global initiative for asthma strategy 2021: executive summary and rationale for key changes. Am J Respir Crit Care Med. 2022;205(1):17&#x2013;35.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34658302</ArticleId></ArticleIdList></Reference><Reference><Citation>Porsbjerg C, Mel&#xe9;n E, Lehtim&#xe4;ki L, Shaw D, Asthma. Lancet (London England). 2023;401(10379):858&#x2013;73.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36682372</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammad H, Lambrecht BN. The basic immunology of asthma. Cell. 2021;184(9):2521&#x2013;2.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33930297</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr TF, Zeki AA, Kraft M. Eosinophilic and noneosinophilic asthma. Am J Respir Crit Care Med. 2018;197(1):22&#x2013;37.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28910134</ArticleId><ArticleId IdType=\"pmc\">5765385</ArticleId></ArticleIdList></Reference><Reference><Citation>Douwes J, Brooks C, Pearce N. Epidemiology of respiratory allergies and asthma. In: Ahrens W, Pigeot I, editors. Handbook of epidemiology. New York, NY: Springer New York; 2025. pp. 1&#x2013;66.</Citation></Reference><Reference><Citation>Calzetta L, Matera MG, Coppola A, Rogliani P. Prospects for severe asthma treatment. Curr Opin Pharmacol. 2021;56:52&#x2013;60.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33310456</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernabe E, Marcenes W, Abdulkader RS, Abreu LG, Afzal S, Alhalaiqa FN, et al. Trends in the global, regional, and National burden of oral conditions from 1990 to 2021: a systematic analysis for the global burden of disease study 2021. Lancet. 2025;405(10482):897&#x2013;910.</Citation></Reference><Reference><Citation>Singh P, Sharma A, Jha R, Arora S, Ahmad R, Rahmani AH, et al. Transcriptomic analysis delineates potential signature genes and MiRNAs associated with the pathogenesis of asthma. Sci Rep. 2020;10(1):13354.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32770056</ArticleId><ArticleId IdType=\"pmc\">7414199</ArticleId></ArticleIdList></Reference><Reference><Citation>Cay P, Singer CA, Ba MA. Gene network analysis for identification of MicroRNA biomarkers for asthma. Respir Res. 2022;23(1):378.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36572876</ArticleId><ArticleId IdType=\"pmc\">9793650</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonnesen B, Jensen J-US, Mathioudakis AG, Corlateanu A, Sivapalan P. Promising treatment biomarkers in asthma. Front Drug Saf Regul. 2023;3:1291471.</Citation></Reference><Reference><Citation>Shi F, Zhang Y, Qiu C. Gene polymorphisms in asthma: a narrative review. Annals Translational Med. 2022;10(12):711.</Citation></Reference><Reference><Citation>Kierbied&#x17a;-Guzik N, Soza&#x144;ska B. MiRNAs as modern biomarkers in asthma therapy. Int J Mol Sci. 2023;24(14).</Citation></Reference><Reference><Citation>Pasha MA, Hopp RJ, Habib N, Tang DD. Biomarkers in asthma, potential for therapeutic intervention. J Asthma. 2024;61(11):1376&#x2013;1391.</Citation></Reference><Reference><Citation>Girodet P-O. Strategies for identifying biomarkers in severe asthma. Am J Respir Crit Care Med. 2024;210(3):251&#x2013;252.</Citation></Reference><Reference><Citation>Salarikia SR, Kashkooli M, Taghipour MJ, Malekpour M, Negahdaripour M. Identification of hub pathways and drug candidates in gastric cancer through systems biology. Sci Rep. 2022;12:9099.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35650297</ArticleId><ArticleId IdType=\"pmc\">9160265</ArticleId></ArticleIdList></Reference><Reference><Citation>Malekpour M, Jafari A, Kashkooli M, Salarikia SR, Negahdaripour M. A systems biology approach for discovering the cellular and molecular aspects of psychogenic non-epileptic seizure. Front Psychiatry. 2023;14:1116892.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37252132</ArticleId><ArticleId IdType=\"pmc\">10213457</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui F, Liu R, Wang L, He J, Xu Y. Identification and validation of differentially expressed genes in allergic asthma pathogenesis using whole-transcriptome sequencing. Front Med (Lausanne). 2025;12:1545095.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">40309741</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Li Y, Wu R, Wang Y, Li P, Jiang T, et al. Epithelial and immune transcriptomic characteristics and possible regulatory mechanisms in asthma exacerbation: insights from integrated studies. Front Immunol. 2025;16:1512053.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">39917297</ArticleId><ArticleId IdType=\"pmc\">11798785</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez JL, Chen A, Diaz MP, Zirn N, Gupta A, Britto C, et al. A network of sputum MicroRNAs is associated with neutrophilic airway inflammation in asthma. Am J Respir Crit Care Med. 2020;202(1):51&#x2013;64.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32255668</ArticleId><ArticleId IdType=\"pmc\">7328332</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M, Alteneder M, Reiter W, Krausgruber T, Dobnikar L, Madern M, Single-cell and chromatin accessibility profiling reveals regulatory programs of pathogenic Th2 cells in allergic asthma. Nat Commun., O&#x2019;Beirne SL, Salit J, Kaner RJ, Crystal RG, Strulovici-Barel Y et al. Up-regulation of ACE2, the SARS-CoV-2 receptor, in asthmatics on maintenance inhaled corticosteroids. Respiratory research. 2021;22(1):200.</Citation></Reference><Reference><Citation>Clough E, Barrett T. The gene expression omnibus database. Stat Genomics: Methods Protocols. 2016;1418:93&#x2013;110.</Citation></Reference><Reference><Citation>Gong R, Wang Z, Tan G, Huang Y. Bioinformatics analysis revealed underlying molecular mechanisms associated with asthma severity and identified GABAergic related pathway as a potential therapy for Th2-high endotype asthma. Heliyon. 2024;10(7):e28401.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">38586354</ArticleId><ArticleId IdType=\"pmc\">10998110</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical Res ed). 2021;372:n71.</Citation></Reference><Reference><Citation>Savardashtaki A, Khalili Alashti S, Vafadar A, Sadeghi M, Baneshi M, Hashemi KS, et al. An integrated bioinformatic analysis of microarray datasets to identify biomarkers and miRNA-based regulatory networks in leishmaniasis. Sci Rep. 2024;14(1):12981.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">38839916</ArticleId><ArticleId IdType=\"pmc\">11153516</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Wang J, Chen J, Zhang X, Guo M, Yu G. A literature review of gene function prediction by modeling gene ontology. Front Genet. 2020;11:400.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32391061</ArticleId><ArticleId IdType=\"pmc\">7193026</ArticleId></ArticleIdList></Reference><Reference><Citation>Doncheva NT, Morris JH, Holze H, Kirsch R, Nastou KC, Cuesta-Astroz Y, et al. Cytoscape StringApp 2.0: analysis and visualization of heterogeneous biological networks. J Proteome Res. 2023;22(2):637&#x2013;46.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36512705</ArticleId></ArticleIdList></Reference><Reference><Citation>Durham J, Zhang J, Humphreys IR, Pei J, Cong Q. Recent advances in predicting and modeling protein-protein interactions. Trends Biochem Sci. 2023;48(6):527&#x2013;38.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37061423</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashemi KS, Aliabadi MK, Mehrara A, Talebi E, Hemmati AA, Rezaeiye RD, et al. A meta-analysis of microarray datasets to identify biological regulatory networks in Alzheimer&#x2019;s disease. Front Genet. 2023;14:1225196.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37705610</ArticleId><ArticleId IdType=\"pmc\">10497115</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajian-Tilaki K. Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation. Caspian J Intern Med. 2013;4(2):627&#x2013;35.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24009950</ArticleId><ArticleId IdType=\"pmc\">3755824</ArticleId></ArticleIdList></Reference><Reference><Citation>Bader GD, Hogue CW. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics. 2003;4:1&#x2013;27.</Citation></Reference><Reference><Citation>Brusselle GG, Koppelman GH. Biologic therapies for severe asthma. N Engl J Med. 2022;386(2):157&#x2013;71.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35020986</ArticleId></ArticleIdList></Reference><Reference><Citation>Gans MD, Gavrilova T. Understanding the immunology of asthma: pathophysiology, biomarkers, and treatments for asthma endotypes. Paediatr Respir Rev. 2020;36:118&#x2013;27.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31678040</ArticleId></ArticleIdList></Reference><Reference><Citation>Pijnenburg MW, Fleming L. Advances in Understanding and reducing the burden of severe asthma in children. Lancet Respiratory Med. 2020;8(10):1032&#x2013;44.</Citation></Reference><Reference><Citation>Peroni DG, Djukanovic R, Bradding P, Feather IH, Montefort S, Howarth PH, et al. Expression of CD44 and integrins in bronchial mucosa of normal and mildly asthmatic subjects. Eur Respir J. 1996;9(11):2236&#x2013;42.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8947066</ArticleId></ArticleIdList></Reference><Reference><Citation>Sano K, Yamauchi K, Hoshi H, Honma M, Tamura G, Shirato K. CD44 expression on blood eosinophils is a novel marker of bronchial asthma. Int Arch Allergy Immunol. 1997;114(Suppl 1):67&#x2013;71.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9363930</ArticleId></ArticleIdList></Reference><Reference><Citation>Katoh S. Critical involvement of CD44 in T helper type 2 Cell-Mediated eosinophilic airway inflammation in a mouse model of acute asthma. Front Immunol. 2021;12:811600.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35069598</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson P, Ruffell B. CD44 and its role in inflammation and inflammatory diseases. Inflamm Allergy Drug Targets. 2009;8(3):208&#x2013;20.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19601881</ArticleId></ArticleIdList></Reference><Reference><Citation>Varricchi G, Brightling CE, Grainge C, Lambrecht BN, Chanez P. Airway remodelling in asthma and the epithelium: on the edge of a new era. Eur Respir J. 2024;63(4).</Citation></Reference><Reference><Citation>Katoh S, Critical Involvement of CD44 in T Helper Type 2 Cell-Mediated Eosinophilic Airway Inflammation in a Mouse Model of Acute Asthma. Front Immunol, Grigoryev D, Breslin L, Cheadle C, Mathias R, Beaty T et al. Keratins: Important candidate genes for asthma and immune responsiveness to cockroach. Journal of Allergy and Clinical Immunology. 2007;119(1):S176.</Citation></Reference><Reference><Citation>Zhang C, Abudula A, Awuti M, Wang H, Aihemaiti X, Tusung T, et al. Plasma proteins as potential targets of abnormal Savda syndrome in asthma patients treated with unique Uighur prescription. Experimental Therapeutic Med. 2017;14(1):267&#x2013;75.</Citation></Reference><Reference><Citation>Nie X, Wei J, Hao Y, Tao J, Li Y, Liu M et al. Consistent biomarkers and related pathogenesis underlying asthma revealed by systems biology approach. Int J Mol Sci. 2019;20(16).</Citation></Reference><Reference><Citation>Wang F, Chen S, Liu HB, Parent CA, Coulombe PA. Keratin 6 regulates collective keratinocyte migration by altering cell&#x2013;cell and cell&#x2013;matrix adhesion. J Cell Biol. 2018;217(12):4314&#x2013;30.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30389720</ArticleId><ArticleId IdType=\"pmc\">6279382</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Shan H. Keratin 6A gene Silencing suppresses cell invasion and metastasis of nasopharyngeal carcinoma via the &#x3b2;&#x2013;catenin cascade. Mol Med Rep. 2019;19(5):3477&#x2013;84.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30896882</ArticleId><ArticleId IdType=\"pmc\">6471251</ArticleId></ArticleIdList></Reference><Reference><Citation>Ha H, Debnath B, Neamati N. Role of the CXCL8-CXCR1/2 Axis in Cancer and inflammatory diseases. Theranostics. 2017;7(6):1543&#x2013;88.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28529637</ArticleId><ArticleId IdType=\"pmc\">5436513</ArticleId></ArticleIdList></Reference><Reference><Citation>Mir MA, Bashir M, Ishfaq. Role of the CXCL8&#x2013;CXCR1/2 Axis in Cancer and inflammatory diseases. Cytokine and chemokine networks in Cancer. Springer; 2023. pp. 291&#x2013;329.</Citation></Reference><Reference><Citation>Georganas C, Liu H, Perlman H, Hoffmann A, Thimmapaya B, Pope RM. Regulation of IL-6 and IL-8 expression in rheumatoid arthritis synovial fibroblasts: the dominant role for NF-&#x3ba;B but not C/EBP&#x3b2; or c-Jun. J Immunol. 2000;165(12):7199&#x2013;206.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11120852</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu YM, Webster S, Flower D, Woll P. Interleukin-8/CXCL8 is a growth factor for human lung cancer cells. Br J Cancer. 2004;91(11):1970&#x2013;6.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15545974</ArticleId><ArticleId IdType=\"pmc\">2409768</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimm M, Elsbury S, Pavli P, Doe W. Interleukin 8: cells of origin in inflammatory bowel disease. Gut. 1996;38(1):90&#x2013;8.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8566866</ArticleId><ArticleId IdType=\"pmc\">1382985</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanabe T, Shimokawaji T, Kanoh S, Rubin BK. IL-33 stimulates CXCL 8/IL&#x2010;8 secretion in goblet cells but not normally differentiated airway cells. Clin Experimental Allergy. 2014;44(4):540&#x2013;52.</Citation></Reference><Reference><Citation>Ordonez CL, Shaughnessy TE, Matthay MA, Fahy JV. Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma: clinical and biologic significance. Am J Respir Crit Care Med. 2000;161(4):1185&#x2013;90.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10764310</ArticleId></ArticleIdList></Reference><Reference><Citation>Daldegan M, Teixeira M, Talvani A. Concentration of CCL11, CXCL8 and TNF-alpha in sputum and plasma of patients undergoing asthma or chronic obstructive pulmonary disease exacerbation. Braz J Med Biol Res. 2005;38:1359&#x2013;65.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16138219</ArticleId></ArticleIdList></Reference><Reference><Citation>Robroeks C, Rijkers G, J&#xf6;bsis Q, Hendriks H, Damoiseaux J, Zimmermann L, et al. Increased cytokines, chemokines and soluble adhesion molecules in exhaled breath condensate of asthmatic children. Clin Experimental Allergy. 2010;40(1):77&#x2013;84.</Citation></Reference><Reference><Citation>Qiu Y, Zhu J, Bandi V, Guntupalli KK, Jeffery PK. Bronchial mucosal inflammation and upregulation of CXC chemoattractants and receptors in severe exacerbations of asthma. Thorax. 2007;62(6):475&#x2013;82.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17234659</ArticleId><ArticleId IdType=\"pmc\">2117215</ArticleId></ArticleIdList></Reference><Reference><Citation>John AE, Zhu YM, Brightling CE, Pang L, Knox AJ. Human airway smooth muscle cells from asthmatic individuals have CXCL8 hypersecretion due to increased NF-&#x3ba;B p65, C/EBP&#x3b2;, and RNA polymerase II binding to the CXCL8 promoter. J Immunol. 2009;183(7):4682&#x2013;92.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19734226</ArticleId></ArticleIdList></Reference><Reference><Citation>Clifford RL, Patel JK, John AE, Tatler AL, Mazengarb L, Brightling CE, et al. CXCL8 histone H3 acetylation is dysfunctional in airway smooth muscle in asthma: regulation by BET. Am J Physiol Lung Cell Mol Physiol. 2015;308(9):L962&#x2013;72.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25713319</ArticleId><ArticleId IdType=\"pmc\">4421784</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes PJ. Transcription factors in airway diseases. Lab Invest. 2006;86(9):867&#x2013;72.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16865089</ArticleId></ArticleIdList></Reference><Reference><Citation>Hachim MY, Elemam NM, Ramakrishnan RK, Bajbouj K, Olivenstein R, Hachim IY, et al. Wnt signaling is deranged in asthmatic bronchial epithelium and fibroblasts. Front Cell Dev Biology. 2021;9:641404.</Citation></Reference><Reference><Citation>Hansel NN, Diette GB. Gene expression profiling in human asthma. Proceedings of the American Thoracic Society. 2007;4(1):32&#x2013;&#x2009;6.</Citation></Reference><Reference><Citation>Jin Y, Wang C, Liu X, Mu W, Chen Z, Yu D, et al. Molecular characterization of the microRNA-138-Fos-like antigen 1 (FOSL1) regulatory module in squamous cell carcinoma. J Biol Chem. 2011;286(46):40104&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21969367</ArticleId><ArticleId IdType=\"pmc\">3220531</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurus K, Hufnagel A, Geiger F, Graf S, Berking C, Heinemann A, et al. The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation. Oncogene. 2017;36(36):5110&#x2013;21.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28481878</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallejo A, Perurena N, Guruceaga E, Mazur PK, Martinez-Canarias S, Zandueta C, et al. An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer. Nat Commun. 2017;8(1):14294.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28220783</ArticleId><ArticleId IdType=\"pmc\">5321758</ArticleId></ArticleIdList></Reference><Reference><Citation>Rapp J, Jaromi L, Kvell K, Miskei G, Pongracz JE. WNT signaling&#x2013;lung cancer is no exception. Respir Res. 2017;18:1&#x2013;16.</Citation></Reference><Reference><Citation>Burgy O, K&#xf6;nigshoff M. The WNT signaling pathways in wound healing and fibrosis. Matrix Biol. 2018;68:67&#x2013;80.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29572156</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain M, Xu C, Lu M, Wu X, Tang L, Wu X. Wnt/&#x3b2;-catenin signaling links embryonic lung development and asthmatic airway remodeling. Biochim Et Biophys Acta (BBA)-Molecular Basis Disease. 2017;1863(12):3226&#x2013;42.</Citation></Reference><Reference><Citation>Elangovan IM, Vaz M, Tamatam CR, Potteti HR, Reddy NM, Reddy SP. FOSL1 promotes Kras-induced lung cancer through Amphiregulin and cell survival gene regulation. Am J Respir Cell Mol Biol. 2018;58(5):625&#x2013;35.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29112457</ArticleId><ArticleId IdType=\"pmc\">5946328</ArticleId></ArticleIdList></Reference><Reference><Citation>Shetty A, Bhosale SD, Tripathi SK, Buchacher T, Biradar R, Rasool O, et al. Interactome networks of FOSL1 and FOSL2 in human Th17 cells. ACS Omega. 2021;6(38):24834&#x2013;47.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34604665</ArticleId><ArticleId IdType=\"pmc\">8482465</ArticleId></ArticleIdList></Reference><Reference><Citation>Manning AM, Davis RJ. Targeting JNK for therapeutic benefit: from junk to gold? Nat Rev Drug Discovery. 2003;2(7):554&#x2013;65.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12815381</ArticleId></ArticleIdList></Reference><Reference><Citation>Nath P, Eynott P, Leung S-Y, Adcock IM, Bennett BL, Chung KF. Potential role of c-Jun NH2-terminal kinase in allergic airway inflammation and remodelling: effects of SP600125. Eur J Pharmacol. 2005;506(3):273&#x2013;83.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15627438</ArticleId></ArticleIdList></Reference><Reference><Citation>Caramori G, Casolari P, Adcock I. Role of transcription factors in the pathogenesis of asthma and COPD. Cell Communication Adhes. 2013;20(1&#x2013;2):21&#x2013;40.</Citation></Reference><Reference><Citation>Christenson SA, Steiling K, van den Berge M, Hijazi K, Hiemstra PS, Postma DS, et al. Asthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;191(7):758&#x2013;66.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25611785</ArticleId><ArticleId IdType=\"pmc\">4407484</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou Y, Huttenlocher A. Advancing chemokine research: the molecular function of CXCL8. J Clin Investig. 2024;134(10).</Citation></Reference><Reference><Citation>Osei ET, Brandsma C-A, Timens W, Heijink IH, Hackett T-L. Current perspectives on the role of interleukin-1 signalling in the pathogenesis of asthma and COPD. Eur Respir J. 2020;55(2).</Citation></Reference><Reference><Citation>Zhang S, Fan Y, Qin L, Fang X, Zhang C, Yue J, et al. IL-1&#x3b2; augments TGF-&#x3b2; inducing epithelial-mesenchymal transition of epithelial cells and associates with poor pulmonary function improvement in neutrophilic asthmatics. Respir Res. 2021;22(1):216.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34344357</ArticleId><ArticleId IdType=\"pmc\">8336269</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkoshi Z, TGF-&#x3b2; IL-1&#x3b2;. IL-6 levels and TGF-&#x3b2;/Smad pathway reactivity regulate the link between allergic diseases, cancer risk, and metabolic dysregulations. Front Immunol. 2024;15:1371753.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">38629073</ArticleId><ArticleId IdType=\"pmc\">11019030</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo X, Wang C, Xie D, Bai C, Mao C, Wang F. Serum dual-specificity phosphatase 1 reflects decreased exacerbation risk, correlates with less advanced exacerbation severity and lower inflammatory cytokines in children with asthma. Allergol Immunopathol. 2022;50(6):60&#x2013;7.</Citation></Reference><Reference><Citation>Jin Y, Hu D, Peterson EL, Eng C, Levin AM, Wells K, et al. Dual-specificity phosphatase 1 as a Pharmacogenetic modifier of inhaled steroid response among asthmatic patients. J Allergy Clin Immunol. 2010;126(3):618&#x2013;25.e1-2.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20673984</ArticleId><ArticleId IdType=\"pmc\">2943151</ArticleId></ArticleIdList></Reference><Reference><Citation>Theodorou J, Nowak E, B&#xf6;ck A, Salvermoser M, Beerweiler C, Zeber K, et al. Mitogen-activated protein kinase signaling in childhood asthma development and environment&#x2010;mediated protection. Pediatr Allergy Immunol. 2022;33(1):e13657.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34455626</ArticleId></ArticleIdList></Reference><Reference><Citation>Manley GCA, Parker LC, Zhang Y. Emerging regulatory roles of Dual-Specificity phosphatases in inflammatory airway disease. Int J Mol Sci. 2019;20(3).</Citation></Reference><Reference><Citation>Hoppst&#xe4;dter J, Ammit AJ. Role of dual-specificity phosphatase 1 in glucocorticoid-driven anti-inflammatory responses. Front Immunol. 2019;10:1446.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31316508</ArticleId><ArticleId IdType=\"pmc\">6611420</ArticleId></ArticleIdList></Reference><Reference><Citation>Rumzhum N, Ammit A. Cyclooxygenase 2: its regulation, role and impact in airway inflammation. Clin Experimental Allergy. 2016;46(3):397&#x2013;410.</Citation></Reference><Reference><Citation>Tsatsanis C, Androulidaki A, Venihaki M, Margioris AN. Signalling networks regulating cyclooxygenase-2. Int J Biochem Cell Biol. 2006;38(10):1654&#x2013;61.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16713323</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T, Zhang L, Joo D, Sun S-C. NF-&#x3ba;B signaling in inflammation. Signal Transduct Target Therapy. 2017;2(1):1&#x2013;9.</Citation></Reference><Reference><Citation>Chan IH, Tang NL, Leung TF, Ma SL, Zhang YP, Wong GW, et al. Association of prostaglandin-endoperoxide synthase 2 gene polymorphisms with asthma and atopy in Chinese children. Allergy. 2007;62(7):802&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17573729</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B, Wu L, Chen J, Dong L, Chen C, Wen Z, et al. Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets. Signal Transduct Target Therapy. 2021;6(1):94.</Citation></Reference><Reference><Citation>Mart&#xed;n-V&#xe1;zquez E, Cobo-Vuilleumier N, L&#xf3;pez-Noriega L, Lorenzo PI, Gauthier BR. The PTGS2/COX2-PGE(2) signaling cascade in inflammation: pro or anti? A case study with type 1 diabetes mellitus. Int J Biol Sci. 2023;19(13):4157&#x2013;65.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37705740</ArticleId><ArticleId IdType=\"pmc\">10496497</ArticleId></ArticleIdList></Reference><Reference><Citation>Vafadar A, Mokaram P, Erfani M, Yousefi Z, Farhadi A, Elham Shirazi T, et al. The effect of decitabine on the expression and methylation of the PPP1CA, BTG2, and PTEN in association with changes in miR-125b, miR&#x2010;17, and miR&#x2010;181b in NALM6 cell line. J Cell Biochem. 2019;120(8):13156&#x2013;67.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30912184</ArticleId></ArticleIdList></Reference><Reference><Citation>Taka S, Tzani-Tzanopoulou P, Wanstall H, Papadopoulos NG. MicroRNAs in asthma and respiratory infections: identifying common pathways. Allergy Asthma Immunol Res. 2019;12(1):4&#x2013;23.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">6875476</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F, Weng X, Zhu J, Tang Q, Lei M, Zhou W. Identification and validation of three potential biomarkers and immune microenvironment for in severe asthma in microarray and single-cell datasets. J Asthma. 2024;61(10):1252&#x2013;64.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">38647226</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S-Y, Chen Y-L, Li P-C, Cheng T-S, Chu Y-S, Shen Y-S, et al. Engineered extracellular vesicles carrying let-7a-5p for alleviating inflammation in acute lung injury. J Biomed Sci. 2024;31(1):30.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">38500170</ArticleId><ArticleId IdType=\"pmc\">10949767</ArticleId></ArticleIdList></Reference><Reference><Citation>Polikepahad S, Knight JM, Naghavi AO, Oplt T, Creighton CJ, Shaw C, et al. Proinflammatory role for let-7 MicroRNAS in experimental asthma. J Biol Chem. 2010;285(39):30139&#x2013;49.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20630862</ArticleId><ArticleId IdType=\"pmc\">2943272</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen K, Ni K, Guo J, Bu B, Liu L, Pan Y, et al. MircroRNA Let-7a-5p in airway smooth muscle cells is most responsive to high stretch in association with cell mechanics modulation. Front Physiol. 2022;13:830406.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35399286</ArticleId><ArticleId IdType=\"pmc\">8990250</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan X, Yu H, Liu Y, Hou J, Yang Q, Zhao Y. miR-27a-3p functions as a tumor suppressor and regulates Non-Small cell lung Cancer cell proliferation via targeting HOXB8. Technol Cancer Res Treat. 2019;18:1533033819861971.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31319766</ArticleId><ArticleId IdType=\"pmc\">6640059</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Yang L, Sun P, Guo C, Jin Y, Jing XJTCRJ. Expression patterns of serum miR-27a&#x2010;3p and activating transcription factor 3 in children with bronchial asthma and their correlations with airway inflammation. Clin Respir J. 2025.19(3):e13631.</Citation></Reference><Reference><Citation>Bayati P, Kalantari M, Assarehzadegan M-A, Poormoghim H, Mojtabavi N. MiR-27a as a diagnostic biomarker and potential therapeutic target in systemic sclerosis. Sci Rep. 2022;12(1):18932.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36344812</ArticleId><ArticleId IdType=\"pmc\">9640682</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma R, Tiwari A, McGeachie MJ. Recent MiRNA research in asthma. Curr Allergy Asthma Rep. 2022;22(12):231&#x2013;58.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36459329</ArticleId><ArticleId IdType=\"pmc\">9732064</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexandrova E, Miglino N, Hashim A, Nassa G, Stellato C, Tamm M et al. Small RNA profiling reveals deregulated PTEN/PI3K/Akt pathway in asthmatic bronchial smooth muscle cells. J Allergy Clin Immunol. 2016;137:58&#x2013;67.</Citation></Reference><Reference><Citation>He L, Liu J, Wang X, Wang Y, Zhu J, Kang X. Identifying a novel serum MicroRNA biomarker panel for the diagnosis of childhood asthma. Experimental Biology Med (Maywood NJ). 2022;247(19):1732&#x2013;40.</Citation></Reference><Reference><Citation>He L, Liu J, Wang X, Wang Y, Zhu J, Kang X. Identifying a novel serum MicroRNA biomarker panel for the diagnosis of childhood asthma. Experimental Biology Med. 2022;247(19):1732&#x2013;40.</Citation></Reference><Reference><Citation>Wang X, Chen Y, Yuan W, Yao L, Wang S, Jia Z, et al. MicroRNA-155-5p is a key regulator of allergic inflammation, modulating the epithelial barrier by targeting PKI&#x3b1;. Cell Death Dis. 2019;10(12):884.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31767859</ArticleId><ArticleId IdType=\"pmc\">6877533</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Panganiban R, Kho AT, McGeachie MJ, Farnam L, Chase RP, et al. Circulating MicroRNAs and treatment response in childhood asthma. Am J Respir Crit Care Med. 2020;202(1):65&#x2013;72.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32272022</ArticleId><ArticleId IdType=\"pmc\">7328325</ArticleId></ArticleIdList></Reference><Reference><Citation>Malmh&#xe4;ll C, Johansson K, Winkler C, Alawieh S, Ekerljung L. R&#xe5;dinger MJSjoi. Altered miR-155 expression in allergic asthmatic airways. Scand J Immunol. 2017;85(4):300&#x2013;7.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28199728</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenberg L, Liu C, Sharma R, Wood C, Vyhlidal CA, Gaedigk R et al. Intrauterine smoke exposure, MicroRNA expression during human lung development, and childhood asthma. Int J Mol Sci. 2023;24(9).</Citation></Reference><Reference><Citation>Park J, Cho M, Cho J, Kim EE, Song EJ. MicroRNA-101-3p suppresses Cancer cell growth by inhibiting the USP47-Induced deubiquitination of RPL11. Cancers. 2022;14(4).</Citation></Reference><Reference><Citation>Fang L, Wang X, Zhang M, Khan P, Tamm M, Roth M. MicroRNA-101-3p suppresses mTOR and causes mitochondrial fragmentation and cell degeneration in COPD. Can Respir J. 2022;2022:5933324.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36518817</ArticleId><ArticleId IdType=\"pmc\">9744603</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahmer T, Krauss-Etschmann S, Buschmann D, Behrends J, Watz H, Kirsten A-M, et al. miR-122-5p and miR-191-5p are increased in plasma small extracellular vesicles in asthma. European Respiratory Society; 2019.</Citation></Reference><Reference><Citation>Negahdaripour M, Owji H, Eskandari S, Zamani M, Vakili B, Nezafat N. Small extracellular vesicles (sEVs): discovery, functions, applications, detection methods and various engineered forms. Expert Opin Biol Ther. 2021;21(3):371&#x2013;94.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32945228</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpi S, Polini B, Nieri D, Doccini S, Conti M, Bazzan E, et al. Extracellular vesicles induce nuclear factor-&#x3ba;b activation and interleukin-8 synthesis through mirna-191-5p contributing to inflammatory processes: potential implications in the pathogenesis of chronic obstructive pulmonary disease. Biomolecules. 2024;14(8):1030.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">39199417</ArticleId><ArticleId IdType=\"pmc\">11352467</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigo-Mu&#xf1;oz JM, Ca&#xf1;as JA, Sastre B, Gil-Mart&#xed;nez M, Garc&#xed;a Latorre R, Sastre J, et al. Role of miR-185-5p as modulator of Periostin synthesis and smooth muscle contraction in asthma. J Cell Physiol. 2022;237(2):1498&#x2013;508.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34698372</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L, Yi M, Tan Y, Yi Z, Zhang Y. A comprehensive analysis of MicroRNAs as diagnostic biomarkers for asthma. Ther Adv Respir Dis. 2020;14:1753466620981863.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33357010</ArticleId><ArticleId IdType=\"pmc\">7768876</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou W, Cai C, Lu J, Fan Q. miR-129&#x2010;2 upregulation induces apoptosis and promotes NSCLC chemosensitivity by targeting SOX4. Thorac Cancer. 2022;13(7):956&#x2013;64.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35146917</ArticleId><ArticleId IdType=\"pmc\">8977175</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">40665407</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>15</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1756-0500</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>15</Day></PubDate></JournalIssue><Title>BMC research notes</Title><ISOAbbreviation>BMC Res Notes</ISOAbbreviation></Journal><ArticleTitle>Burden level and quality of life of caregivers of hemodialysis patient's in central India: a mixed-method cross-sectional study.</ArticleTitle><Pagination><StartPage>291</StartPage><MedlinePgn>291</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1186/s13104-025-07374-1</ELocationID><Abstract><AbstractText Label=\"PURPOSE\" NlmCategory=\"OBJECTIVE\">Caregivers of hemodialysis patients are at high risk of developing reduced quality of life (QoL) and increased caregiver burden.</AbstractText><AbstractText Label=\"AIM\" NlmCategory=\"OBJECTIVE\">This study aims to explore the level of caregiver burden and quality of life in caregivers of hemodialysis patients in central India.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"METHODS\">This cross-sectional mixed-method study was undertaken among caregivers of stable hemodialysis patients attending a tertiary care hospital in central India. The Zarit Burden Interview (ZBI) and WHOQoL BREF questionnaire measured caregiver burden and QoL. The qualitative data was gathered through in-depth interviews using a semi-structured open-ended questionnaire that delved into their personal experiences with caregiving. The transcripts of these interviews were analysed using applied thematic analysis, allowing for the identification and exploration of recurring themes and patterns within the data.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">A total of 105 caregivers took part in this study, with a mean age of 40.04&#x2009;&#xb1;&#x2009;12.96 years. 56 (53.3%) caregivers were female. Most (48.6%, n&#x2009;=&#x2009;51) were spouses/partners. Ten caregivers (9.5%) had to change their occupations due to caregiving responsibilities. 14 (23.33%) had comorbidities (diabetes, hypertension, asthma, and arthritis) themselves. The mean caregiver burden level (ZBI) was 18.55&#x2009;&#xb1;&#x2009;7.58. Most (59.0%) experienced mild to moderate burden, while 28.6% reported a high burden. The WHOQoL BREF mean score of various domains of physical health, psychological, social relationship and environmental was 35.70&#x2009;&#xb1;&#x2009;12.14, 44.20&#x2009;&#xb1;&#x2009;13.28, 44.28&#x2009;&#xb1;&#x2009;15.10 and 40.07&#x2009;&#xb1;&#x2009;13.36 respectively. The thematic analysis revealed, difficulty in continuing education and employment, changing jobs, the need to travel long distances to reach dialysis facilities and hardship due to COVID-19 pandemic as recurring challenges among caregivers.</AbstractText><AbstractText Label=\"CONCLUSION\" NlmCategory=\"CONCLUSIONS\">Caregivers of Hemodialysis patients had significant caregiver burden and poor QoL. Regular assessment and special attention are needed for these caregivers.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Ramasamy</LastName><ForeName>Senthilkumar</ForeName><Initials>S</Initials><Identifier Source=\"ORCID\">0000-0002-4896-4576</Identifier><AffiliationInfo><Affiliation>School of Public Health (at time of study), All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vedanta Medical Research Foundation (BALCO Medical Centre), Raipur, Chhattisgarh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Rathore</LastName><ForeName>Vinay</ForeName><Initials>V</Initials><Identifier Source=\"ORCID\">0000-0003-4315-5072</Identifier><AffiliationInfo><Affiliation>Department of Nephrology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Agrawal</LastName><ForeName>Varun</ForeName><Initials>V</Initials><Identifier Source=\"ORCID\">0009-0007-5301-7163</Identifier><AffiliationInfo><Affiliation>Department of Nephrology, Dau Kalyan Singh Post Graduate Institute and Research center, Raipur, Chhattisgarh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Galhotra</LastName><ForeName>Abhiruchi</ForeName><Initials>A</Initials><Identifier Source=\"ORCID\">0000-0001-6169-8527</Identifier><AffiliationInfo><Affiliation>Department of Community &amp; Family Medicine, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India. abhiruchigalhotra@aiimsraipur.edu.in.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2025</Year><Month>07</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Res Notes</MedlineTA><NlmUniqueID>101462768</NlmUniqueID><ISSNLinking>1756-0500</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D005260\" MajorTopicYN=\"N\">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D003430\" MajorTopicYN=\"N\">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008297\" MajorTopicYN=\"N\">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D007194\" MajorTopicYN=\"N\" Type=\"Geographic\">India</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011788\" MajorTopicYN=\"Y\">Quality of Life</DescriptorName><QualifierName UI=\"Q000523\" MajorTopicYN=\"N\">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D006435\" MajorTopicYN=\"Y\">Renal Dialysis</DescriptorName><QualifierName UI=\"Q000523\" MajorTopicYN=\"N\">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000328\" MajorTopicYN=\"N\">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D017028\" MajorTopicYN=\"Y\">Caregivers</DescriptorName><QualifierName UI=\"Q000523\" MajorTopicYN=\"N\">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D008875\" MajorTopicYN=\"N\">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011795\" MajorTopicYN=\"N\">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D017281\" MajorTopicYN=\"Y\">Cost of Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000084802\" MajorTopicYN=\"Y\">Caregiver Burden</DescriptorName><QualifierName UI=\"Q000523\" MajorTopicYN=\"N\">psychology</QualifierName><QualifierName UI=\"Q000453\" MajorTopicYN=\"N\">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Caregiver burden</Keyword><Keyword MajorTopicYN=\"N\">Hemodialysis</Keyword><Keyword MajorTopicYN=\"N\">WHOQoL BREF</Keyword><Keyword MajorTopicYN=\"N\">Zarit burden interview</Keyword></KeywordList><CoiStatement>Declarations. Ethical approval and consent to participate: This study was approved by the Institutional Ethical Committee with IEC Proposal No: AIIMSRPR/IEC/2021/1041 from the All India Institute of Medical Sciences, Raipur, Chhattisgarh, India. All participants signed an informed written consent before participation and informed consent was obtained from parents and/or legal guardians of minor/illiterate study participants. The study was conducted under the principles of the Helsinki Declaration. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>12</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2025</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>0</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2025</Year><Month>7</Month><Day>15</Day><Hour>23</Hour><Minute>56</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">40665407</ArticleId><ArticleId IdType=\"doi\">10.1186/s13104-025-07374-1</ArticleId><ArticleId IdType=\"pii\">10.1186/s13104-025-07374-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lv JC, Zhang LX. Prevalence and disease burden of chronic kidney disease. Adv Exp Med Biol. 2019;1165:3&#x2013;15.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31399958</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh AK, Farag YMK, Mittal BV, Subramanian KK, Reddy SRK, Acharya VN, et al. Epidemiology and risk factors of chronic kidney disease in India - results from the SEEK (Screening and early evaluation of kidney Disease) study. BMC Nephrol. 2013;14:114.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23714169</ArticleId><ArticleId IdType=\"pmc\">3848478</ArticleId></ArticleIdList></Reference><Reference><Citation>Luyckx VA, Harris DCH, Varghese C, Jha V. Bringing equity in access to quality dialysis. Lancet. 2021;398(10294):10&#x2013;1.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33865498</ArticleId></ArticleIdList></Reference><Reference><Citation>Salehitali S, Ahmadi F, Hasanpour Dehkordi A, Noorian K, Fereidooni-Moghadam M, Zarea K. Progressive exhaustion: a qualitative study on the experiences of Iranian family caregivers regarding patients undergoing Hemodialysis. Int J Nurs Sci. 2018;5(2):193&#x2013;200.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31406824</ArticleId><ArticleId IdType=\"pmc\">6626230</ArticleId></ArticleIdList></Reference><Reference><Citation>Mapes DL, Bragg-Gresham JL, Bommer J, Fukuhara S, McKevitt P, Wikstr&#xf6;m B, et al. Health-related quality of life in the Dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis. 2004;44(5 Suppl 2):54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15486875</ArticleId></ArticleIdList></Reference><Reference><Citation>Suri RS, Larive B, Garg AX, Hall YN, Pierratos A, Chertow GM, Gorodetskeya I, Kliger AS, FHN Study Group. Burden on caregivers as perceived by Hemodialysis patients in the frequent Hemodialysis network (FHN) trials. Nephrol Dial Transpl. 2011;26(7):2316&#x2013;22.</Citation></Reference><Reference><Citation>WHO. Guidelines on community-level interventions to manage declines in intrinsic capacity evidence profile. Integrated care for older people (ICOPE). caregiver support; 2017.</Citation></Reference><Reference><Citation>Vovlianou S, Koutlas V, Ikonomou M, Vassilikopoulos T, Papoulidou F, Dounousi E. Quality of life of caregivers of end-stage kidney disease patients: caregivers or care recipients? J Ren Care. 2023;49(1):56&#x2013;72.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34706151</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaji KS, Reddy MS. Caregiving: a public health priority. Indian J Psychol Med. 2012;34(4):303&#x2013;5.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23723535</ArticleId><ArticleId IdType=\"pmc\">3662124</ArticleId></ArticleIdList></Reference><Reference><Citation>Bharati J, Jha V. Global Dialysis perspective: India. Kidney360. 2020;1(10):1143&#x2013;7.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35368789</ArticleId><ArticleId IdType=\"pmc\">8815477</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H, Chang M, Rose K, Kim S. Predictors of caregiver burden in caregivers of individuals with dementia. J Adv Nurs. 2012;68(4):846&#x2013;55.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21793872</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafari H, Ebrahimi A, Aghaei A, Khatony A. The relationship between care burden and quality of life in caregivers of Hemodialysis patients. BMC Nephrol. 2018;19(1):321.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30419837</ArticleId><ArticleId IdType=\"pmc\">6233261</ArticleId></ArticleIdList></Reference><Reference><Citation>Beanlands H, Horsburgh ME, Fox S, Howe A, Locking-Cusolito H, Pare K, Thrasher C. Caregiving by family and friends of adults receiving dialysis. Nephrol Nurs J. 2005 Nov-Dec;32(6):621&#x2013;31.</Citation></Reference><Reference><Citation>Sajadi SA, Farsi Z, Akbari R, Sadeghi A, Akbarzadeh Pasha A. Investigating the relationship between quality of life and hope in family caregivers of Hemodialysis patients and related factors. BMC Nephrol. 2021;22(1):383.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34781888</ArticleId><ArticleId IdType=\"pmc\">8594219</ArticleId></ArticleIdList></Reference><Reference><Citation>Himmelfarb J, Vanholder R, Mehrotra R, Tonelli M. The current and future landscape of dialysis. Nat Rev Nephrol. 2020;16(10):573&#x2013;85.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32733095</ArticleId><ArticleId IdType=\"pmc\">7391926</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe9;dard M, Molloy DW, Squire L, Dubois S, Lever JA, O&#x2019;Donnell M. The Zarit burden interview: a new short version and screening version. Gerontologist. 2001;41(5):652&#x2013;7.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11574710</ArticleId></ArticleIdList></Reference><Reference><Citation>Development of the World Health Organization WHOQOL-BREF quality of life assessment. WHOQOL Group Psychol Med. 1998;28(3):551&#x2013;8.</Citation></Reference><Reference><Citation>Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Res Psychol. 2006;3(2):77&#x2013;101.</Citation></Reference><Reference><Citation>Mishra S, Gulia A, Satapathy S, Gogia A, Sharma A, Bhatnagar S. Caregiver burden and quality of life among family caregivers of Cancer patients on chemotherapy: A prospective observational study. Indian J Palliat Care. 2021 Jan-Mar;27(1):109&#x2013;12.</Citation></Reference><Reference><Citation>Joseph SJ, Bhandari SS, Dutta S, Khatri D, Upadhyay A. Assessing burden and its determinants in caregivers of chronic kidney disease patients undergoing haemodialysis. Open J Psychiatry Allied Sci. 2021 Jul-Dec;12(2):96&#x2013;100.</Citation></Reference><Reference><Citation>Joy J, TJ HK, Abraham PM, Gopalakrishnan S. Burden and resilience in caregivers of patients on maintenance haemodialysis. Int J Res Med Sci. 2019;7(11):4033&#x2013;7.</Citation></Reference><Reference><Citation>Mon&#xe1;rrez-Espino J, Delgado-Valles JA, Ram&#xed;rez-Garc&#xed;a G. Quality of life in primary caregivers of patients in peritoneal dialysis and Hemodialysis. J Bras Nefrol. 2021 Oct-Dec;43(4):486&#x2013;94.</Citation></Reference><Reference><Citation>Usman Shah HB, Atif I, Rashid F, Babar MW, Arshad F, Qamar W, Khan OA, Qadir ML. Assessment of caregiver burden of patients receiving dialysis treatment in Rawalpindi. J Pak Med Assoc. 2017;67(10):1498&#x2013;501.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28955063</ArticleId></ArticleIdList></Reference><Reference><Citation>Alshammari B, Noble H, McAneney H, Alshammari F, O&#x2019;Halloran P. Caregiver burden in informal caregivers of patients in Saudi Arabia receiving hemodialysis: A Mixed-Methods study. Healthc (Basel). 2023;11(3):366.</Citation></Reference><Reference><Citation>Mata-Lima A, Paquete AR, Serrano-Olmedo JJ. Remote patient monitoring and management in nephrology: A systematic review. Nefrolog&#xed;a. 2024;44(5):639&#x2013;67.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">39547777</ArticleId></ArticleIdList></Reference><Reference><Citation>Lobbedez T, Verger C, Ryckelynck JP, Fabre E, Evans D. Is assisted peritoneal dialysis associated with technique survival when competing events are considered? Clin J Am Soc Nephrol. 2012;7(4):612&#x2013;8. https://doi.org/10.2215/CJN.10161011</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2215/CJN.10161011</ArticleId><ArticleId IdType=\"pubmed\">22344506</ArticleId></ArticleIdList></Reference><Reference><Citation>Benain JP, Faller B, Briat C, Jacquelinet C, Brami M, Aoustin M, Dubois JP, Rieu P, Behaghel C, Duru G. Co&#xfb;t de La prise En charge de La dialyse En France [Cost of dialysis in France]. Nephrol Ther. 2007;3(3):96&#x2013;106.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17540311</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaul S, Singh NP, Gupta AK, Sarkar T. PS-C18-12: stress and coping strategy among caregivers of hypertensive patients undergoing hemodialysis- a prospective study. J Hypertens. 2023;41(Suppl 1):e388.</Citation></Reference><Reference><Citation>Sotoudeh R, Alavi M. The effect of educational intervention on the quality of life of family caregivers of Hemodialysis patients: A randomised controlled trial. J Educ Health Promot. 2023;12:62.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37113425</ArticleId><ArticleId IdType=\"pmc\">10127472</ArticleId></ArticleIdList></Reference><Reference><Citation>Jardim VR, Reis IA, Amaral SV, Torres HD. Quality of life of family caregivers of patients under Hemodialysis. Acta Paulista De Enfermagem. 2023;36:eAPE00372.</Citation></Reference><Reference><Citation>Nawal AF, Dalia I, Seif EL, Eman M. Quality of life among family caregivers of patients undergoing Hemodialysis. Med J Cairo Univ. 2018;86(December):4137&#x2013;44.</Citation></Reference><Reference><Citation>Hileman JW, Lackey NR, Hassanein RS. Identifying the needs of home caregivers of patients with cancer. Oncol Nurs Forum. 1992;19(5):771&#x2013;7.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">1608841</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews M, Reid J, McKeaveney C, Noble H. Knowledge requirements and unmet needs of informal caregivers of patients with End-Stage kidney disease (ESKD) receiving haemodialysis: A narrative review. Healthc (Basel). 2021;10(1):57.</Citation></Reference><Reference><Citation>Sheets DJ, Black K, Kaye LW. Who cares for caregivers? Evidence-based approaches to family support. J Gerontol Soc Work. 2014;57(6&#x2013;7):525&#x2013;30.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25105462</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbasi A, Rahmani H, Shariati A, Asayesh H, Ashrafrezaee N, Mollaei E, et al. The relationship between caring burden and coping strategies in Hemodialysis patients caregivers. J Urmia Nurs Midwifery Fac. 2012;10(4):533&#x2013;9.</Citation></Reference><Reference><Citation>Askaryzadeh Mahani M, Ghasemi M, Arab M, Baniasadi Z, Omidi A, Irani PS. The correlation between caregiver burden with depression and quality of life among informal caregivers of Hemodialysis and thalassemia patients during the COVID-19 pandemic: a cross-sectional study. BMC Nurs. 2023;22(1):183.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37246222</ArticleId><ArticleId IdType=\"pmc\">10225281</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor F, Gutteridge R, Willis C. Peer support for CKD patients and carers: overcoming barriers and facilitating access. Health Expect. 2016;19(3):617&#x2013;30.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25649115</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">40665383</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>15</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1546-0096</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>15</Day></PubDate></JournalIssue><Title>Pediatric rheumatology online journal</Title><ISOAbbreviation>Pediatr Rheumatol Online J</ISOAbbreviation></Journal><ArticleTitle>Utility of patient-reported outcomes for pulmonary symptoms and sleep disturbance and impairment in children with systemic juvenile idiopathic arthritis.</ArticleTitle><Pagination><StartPage>74</StartPage><MedlinePgn>74</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1186/s12969-025-01126-y</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\" NlmCategory=\"BACKGROUND\">Patient-reported outcomes (PROs) are critical assessment tools for clinical practice, observational studies, and interventional trials. While families of children with systemic juvenile idiopathic arthritis (SJIA) and SJIA-associated lung disease (SJIA-LD) report significant limitations in their quality of life, existing PROs for juvenile idiopathic arthritis may not properly measure the full impact of these disorders. Our objective was to utilize a newly developed lung symptom survey as well as existing, validated Patient-Reported Outcomes Measurement Information System (PROMIS) measures in children with SJIA with and without LD.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"METHODS\">Participants were parents/guardians of SJIA patients&#x2009;&#x2264;&#x2009;18 years and were invited to participate using the Cincinnati Children's Hospital Medical Center (CCHMC) JIA Registry, and memberships in the Systemic JIA Foundation, and SJIA Facebook Group. Participants provided proxy-reports for their child using several PRO questionnaires [CCHMC Lung Symptom Survey; PROMIS Asthma Impact, Sleep Disturbance, Sleep Impairment Forms] and selected demographic and SJIA specific information.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">There were 139 responses, of which 40.3% (n&#x2009;=&#x2009;57) reported some lung disease including 12.9% (n&#x2009;=&#x2009;20) with interstitial lung disease (ILD), pulmonary alveolar proteinosis (PAP) and/or pulmonary artery hypertension (PAH). All SJIA patients with any lung disease and those with ILD/PAP/PAH had significantly higher total questionnaire scores than patients without lung disease on the CCHMC Lung Symptoms Survey. Both the full survey and individual questions showed good ability to distinguish patients with ILD/PAP/PAH from those without (area under the curve (AUC)&#x2009;&gt;&#x2009;0.7). The majority of patients reported some level of sleep disturbance (n&#x2009;=&#x2009;71/139&#x2009;=&#x2009;51.1%) and sleep impairment 53.2% (n&#x2009;=&#x2009;74) regardless of presence or absence of lung disease, including moderate to severe sleep impairment and/or disturbance in 48% of SJIA patients.</AbstractText><AbstractText Label=\"CONCLUSIONS\" NlmCategory=\"CONCLUSIONS\">Children with SJIA and lung problems had higher scores on the CCHMC Lung Symptom Survey; however, these measures did not discriminate between SJIA-LD and other pulmonary conditions such as asthma. Based on PROMIS measures, a majority of children with SJIA had sleep disturbance and impairment, regardless of steroid use or presence of lung disease.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Nguyen</LastName><ForeName>Kim</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, TriHealth Hospital System, Cincinnati, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Yasin</LastName><ForeName>Shima</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, 3333 Burnet Ave, MLC 4010, Cincinnati, OH, 45208, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Fall</LastName><ForeName>Ndate</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, 3333 Burnet Ave, MLC 4010, Cincinnati, OH, 45208, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Grom</LastName><ForeName>Alexei A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, 3333 Burnet Ave, MLC 4010, Cincinnati, OH, 45208, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Brunner</LastName><ForeName>Hermine I</ForeName><Initials>HI</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, 3333 Burnet Ave, MLC 4010, Cincinnati, OH, 45208, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Towe</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Pulmonary Medicine, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave, MLC 4010, Cincinnati, OH, 45208, USA. Christopher.towe@cchmc.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA. Christopher.towe@cchmc.org.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Schulert</LastName><ForeName>Grant S</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, 3333 Burnet Ave, MLC 4010, Cincinnati, OH, 45208, USA. Grant.schulert@cchmc.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA. Grant.schulert@cchmc.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>GAP Award</GrantID><Agency>Cincinnati Children's Research Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2025</Year><Month>07</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Pediatr Rheumatol Online J</MedlineTA><NlmUniqueID>101248897</NlmUniqueID><ISSNLinking>1546-0096</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D001171\" MajorTopicYN=\"Y\">Arthritis, Juvenile</DescriptorName><QualifierName UI=\"Q000150\" MajorTopicYN=\"N\">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000071066\" MajorTopicYN=\"Y\">Patient Reported Outcome Measures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D002648\" MajorTopicYN=\"N\">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008297\" MajorTopicYN=\"N\">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D005260\" MajorTopicYN=\"N\">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D012893\" MajorTopicYN=\"Y\">Sleep Wake Disorders</DescriptorName><QualifierName UI=\"Q000209\" MajorTopicYN=\"N\">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000293\" MajorTopicYN=\"N\">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011788\" MajorTopicYN=\"N\">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008171\" MajorTopicYN=\"Y\">Lung Diseases</DescriptorName><QualifierName UI=\"Q000209\" MajorTopicYN=\"N\">etiology</QualifierName><QualifierName UI=\"Q000175\" MajorTopicYN=\"N\">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D011795\" MajorTopicYN=\"N\">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D002675\" MajorTopicYN=\"N\">Child, Preschool</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Interstitial lung disease</Keyword><Keyword MajorTopicYN=\"N\">Macrophage activation syndrome</Keyword><Keyword MajorTopicYN=\"N\">Pulmonary alveolar proteinosis</Keyword><Keyword MajorTopicYN=\"N\">Systemic juvenile idiopathic arthritis-associated lung disease</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: This study was reviewed and approved by the Cincinnati Children&#x2019;s Hospital Medical Center Institutional Review Board (2019&#x2009;&#x2212;&#x2009;0888) with a waiver of consent. Competing interests: Dr. Schulert has received consulting fees from Novartis and Boehringer Ingelheim and research support from IpiNovyx. Dr. Grom has received consulting fees from Novartis and SOBI. All author authors report no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2025</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2025</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>0</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2025</Year><Month>7</Month><Day>15</Day><Hour>23</Hour><Minute>55</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">40665383</ArticleId><ArticleId IdType=\"doi\">10.1186/s12969-025-01126-y</ArticleId><ArticleId IdType=\"pii\">10.1186/s12969-025-01126-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fautrel B, Mitrovic S, De Matteis A, Bindoli S, Ant&#xf3;n J, Belot A et al. EULAR/PReS recommendations for the diagnosis and management of Still&#x2019;s disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still&#x2019;s disease. Ann Rheum Dis. 2024 [cited 2025 May 26];83. Available from: https://pubmed.ncbi.nlm.nih.gov/39317417/</Citation></Reference><Reference><Citation>Lee JJY, Schneider R. Systemic Juvenile Idiopathic Arthritis. Pediatr Clin North Am. 2018 [cited 2021 Jan 31];65:691&#x2013;709. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30031494</Citation></Reference><Reference><Citation>Grom AA, Horne A, De Benedetti F. Macrophage activation syndrome in the era of biologic therapy. Nat Rev Rheumatol. 2016 [cited 2016 Oct 27];12:259&#x2013;68. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27009539</Citation></Reference><Reference><Citation>Schulert GS, Yasin S, Carey B, Chalk C, Do T, Schapiro AH et al. Systemic Juvenile Idiopathic Arthritis-Lung Disease: Characterization and Risk Factors. Arthritis &amp; Rheumatology. 2019 [cited 2019 Aug 19];art.41073. Available from: https://onlinelibrary.wiley.com/doi/abs/ https://doi.org/10.1002/art.41073</Citation></Reference><Reference><Citation>Kimura Y, Weiss JE, Haroldson KL, Lee T, Punaro M, Oliveira S et al. Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2013 [cited 2015 Sep 1];65:745&#x2013;52. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4476507%26;tool=pmcentrez%26;rendertype=abstract</Citation></Reference><Reference><Citation>Saper VE, Chen G, Deutsch GH, Guillerman RP, Birgmeier J, Jagadeesh K et al. Emergent high fatality lung disease in systemic juvenile arthritis. Ann Rheum Dis. 2019 [cited 2019 Nov 18];78:1722&#x2013;31. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31562126</Citation></Reference><Reference><Citation>Zhan W, Yang J, Qiu L, Yang K, Ye X, Shangguan Y et al. Clinical characteristics and prognosis of interstitial lung disease in systemic juvenile idiopathic arthritis: a two-center retrospective observational cohort study. Pediatr Rheumatol Online J. 2024 [cited 2025 Feb 9];22:96. Available from: https://pubmed.ncbi.nlm.nih.gov/39449050/</Citation></Reference><Reference><Citation>Wobma H, Bachrach R, Farrell J, Chang MH, Day-Lewis M, Dedeoglu F et al. Development of a Screening Algorithm for Lung Disease in Systemic Juvenile Idiopathic Arthritis. ACR Open Rheumatol. 2023 [cited 2024 Oct 23];5:556&#x2013;62. Available from: https://pubmed.ncbi.nlm.nih.gov/37688362/</Citation></Reference><Reference><Citation>Towe C, Grom AA, Schulert GS. Diagnosis and Management of the Systemic Juvenile Idiopathic Arthritis Patient with Emerging Lung Disease. Paediatr Drugs. 2023 [cited 2024 Oct 23];25:649&#x2013;58. Available from: https://pubmed.ncbi.nlm.nih.gov/37787872/</Citation></Reference><Reference><Citation>Canna SW, Schulert GS, de Jesus A, Pickering A, Brunner H, Gadina M et al. Proceedings from the 2nd Next Gen Therapies for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome symposium held on October 3&#x2013;4, 2019. Pediatr Rheumatol Online J. 2020 [cited 2020 Aug 17];18:53. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32664935</Citation></Reference><Reference><Citation>Saidi O, Rochette E, Bourdier P, Ratel S, Merlin E, Pereira B et al. Sleep in children and adolescents with juvenile idiopathic arthritis: a systematic review and meta-analysis of case-control studies. Sleep. 2022;45.</Citation></Reference><Reference><Citation>Stinson JN, Hayden JA, Ahola Kohut S, Soobiah C, Cartwright J, Weiss SK et al. Sleep problems and associated factors in children with juvenile idiopathic arthritis: a systematic review. Pediatr Rheumatol Online J. 2014 [cited 2024 Oct 24];12. Available from: https://pubmed.ncbi.nlm.nih.gov/24940168/</Citation></Reference><Reference><Citation>Huang Y, Sompii-Montgomery L, Patti J, Pickering A, Yasin S, Do T et al. Disease Course, Treatments, and Outcomes of Children With Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease. Arthritis Care Res (Hoboken). 2024 [cited 2024 Oct 24];76:328&#x2013;39. Available from: https://pubmed.ncbi.nlm.nih.gov/37691306/</Citation></Reference><Reference><Citation>The promise of PROMIS. using item response theory to improve assessment of patient-reported outcomes - PubMed. [cited 2024 Oct 24]. Available from: https://pubmed.ncbi.nlm.nih.gov/16273785/</Citation></Reference><Reference><Citation>Niemitz M, Schwerk N, Goldbeck L, Griese M. Development and validation of a health-related quality of life questionnaire for pediatric patients with interstitial lung disease. Pediatr Pulmonol. 2018 [cited 2022 Jun 7];53:954&#x2013;63. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29687642</Citation></Reference><Reference><Citation>Butbul Aviel Y, Stremler R, Benseler SM, Cameron B, Laxer RM, Ota S et al. Sleep and fatigue and the relationship to pain, disease activity and quality of life in juvenile idiopathic arthritis and juvenile dermatomyositis. Rheumatology (Oxford). 2011 [cited 2022 Nov 27];50:2051&#x2013;60. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21873265</Citation></Reference><Reference><Citation>Arnstad ED, Glerup M, Rypdal V, Peltoniemi S, Fasth A, Nielsen S et al. Fatigue in young adults with juvenile idiopathic arthritis 18 years after disease onset: data from the prospective Nordic JIA cohort. Pediatr Rheumatol Online J. 2021 [cited 2024 Oct 23];19. Available from: https://pubmed.ncbi.nlm.nih.gov/33736650/</Citation></Reference><Reference><Citation>Swanson C, Khan EK, Cooper A, Ibarra M, Tam-Williams J. Pediatric systemic juvenile idiopathic arthritis-related lung disease: Description of clinical cohort and review of management. Pediatr Pulmonol. 2024 [cited 2024 Oct 23];59:724&#x2013;33. Available from: https://pubmed.ncbi.nlm.nih.gov/38155594/</Citation></Reference><Reference><Citation>Steroid-Induced Sleep Disturbance and Delirium. A Focused Review for Critically Ill Patients - PubMed. [cited 2025 Feb 9]. Available from: https://pubmed.ncbi.nlm.nih.gov/32669778/</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">40665361</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>15</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1752-1947</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of medical case reports</Title><ISOAbbreviation>J Med Case Rep</ISOAbbreviation></Journal><ArticleTitle>A mixed immediate and delayed allergy to oral vitamin D supplementation: a case report.</ArticleTitle><Pagination><StartPage>344</StartPage><MedlinePgn>344</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1186/s13256-025-05067-8</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\" NlmCategory=\"BACKGROUND\">Vitamin D deficiency is common worldwide and of particular concern for populations at higher latitudes, including those in developed areas such as Australia. The role of vitamin D in modulating bone health and the immune system is well recognized. Patients frequently have vitamin D deficiency identified and managed in the primary healthcare setting. Despite the high prevalence of use in Australia, allergies to supplemental vitamin D are uncommon.</AbstractText><AbstractText Label=\"CASE PRESENTATION\" NlmCategory=\"METHODS\">The case presented here is a 53-year-old Caucasian female of Northern European ancestry, with a history of asthma and irritable bowel syndrome who was prescribed supplemental vitamin D. She experienced dyspepsia and stomach cramps within minutes of ingesting a vitamin D supplement. An alternative formulation of vitamin D produced similar gastrointestinal effects, worsening asthma and a rash. The results of the investigations were unremarkable except for mildly elevated total immunoglobulin levels. The patient was referred to an allergy clinic where a diagnosis of vitamin D hypersensitivity, with features of both immunoglobulin-E-mediated (type 1) and T-cell (type 4)-mediated pathways, was made. A desensitization program was commenced using a modified Australian protocol. During the 18-week course, the patient was exposed to increasing doses of vitamin D, and after 6&#xa0;months, a daily dose of 1000&#xa0;IU was tolerated. She continues to use daily antihistamines and avoids foods rich in vitamin D.</AbstractText><AbstractText Label=\"CONCLUSION\" NlmCategory=\"CONCLUSIONS\">This case report highlights a rare likely allergic reaction to supplemental vitamin D. The patient was never known to have supratherapeutic levels of vitamin D, but her history of atopy may increase the likelihood of an immune-mediated response to the supplement. While skin sensitivity testing was negative, a provocation test and the Naranjo scoring system indicated that a \"probable\" allergy occurred. Vitamin D deficiency is easily detected in primary healthcare, and oral supplementation is usually a safe and effective means to restore blood levels. While reactions to vitamin D supplementation in normal doses are rare, an allergic cause should be considered when there are no other likely precipitants. Personalized, carefully supervised, desensitization to vitamin D may enable the resumption of supplementation and help prevent unnecessary morbidity and mortality from vitamin D deficiency.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Ridge</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><Identifier Source=\"ORCID\">0000-0002-5417-9873</Identifier><AffiliationInfo><Affiliation>School of Pharmacy and Pharmacology, College of Health and Medicine, University of Tasmania, Hobart, TAS, 7000, Australia. a.ridge@utas.edu.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ochre Health Research Network, c/- 85 Main Road, Huonville, TAS, 7109, Australia. a.ridge@utas.edu.au.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Cooling</LastName><ForeName>Nick</ForeName><Initials>N</Initials><Identifier Source=\"ORCID\">0000-0003-3211-1656</Identifier><AffiliationInfo><Affiliation>School of Medicine, College of Health and Medicine, University of Tasmania, Hobart, TAS, 7000, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Seidel</LastName><ForeName>Bastian</ForeName><Initials>B</Initials><Identifier Source=\"ORCID\">0000-0001-9404-9013</Identifier><AffiliationInfo><Affiliation>Ochre Health Research Network, c/- 85 Main Road, Huonville, TAS, 7109, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, College of Health and Medicine, University of Tasmania, Hobart, TAS, 7000, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D002363\">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2025</Year><Month>07</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Med Case Rep</MedlineTA><NlmUniqueID>101293382</NlmUniqueID><ISSNLinking>1752-1947</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>1406-16-2</RegistryNumber><NameOfSubstance UI=\"D014807\">Vitamin D</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D014815\">Vitamins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D005260\" MajorTopicYN=\"N\">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008875\" MajorTopicYN=\"N\">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D014807\" MajorTopicYN=\"Y\">Vitamin D</DescriptorName><QualifierName UI=\"Q000009\" MajorTopicYN=\"N\">adverse effects</QualifierName><QualifierName UI=\"Q000008\" MajorTopicYN=\"N\">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D019587\" MajorTopicYN=\"Y\">Dietary Supplements</DescriptorName><QualifierName UI=\"Q000009\" MajorTopicYN=\"N\">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D004342\" MajorTopicYN=\"Y\">Drug Hypersensitivity</DescriptorName><QualifierName UI=\"Q000209\" MajorTopicYN=\"N\">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D014808\" MajorTopicYN=\"Y\">Vitamin D Deficiency</DescriptorName><QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D006969\" MajorTopicYN=\"Y\">Hypersensitivity, Immediate</DescriptorName><QualifierName UI=\"Q000139\" MajorTopicYN=\"N\">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D001315\" MajorTopicYN=\"N\" Type=\"Geographic\">Australia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006968\" MajorTopicYN=\"Y\">Hypersensitivity, Delayed</DescriptorName><QualifierName UI=\"Q000139\" MajorTopicYN=\"N\">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D014815\" MajorTopicYN=\"Y\">Vitamins</DescriptorName><QualifierName UI=\"Q000009\" MajorTopicYN=\"N\">adverse effects</QualifierName><QualifierName UI=\"Q000008\" MajorTopicYN=\"N\">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D003888\" MajorTopicYN=\"Y\">Desensitization, Immunologic</DescriptorName><QualifierName UI=\"Q000379\" MajorTopicYN=\"N\">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000284\" MajorTopicYN=\"N\">Administration, Oral</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Allergy</Keyword><Keyword MajorTopicYN=\"N\">Desensitization</Keyword><Keyword MajorTopicYN=\"N\">Primary care</Keyword><Keyword MajorTopicYN=\"N\">Vitamin D</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: An exemption from ethical review was granted by the University of Tasmania Human Research Ethics Committee (Project ID: 30944). Consent for publication: Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal. Competing interests: The authors declare that there are no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2025</Year><Month>1</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>0</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2025</Year><Month>7</Month><Day>15</Day><Hour>23</Hour><Minute>54</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">40665361</ArticleId><ArticleId IdType=\"doi\">10.1186/s13256-025-05067-8</ArticleId><ArticleId IdType=\"pii\">10.1186/s13256-025-05067-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lips P, De Jongh RT, Van Schoor NM. Trends in Vitamin D status around the world. JBMR Plus. 2021. https://doi.org/10.1002/jbm4.10585 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/jbm4.10585</ArticleId><ArticleId IdType=\"pubmed\">34950837</ArticleId><ArticleId IdType=\"pmc\">8674774</ArticleId></ArticleIdList></Reference><Reference><Citation>Australian Bureau of Statistics. Australian Health Survey: Biomedical results for nutrients; 2013. https://www.abs.gov.au/statistics/health/health-conditions-and-risks/australian-health-survey-biomedical-results-nutrients/latest-release . Accessed 14 Sept 2023.</Citation></Reference><Reference><Citation>Winzenberg T, van der Mei I, Mason RS, et&#xa0;al. Vitamin D: and the musculoskeletal health of older adults. Aust Fam Physician. 2012;41:92&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22396920</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennel KA, Drake MT, Hurley DL. Vitamin D deficiency in adults: when to test and how to treat. Mayo Clin Proc. 2010;85:752&#x2013;8. https://doi.org/10.4065/mcp.2010.0138 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.4065/mcp.2010.0138</ArticleId><ArticleId IdType=\"pubmed\">20675513</ArticleId><ArticleId IdType=\"pmc\">2912737</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanlint SJ. Vitamin D and adult bone health in Australia and New Zealand: a position statement. Med J Aust. 2005;182:281&#x2013;5.</Citation></Reference><Reference><Citation>Joshi D, Center JR, Eisman JA. Vitamin D deficiency in adults. Aust Prescr. 2010;33:103&#x2013;6.</Citation></Reference><Reference><Citation>Capra S. Nutrient reference values for Australia and New Zealand: Including recommended dietary intakes; 2006. https://www.nhmrc.gov.au/sites/default/files/images/nutrient-refererence-dietary-intakes.pdf . Accessed 14 Sept 2023.</Citation></Reference><Reference><Citation>Pludowski P, Holick MF, Pilz S, et&#xa0;al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun Rev. 2013;12(976&#x2013;989):20130328. https://doi.org/10.1016/j.autrev.2013.02.004 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.autrev.2013.02.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahota O. Understanding vitamin D deficiency. Age Ageing. 2014;43(589&#x2013;591):20140728. https://doi.org/10.1093/ageing/afu104 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/ageing/afu104</ArticleId></ArticleIdList></Reference><Reference><Citation>Pludowski P, Holick MF, Grant WB, et&#xa0;al. Vitamin D supplementation guidelines. J Steroid Biochem Mol Biol. 2018;175:125&#x2013;35.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28216084</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawrylowicz CM, Santos AF. Vitamin D: can the sun stop the atopic epidemic? Curr Opin Allergy Clin Immunol. 2020;20:181&#x2013;7.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31895129</ArticleId></ArticleIdList></Reference><Reference><Citation>Poole A, Song Y, Brown H, et&#xa0;al. Cellular and molecular mechanisms of vitamin D in food allergy. J Cell Mol Med. 2018;22:3270&#x2013;7. https://doi.org/10.1111/jcmm.13607 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/jcmm.13607</ArticleId><ArticleId IdType=\"pubmed\">29577619</ArticleId><ArticleId IdType=\"pmc\">6010899</ArticleId></ArticleIdList></Reference><Reference><Citation>Hypp&#xf6;nen E, Berry DJ, Wjst M, et&#xa0;al. Serum 25-hydroxyvitamin D and IgE - a significant but nonlinear relationship. Allergy. 2009;64:613&#x2013;20. https://doi.org/10.1111/j.1398-9995.2008.01865.x .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1398-9995.2008.01865.x</ArticleId><ArticleId IdType=\"pubmed\">19154546</ArticleId></ArticleIdList></Reference><Reference><Citation>Amandeep S, Lomaestro B, Meuwissen HJ. Hypersensitivity to intravenous and oral calcitriol with successful desensitization. J Allergy Clin Immunol. 1999;103:176.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9893204</ArticleId></ArticleIdList></Reference><Reference><Citation>Anantharajah A, Lamproglou A, Bridle S, et&#xa0;al. Successful cholecalciferol desensitisation in a case of delayed hypersensitivity. Asia Pac Allergy. 2019;9(e14):20190418. https://doi.org/10.5415/apallergy.2019.9.e14 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.5415/apallergy.2019.9.e14</ArticleId></ArticleIdList></Reference><Reference><Citation>Unal D, Coskun R, Demir D, et&#xa0;al. Successful desensitization to vitamin D in a patient with vitamin D deficiency. J Investig Allergol Clin Immunol. 2016;26:392&#x2013;3. https://doi.org/10.18176/jiaci.0108 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.18176/jiaci.0108</ArticleId><ArticleId IdType=\"pubmed\">27996953</ArticleId></ArticleIdList></Reference><Reference><Citation>Alswailmi FK, Sikandar MZ, Shah SIA. Biological roles of vitamin D and immunoglobulin E: implications in allergic disorders. Pak J Med Health Sci. 2020;14:495&#x2013;8.</Citation></Reference><Reference><Citation>Roy S, Shrinivas K, Bagchi B. A stochastic chemical dynamic approach to correlate autoimmunity and optimal vitamin-D range. PLoS ONE. 2014;9: e100635. https://doi.org/10.1371/journal.pone.0100635 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0100635</ArticleId><ArticleId IdType=\"pubmed\">24971516</ArticleId><ArticleId IdType=\"pmc\">4074107</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders KM, Nicholson GC, Ebeling PR. Is high dose vitamin D harmful? Calcif Tissue Int. 2013;92:191&#x2013;206. https://doi.org/10.1007/s00223-012-9679-1 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s00223-012-9679-1</ArticleId><ArticleId IdType=\"pubmed\">23250508</ArticleId></ArticleIdList></Reference><Reference><Citation>Naranjo CA, Busto U, Sellers EM, et&#xa0;al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239&#x2013;45. https://doi.org/10.1038/clpt.1981.154 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/clpt.1981.154</ArticleId><ArticleId IdType=\"pubmed\">7249508</ArticleId></ArticleIdList></Reference><Reference><Citation>Saff RR. Skin testing as a biomarker in drug allergy. Ann Allergy Asthma Immunol. 2023;130:161&#x2013;8. https://doi.org/10.1016/j.anai.2022.10.006 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.anai.2022.10.006</ArticleId><ArticleId IdType=\"pubmed\">36243283</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbas AK, Lichtman AH, Pillai S. Basic immunology: functions and disorders of the immune system. Elsevier Health Sciences; 2015.</Citation></Reference><Reference><Citation>Dispenza MC. Classification of hypersensitivity reactions. Allergy Asthma Proc. 2019;40:470&#x2013;3. https://doi.org/10.2500/aap.2019.40.4274 .</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2500/aap.2019.40.4274</ArticleId><ArticleId IdType=\"pubmed\">31690397</ArticleId></ArticleIdList></Reference><Reference><Citation>Therapeutic Goods Administration. Summary for ARTG Entry: (256292) OsteVit-D One-A-Week colecalciferol 7000IU (175mcg) capsule blister pack; 2015. https://www.tga.gov.au/resources/artg/256292 . Accessed 18 Sept 2023.</Citation></Reference><Reference><Citation>Wang J. Drug desensitization. Allergy Clin Immunol; 2015. p. 308&#x2013;13.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">40665105</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>15</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">2045-2322</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>15</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Association between neighborhood deprivation and type 2 diabetes risks among asthma patients: a nationwide population-based cohort study.</ArticleTitle><Pagination><StartPage>25570</StartPage><MedlinePgn>25570</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1038/s41598-025-09150-4</ELocationID><Abstract><AbstractText>This study aimed to investigate the potential impact of neighborhood deprivation on the incidence of type 2 diabetes mellitus (T2DM) among individuals with asthma. This nationwide, open cohort study conducted in Sweden from 1997 to 2018 included asthma patients of all ages (n&#x2009;=&#x2009;1,051,240) to assess their subsequent risk of developing T2DM. The study compared asthma patients residing in highly deprived neighborhoods with those living in moderately or less deprived areas (reference group). Cox proportional hazards regression models were employed to analyze the association between neighborhood deprivation and T2DM incidence, with results expressed as hazard ratios (HRs) and 95% confidence intervals (95% CIs). Analyses were stratified by sex and adjusted for potential confounders. A significant association between neighborhood deprivation and T2DM risk in asthma patients was shown. These associations remained statistically significant after adjusting for confounders, with adjusted HRs of 1.44 (95% CI 1.38-1.50) for men and 1.51 (95% CI 1.46-1.57) for women. Furthermore, a graded relationship was observed, with higher levels of neighborhood deprivation associated with an increased incidence of T2DM among asthma patients. These findings underscore critical clinical and public health concerns. The results of this study provide valuable insights for policymakers, highlighting the need to consider neighborhood deprivation when allocating resources in primary healthcare settings. They also offer guidance for optimizing clinical care strategies for patients in socioeconomically disadvantaged communities.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Wang</LastName><ForeName>Yuwen</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Public Health, Ningxia Medical University, Yinchuan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Environmental Factors and Chronic Disease Control, Ningxia Medical University, Yinchuan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Primary Health Care Research, Department of Clinical Sciences, Lund University, Jan Waldenstr&#xf6;ms gata 35, 20502, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Clinic Primary Care, Sk&#xe5;ne University Hospital, Region Sk&#xe5;ne, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhang</LastName><ForeName>Yuhong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Public Health, Ningxia Medical University, Yinchuan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Environmental Factors and Chronic Disease Control, Ningxia Medical University, Yinchuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Sundquist</LastName><ForeName>Kristina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Center for Primary Health Care Research, Department of Clinical Sciences, Lund University, Jan Waldenstr&#xf6;ms gata 35, 20502, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Clinic Primary Care, Sk&#xe5;ne University Hospital, Region Sk&#xe5;ne, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departments of Family and Community Medicine and of Epidemiology, The University of Texas Health Science Center, Houston, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Community-based Healthcare Research and Education (CoHRE), Department of Functional Pathology, School of Medicine, Matsue, Shimane University, Matsue, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Sundquist</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Primary Health Care Research, Department of Clinical Sciences, Lund University, Jan Waldenstr&#xf6;ms gata 35, 20502, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Clinic Primary Care, Sk&#xe5;ne University Hospital, Region Sk&#xe5;ne, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departments of Family and Community Medicine and of Epidemiology, The University of Texas Health Science Center, Houston, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Community-based Healthcare Research and Education (CoHRE), Department of Functional Pathology, School of Medicine, Matsue, Shimane University, Matsue, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Yang</LastName><ForeName>Huifang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>School of Public Health, Ningxia Medical University, Yinchuan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Environmental Factors and Chronic Disease Control, Ningxia Medical University, Yinchuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Li</LastName><ForeName>Xinjun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Center for Primary Health Care Research, Department of Clinical Sciences, Lund University, Jan Waldenstr&#xf6;ms gata 35, 20502, Malm&#xf6;, Sweden. xinjun.li@med.lu.se.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Clinic Primary Care, Sk&#xe5;ne University Hospital, Region Sk&#xe5;ne, Sweden. xinjun.li@med.lu.se.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2025</Year><Month>07</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D001249\" MajorTopicYN=\"Y\">Asthma</DescriptorName><QualifierName UI=\"Q000453\" MajorTopicYN=\"N\">epidemiology</QualifierName><QualifierName UI=\"Q000150\" MajorTopicYN=\"N\">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D005260\" MajorTopicYN=\"N\">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D003924\" MajorTopicYN=\"Y\">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI=\"Q000453\" MajorTopicYN=\"N\">epidemiology</QualifierName><QualifierName UI=\"Q000209\" MajorTopicYN=\"N\">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D008297\" MajorTopicYN=\"N\">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008875\" MajorTopicYN=\"N\">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D013548\" MajorTopicYN=\"N\" Type=\"Geographic\">Sweden</DescriptorName><QualifierName UI=\"Q000453\" MajorTopicYN=\"N\">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000328\" MajorTopicYN=\"N\">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015331\" MajorTopicYN=\"N\">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015994\" MajorTopicYN=\"N\">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D012307\" MajorTopicYN=\"N\">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000368\" MajorTopicYN=\"N\">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D012111\" MajorTopicYN=\"Y\">Residence Characteristics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000091542\" MajorTopicYN=\"Y\">Neighborhood Characteristics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000293\" MajorTopicYN=\"N\">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D016016\" MajorTopicYN=\"N\">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D055815\" MajorTopicYN=\"N\">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Asthma</Keyword><Keyword MajorTopicYN=\"N\">Neighborhood deprivation</Keyword><Keyword MajorTopicYN=\"N\">Sweden</Keyword><Keyword MajorTopicYN=\"N\">Type 2 diabetes mellitus</Keyword></KeywordList><CoiStatement>Declarations. Competing interests: The authors declare no competing interests. Ethics approval: This study was approved by the regional ethical review board in Lund, Sweden on Feb. 6th, 2013 (registration No 2012/795) and later amendments. Guidelines of the Helsinki Declaration were followed. Data were obtained from the national registers collected by various Swedish health and social agencies. The agency Statistics Sweden linked the (pseudonymised) unique personal identification number assigned to all Swedish residents at birth or migration. Informed consent: Informed consent was not applicable, as the study was based on secondary pseudonymized data from registers.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2025</Year><Month>4</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2025</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>0</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2025</Year><Month>7</Month><Day>15</Day><Hour>23</Hour><Minute>40</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">40665105</ArticleId><ArticleId IdType=\"doi\">10.1038/s41598-025-09150-4</ArticleId><ArticleId IdType=\"pii\">10.1038/s41598-025-09150-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Torres, R. M., Souza, M. D. S., Coelho, A. C. C., de Mello, L. M. &amp; Souza-Machado, C. Association between asthma and Type 2 diabetes mellitus: Mechanisms and impact on asthma control-A literature review. Can. Respir. J. 2021, 8830439 (2021).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33520042</ArticleId><ArticleId IdType=\"pmc\">7817304</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller, N. T. et al. Asthma and the risk of type 2 diabetes in the Singapore Chinese health study. Diabetes Res. Clin. Pract. 99, 192&#x2013;199 (2013).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23260853</ArticleId></ArticleIdList></Reference><Reference><Citation>Song, Y., Klevak, A., Manson, J. E., Buring, J. E. &amp; Liu, S. Asthma, chronic obstructive pulmonary disease, and type 2 diabetes in the women&#x2019;s health study. Diabetes Res. Clin. Pract. 90, 365&#x2013;371 (2010).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20926152</ArticleId><ArticleId IdType=\"pmc\">2993844</ArticleId></ArticleIdList></Reference><Reference><Citation>Mubanga, M. et al. Association between asthma and type 2 diabetes in a Swedish adult population: a register-based cross-sectional study. Thorax 80(6), 385&#x2013;391 (2025).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">40122610</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapiro, M. et al. Asthma in youth and early-onset type 2 Diabetes: A nationwide study of 1.72 million Israeli adolescents. J. Clin. Endocrinol. Metab. 106, e5043&#x2013;e5053 (2021).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34291806</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilal, U., Auchincloss, A. H. &amp; Diez-Roux, A. V. Neighborhood environments and diabetes risk and control. Curr. Diab.Rep. 18, 62 (2018).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29995252</ArticleId></ArticleIdList></Reference><Reference><Citation>Mezuk, B. et al. Depression, neighborhood deprivation and risk of type 2 diabetes. Health Place 23, 63&#x2013;69 (2013).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23771166</ArticleId><ArticleId IdType=\"pmc\">3773725</ArticleId></ArticleIdList></Reference><Reference><Citation>Mujahid, M. S. et al. The impact of neighborhoods on diabetes risk and outcomes: Centering health equity. Diabetes Care 46, 1609&#x2013;1618 (2023).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37354326</ArticleId><ArticleId IdType=\"pmc\">10465989</ArticleId></ArticleIdList></Reference><Reference><Citation>White, J. S. et al. Long-term effects of neighbourhood deprivation on diabetes risk: quasi-experimental evidence from a refugee dispersal policy in Sweden. Lancet Diabetes Endocrinol. 4, 517&#x2013;524 (2016).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27131930</ArticleId><ArticleId IdType=\"pmc\">4875844</ArticleId></ArticleIdList></Reference><Reference><Citation>Christine, P. J. et al. Longitudinal associations between neighborhood physical and social environments and incident type 2 diabetes mellitus: The multi-ethnic study of atherosclerosis (MESA). JAMA Intern. Med. 175, 1311&#x2013;1320 (2015).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26121402</ArticleId><ArticleId IdType=\"pmc\">4799846</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu, M. D. et al. Neighborhood deprivation, obesity, and diabetes in residents of the US gulf coast. Am. J. Epidemiol. 190, 295&#x2013;304 (2021).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33524122</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundquist, K., Malmstrom, M. &amp; Johansson, S. E. Neighbourhood deprivation and incidence of coronary heart disease: A multilevel study of 2.6 million women and men in Sweden. J. Epidemiol. Commun. Health 58, 71&#x2013;77 (2004).</Citation></Reference><Reference><Citation>Scheer, C. et al. Exposure to green spaces, cardiovascular risk biomarkers and incident cardiovascular disease in older adults: The seniors-Enrica II cohort. Environ. Int. 185, 108570 (2024).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">38484611</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanobetti, A. et al. Childhood asthma incidence, early and persistent wheeze, and neighborhood socioeconomic factors in the ECHO/CREW consortium. JAMA Pediatr. 176, 759&#x2013;767 (2022).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35604671</ArticleId><ArticleId IdType=\"pmc\">9127710</ArticleId></ArticleIdList></Reference><Reference><Citation>Temam, S. et al. Low socioeconomic position and neighborhood deprivation are associated with uncontrolled asthma in elderly. Respir. Med. 158, 70&#x2013;77 (2019).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31610380</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkleby, M., Sundquist, K. &amp; Cubbin, C. Inequities in CHD incidence and case fatality by neighborhood deprivation. Am J. Prev. Med. 32, 97&#x2013;106 (2007).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17234484</ArticleId><ArticleId IdType=\"pmc\">2225531</ArticleId></ArticleIdList></Reference><Reference><Citation>Textor, J., van der Zander, B., Gilthorpe, M. S., Liskiewicz, M. &amp; Ellison, G. T. Robust causal inference using directed acyclic graphs: The R package &#x201c;dagitty&#x201d;. Int. J. Epidemiol. 45, 1887&#x2013;1894 (2016).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28089956</ArticleId></ArticleIdList></Reference><Reference><Citation>Yun, H. D. et al. Asthma and proinflammatory conditions: A population-based retrospective matched cohort study. Mayo Clin. Proc. 87, 953&#x2013;960 (2012).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22980164</ArticleId><ArticleId IdType=\"pmc\">3538394</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney, J. et al. Comorbidity in severe asthma requiring systemic corticosteroid therapy: Cross-sectional data from the optimum patient care research database and the British thoracic difficult asthma registry. Thorax 71, 339&#x2013;346 (2016).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26819354</ArticleId></ArticleIdList></Reference><Reference><Citation>Baek, J. Y., Lee, S. E., Han, K. &amp; Koh, E. H. Association between diabetes and asthma: Evidence from a nationwide Korean study. Ann. Allergy Asthma Immunol. 121, 699&#x2013;703 (2018).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30134180</ArticleId></ArticleIdList></Reference><Reference><Citation>Gershon, A. S., Guan, J., Wang, C., Victor, J. C. &amp; To, T. Describing and quantifying asthma comorbidity [corrected]: A population study. PLoS ONE 7, e34967 (2012).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22586445</ArticleId><ArticleId IdType=\"pmc\">3346768</ArticleId></ArticleIdList></Reference><Reference><Citation>Su, X. et al. Prevalence of comorbidities in asthma and nonasthma patients: A meta-analysis. Medicine 95, e3459 (2016).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27258489</ArticleId><ArticleId IdType=\"pmc\">4900697</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein, O. L. et al. Hispanics/Latinos with type 2 diabetes have functional and symptomatic pulmonary impairment mirroring kidney microangiopathy: Findings from the Hispanic community health study/study of Latinos (HCHS/SOL). Diabetes Care 39, 2051&#x2013;2057 (2016).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27612502</ArticleId><ArticleId IdType=\"pmc\">5079610</ArticleId></ArticleIdList></Reference><Reference><Citation>Moody, A., Cowley, G., Ng Fat, L. &amp; Mindell, J. S. Social inequalities in prevalence of diagnosed and undiagnosed diabetes and impaired glucose regulation in participants in the health surveys for England series. BMJ Open 6, e010155 (2016).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26857106</ArticleId><ArticleId IdType=\"pmc\">4746474</ArticleId></ArticleIdList></Reference><Reference><Citation>Bush, K. J. et al. Influence of neighborhood-level socioeconomic deprivation and individual socioeconomic position on risk of developing type 2 diabetes in older men: a longitudinal analysis in the British regional heart study cohort. BMJ Open Diabetes Res. Care 11, e003559 (2023).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37907278</ArticleId><ArticleId IdType=\"pmc\">10619023</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen, A. F. et al. Life-course socio-economic position, area deprivation and Type 2 diabetes: Findings from the British women&#x2019;s heart and health study. Diabet. Med. 25, 1462&#x2013;1468 (2008).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19046246</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu, M. D. et al. Neighborhood deprivation, obesity, and diabetes in residents of the US Gulf coast. Am. J. Epidemiol. 190, 295&#x2013;304 (2020).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">7850038</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundquist, J., Malmstr&#xf6;m, M. &amp; Johansson, S. E. Cardiovascular risk factors and the neighbourhood environment: a multilevel analysis. Int. J. Epidemiol. 28, 841&#x2013;845 (1999).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10597980</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundquist, K., Eriksson, U., Mezuk, B. &amp; Ohlsson, H. Neighborhood walkability, deprivation and incidence of type 2 diabetes: A population-based study on 512,061 Swedish adults. Health Place 31, 24&#x2013;30 (2015).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25463914</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Gonz&#xe1;lez, &#xc1;. A. et al. Association between sociodemographic variables, healthy habits and stress with diabesity. Clin. Investig. Arterioscler 37(3), 500754 (2025).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">39824668</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullie, P., Clarys, P., Hulens, M. &amp; Vansant, G. Dietary patterns and socioeconomic position. Eur. J. Clin. Nutr. 64, 231&#x2013;238 (2010).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20087378</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundquist, K. et al. Neighborhood violent crime and unemployment increase the risk of coronary heart disease: A multilevel study in an urban setting. Soc. Sci. Med. 62, 2061&#x2013;2071 (2006).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16203075</ArticleId></ArticleIdList></Reference><Reference><Citation>Huikari, S. et al. Leisure-time physical activity is associated with socio-economic status beyond income&#x2014;cross-sectional survey of the northern Finland birth cohort 1966 study. Econ. Hum. Biol. 41, 100969 (2021).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33429255</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawakami, N., Winkleby, M., Skog, L., Szulkin, R. &amp; Sundquist, K. Differences in neighborhood accessibility to health-related resources: A nationwide comparison between deprived and affluent neighborhoods in Sweden. Health Place 17, 132&#x2013;139 (2011).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20961797</ArticleId></ArticleIdList></Reference><Reference><Citation>Skoog, J., Midl&#xf6;v, P., Beckman, A., Sundquist, J. &amp; Halling, A. Drugs prescribed by general practitioners according to age, gender and socioeconomic status after adjustment for multimorbidity level. BMC Fam. Pract. 15, 183 (2014).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25421269</ArticleId><ArticleId IdType=\"pmc\">4246463</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Y. et al. Association between residential Neighborhood social conditions and health care utilization and costs. Med. Care 58, 586&#x2013;593 (2020).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32520834</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas, J. A. et al. Mobility and social deprivation on primary care utilisation among paediatric patients with asthma. Fam. Med. Commun. Health 9, e001085 (2021).</Citation></Reference><Reference><Citation>Lucas, J. A. et al. Role of social deprivation on asthma care quality among a cohort of children in US community health centres. BMJ Open 11, e045131 (2021).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34162640</ArticleId><ArticleId IdType=\"pmc\">8230996</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, X., Sundquist, J. &amp; Sundquist, K. Socioeconomic and occupational groups and risk of asthma in Sweden. Occup. Med. (Lond) 58, 161&#x2013;168 (2008).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18296686</ArticleId></ArticleIdList></Reference><Reference><Citation>Grintsova, O., Maier, W. &amp; Mielck, A. Inequalities in health care among patients with type 2 diabetes by individual socio-economic status (SES) and regional deprivation: A systematic literature review. Int. J. Equity Health 13, 43 (2014).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24889694</ArticleId><ArticleId IdType=\"pmc\">4055912</ArticleId></ArticleIdList></Reference><Reference><Citation>Haregu, T. N., Oti, S., Egondi, T. &amp; Kyobutungi, C. Co-occurrence of behavioral risk factors of common non-communicable diseases among urban slum dwellers in Nairobi, Kenya. Glob. Health Action 8, 28697 (2015).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26385542</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Lenick, C. R. et al. Assessment of neighbourhood-level socioeconomic status as a modifier of air pollution-asthma associations among children in Atlanta. J. Epidemiol. Commun. Health 71, 129&#x2013;136 (2017).</Citation></Reference><Reference><Citation>Bacon, S. L., Bouchard, A., Loucks, E. B. &amp; Lavoie, K. L. Individual-level socioeconomic status is associated with worse asthma morbidity in patients with asthma. Respir. Res. 10, 125 (2009).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20017907</ArticleId><ArticleId IdType=\"pmc\">2806364</ArticleId></ArticleIdList></Reference><Reference><Citation>Krueger, P. M. &amp; Reither, E. N. Mind the gap: Race/ethnic and socioeconomic disparities in obesity. Curr. Diab. Rep. 15, 95 (2015).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26377742</ArticleId><ArticleId IdType=\"pmc\">4947380</ArticleId></ArticleIdList></Reference><Reference><Citation>Cromer, S. J. et al. Association and interaction of genetics and area-level socioeconomic factors on the prevalence of type 2 diabetes and obesity. Diabetes Care 46, 944&#x2013;952 (2023).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36787958</ArticleId><ArticleId IdType=\"pmc\">10154653</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragnarson Tennvall, G., Apelqvist, J. &amp; Eneroth, M. The inpatient care of patients with diabetes mellitus and foot ulcers. A validation study of the correspondence between medical records and the Swedish inpatient registry with the consequences for cost estimations. J. Intern. Med. 248, 397&#x2013;405 (2000).</Citation></Reference><Reference><Citation>Ludvigsson, J. F. et al. External review and validation of the Swedish national inpatient register. BMC Public Health 11, 450 (2011).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21658213</ArticleId><ArticleId IdType=\"pmc\">3142234</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitley, R. &amp; McKenzie, K. Social Capital and psychiatry: Review of the literature. Harv. Rev. Psychiatry 13, 71&#x2013;84 (2005).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16020022</ArticleId></ArticleIdList></Reference><Reference><Citation>Huie, S. A. B. The concept of Neighborhood in health and mortality research. Sociol. Spectr. 21, 341&#x2013;358 (2001).</Citation></Reference><Reference><Citation>Watson, J. P., Cowen, P. &amp; Lewis, R. A. The relationship between asthma admission rates, routes of admission, and socioeconomic deprivation. Eur. Respir. J. 9, 2087&#x2013;2093 (1996).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8902471</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundquist, K. et al. Linking social capital and mortality in the elderly: A Swedish national cohort study. Exp. Gerontol. 55, 29&#x2013;36 (2014).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24632181</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">40665053</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>15</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1546-170X</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2025</Year><Month>Jul</Month><Day>15</Day></PubDate></JournalIssue><Title>Nature medicine</Title><ISOAbbreviation>Nat Med</ISOAbbreviation></Journal><ArticleTitle>Deep phenotyping of health-disease continuum in the Human Phenotype Project.</ArticleTitle><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1038/s41591-025-03790-9</ELocationID><Abstract><AbstractText>The Human Phenotype Project (HPP) is a large-scale deep-phenotype prospective cohort. To date, approximately 28,000 participants have enrolled, with more than 13,000 completing their initial visit. The project is aimed at identifying novel molecular signatures with diagnostic, prognostic and therapeutic value, and at developing artificial intelligence (AI)-based predictive models for disease onset and progression. The HPP includes longitudinal profiling encompassing medical history, lifestyle and nutrition, anthropometrics, blood tests, continuous glucose and sleep monitoring, imaging and multi-omics data, including genetics, transcriptomics, microbiome (gut, vaginal and oral), metabolomics and immune profiling. Analysis of these data highlights the variation of phenotypes with age and ethnicity and unravels molecular signatures of disease by comparison with matched healthy controls. Leveraging extensive dietary and lifestyle data, we identify associations between lifestyle factors and health outcomes. Finally, we present a multi-modal foundation AI model, trained using self-supervised learning on diet and continuous-glucose-monitoring data, that outperforms existing methods in predicting disease onset. This framework can be extended to integrate other modalities and act as a personalized digital twin. In summary, we present a deeply phenotyped cohort that serves as a platform for advancing biomarker discovery, enabling the development of multi-modal AI models and personalized medicine approaches.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s), under exclusive licence to Springer Nature America, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\" EqualContrib=\"Y\"><LastName>Reicher</LastName><ForeName>Lee</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lis Maternity and Women's Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\" EqualContrib=\"Y\"><LastName>Shilo</LastName><ForeName>Smadar</ForeName><Initials>S</Initials><Identifier Source=\"ORCID\">0000-0003-2399-1866</Identifier><AffiliationInfo><Affiliation>Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Jesse Z and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Godneva</LastName><ForeName>Anastasia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lutsker</LastName><ForeName>Guy</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zahavi</LastName><ForeName>Liron</ForeName><Initials>L</Initials><Identifier Source=\"ORCID\">0000-0001-8867-1287</Identifier><AffiliationInfo><Affiliation>Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Shoer</LastName><ForeName>Saar</ForeName><Initials>S</Initials><Identifier Source=\"ORCID\">0000-0003-0883-1434</Identifier><AffiliationInfo><Affiliation>Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Krongauz</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source=\"ORCID\">0000-0003-4017-1122</Identifier><AffiliationInfo><Affiliation>Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Rein</LastName><ForeName>Michal</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kohn</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><Identifier Source=\"ORCID\">0000-0001-9912-5935</Identifier><AffiliationInfo><Affiliation>Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Segev</LastName><ForeName>Tomer</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Schlesinger</LastName><ForeName>Yishay</ForeName><Initials>Y</Initials><Identifier Source=\"ORCID\">0009-0009-4746-5677</Identifier><AffiliationInfo><Affiliation>Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Barak</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Levine</LastName><ForeName>Zachary</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Keshet</LastName><ForeName>Ayya</ForeName><Initials>A</Initials><Identifier Source=\"ORCID\">0000-0002-1841-7918</Identifier><AffiliationInfo><Affiliation>Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Shaulitch</LastName><ForeName>Rotem</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lotan-Pompan</LastName><ForeName>Maya</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Elkan</LastName><ForeName>Matan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine A, Shamir Medical Center (Assaf Harofeh), Zerifin, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Talmor-Barkan</LastName><ForeName>Yeela</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Rabin Medical Center, Petah-Tikva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Aviv</LastName><ForeName>Yaron</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Rabin Medical Center, Petah-Tikva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Dadiani</LastName><ForeName>Maya</ForeName><Initials>M</Initials><Identifier Source=\"ORCID\">0000-0002-1561-0755</Identifier><AffiliationInfo><Affiliation>Cancer Research Center, Sheba Medical Center, Ramat-Gan, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Tsodyks</LastName><ForeName>Yonatan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Cancer Research Center, Sheba Medical Center, Ramat-Gan, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gal-Yam</LastName><ForeName>Einav Nili</ForeName><Initials>EN</Initials><AffiliationInfo><Affiliation>Institute of Breast Oncology, the Jusidman Cancer Center, Sheba Medical Center, Ramat-Gan, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Leibovitzh</LastName><ForeName>Haim</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>The Department of Gastroenterology and Liver Disease, Tel Aviv Medical Center, affiliated to the Grey Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Werner</LastName><ForeName>Lael</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>The Department of Gastroenterology and Liver Disease, Tel Aviv Medical Center, affiliated to the Grey Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Tzadok</LastName><ForeName>Roie</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>The Department of Gastroenterology and Liver Disease, Tel Aviv Medical Center, affiliated to the Grey Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Maharshak</LastName><ForeName>Nitsan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>The Department of Gastroenterology and Liver Disease, Tel Aviv Medical Center, affiliated to the Grey Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Koga</LastName><ForeName>Shin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, SBS Shizuoka Health Promotion Center, Shizuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Glick-Gorman</LastName><ForeName>Yulia</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Jusidman Cancer Center, Sheba Medical Center, Tel Hashomer, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Stossel</LastName><ForeName>Chani</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>The Jusidman Cancer Center, Sheba Medical Center, Tel Hashomer, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Raitses-Gurevich</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Jusidman Cancer Center, Sheba Medical Center, Tel Hashomer, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Golan</LastName><ForeName>Talia</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Jusidman Cancer Center, Sheba Medical Center, Tel Hashomer, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Dhir</LastName><ForeName>Raja</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Reisner</LastName><ForeName>Yotam</ForeName><Initials>Y</Initials><Identifier Source=\"ORCID\">0000-0001-9192-7167</Identifier><AffiliationInfo><Affiliation>Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pheno.AI, Tel-Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Weinberger</LastName><ForeName>Adina</ForeName><Initials>A</Initials><Identifier Source=\"ORCID\">0000-0003-2231-4687</Identifier><AffiliationInfo><Affiliation>Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Rossman</LastName><ForeName>Hagai</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Pheno.AI, Tel-Aviv, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mohamed bin Zayed University of Artificial Intelligence, Abu Dhabi, UAE.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Song</LastName><ForeName>Le</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Mohamed bin Zayed University of Artificial Intelligence, Abu Dhabi, UAE.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>GenBio AI, Palo Alto, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Xing</LastName><ForeName>Eric P</ForeName><Initials>EP</Initials><Identifier Source=\"ORCID\">0000-0002-3683-4280</Identifier><AffiliationInfo><Affiliation>Mohamed bin Zayed University of Artificial Intelligence, Abu Dhabi, UAE. Eric.Xing@mbzuai.ac.ae.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Carnegie Mellon University Pittsburgh, Pittsburgh, PA, USA. Eric.Xing@mbzuai.ac.ae.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Segal</LastName><ForeName>Eran</ForeName><Initials>E</Initials><Identifier Source=\"ORCID\">0000-0002-6859-1164</Identifier><AffiliationInfo><Affiliation>Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel. eran.segal@weizmann.ac.il.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mohamed bin Zayed University of Artificial Intelligence, Abu Dhabi, UAE. eran.segal@weizmann.ac.il.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2025</Year><Month>07</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Med</MedlineTA><NlmUniqueID>9502015</NlmUniqueID><ISSNLinking>1078-8956</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CoiStatement>Competing interests: Y.R., H.R. and Y.T.B are employees at Pheno.AI. A.K., A.W. and E.S. are paid consultants of Pheno.AI. N.M. has received speaking and consulting fees from Pfizer, Abbvie, Lilly, Takeda, Janssen, Ferring, BiomX, BMS, Nestle and Teva and grant support from Takeda, Janssen, Abbott, Abbvie, Pfizer, BMS, Corundum Innovation, Nestle and the Helmsely Charitable Trust. The other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2025</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>0</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>0</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2025</Year><Month>7</Month><Day>15</Day><Hour>23</Hour><Minute>38</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">40665053</ArticleId><ArticleId IdType=\"doi\">10.1038/s41591-025-03790-9</ArticleId><ArticleId IdType=\"pii\">10.1038/s41591-025-03790-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Coppola, L. et al. Biobanking in health care: evolution and future directions. J. Transl. Med. 17, 172 (2019).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31118074</ArticleId><ArticleId IdType=\"pmc\">6532145</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudlow, C. et al. UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 12, e1001779 (2015).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25826379</ArticleId><ArticleId IdType=\"pmc\">4380465</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng, Y.-C. A. et al. Taiwan Biobank: a rich biomedical research database of the Taiwanese population. Cell Genomics 2, 100197 (2022).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36776991</ArticleId><ArticleId IdType=\"pmc\">9903657</ArticleId></ArticleIdList></Reference><Reference><Citation>Sijtsma, A. et al. Cohort Profile Update: lifelines, a three-generation cohort study and biobank. Int. J. Epidemiol. 51, e295&#x2013;e302 (2022).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34897450</ArticleId></ArticleIdList></Reference><Reference><Citation>All of Us Research Program Investigators et al. The &#x2018;All of Us&#x2019; Research Program. N. Engl. J. Med. 381, 668&#x2013;676 (2019).</Citation></Reference><Reference><Citation>All of Us Research Program Genomics Investigators. Genomic data in the All of Us Research Program. Nature 627, 340&#x2013;346 (2024).</Citation></Reference><Reference><Citation>Yang, G. et al. Association of unhealthy lifestyle and childhood adversity with acceleration of aging among UK biobank participants. JAMA Netw. Open 5, e2230690 (2022).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36066889</ArticleId><ArticleId IdType=\"pmc\">9449787</ArticleId></ArticleIdList></Reference><Reference><Citation>Shilo, S., Rossman, H. &amp; Segal, E. Axes of a revolution: challenges and promises of big data in healthcare. Nat. Med. 26, 29&#x2013;38 (2020).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31932803</ArticleId></ArticleIdList></Reference><Reference><Citation>Shilo, S. et al. 10 K: a large-scale prospective longitudinal study in Israel. Eur. J. Epidemiol. 36, 1187&#x2013;1194 (2021).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33993378</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen, B., Waitzberg, R. &amp; Merkur, S. Israel: health system review. Health Syst. Transit. 17, 1&#x2013;212 (2015).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27050102</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf8;ttern, J., Stage, T. B. &amp; Dunvald, A.-C. D. Sex, racial, and ethnic diversity in clinical trials. Clin. Transl. Sci. 16, 937&#x2013;945 (2023).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36908052</ArticleId><ArticleId IdType=\"pmc\">10264921</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke, G. et al. LightGBM: a highly efficient gradient boosting decision tree. In Proc. 31st Conference on Neural Information Processing Systems (eds Guyon, I. et al.) 3149&#x2013;3157 (Curran Associates, 2017).</Citation></Reference><Reference><Citation>Rothschild, D. et al. Environment dominates over host genetics in shaping human gut microbiota. Nature 555, 210&#x2013;215 (2018).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29489753</ArticleId></ArticleIdList></Reference><Reference><Citation>Whyte, M. B. &amp; Kelly, P. The normal range: it is not normal and it is not a range. Postgrad. Med. J. 94, 613&#x2013;616 (2018).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30425140</ArticleId></ArticleIdList></Reference><Reference><Citation>Timbrell, N. E. The role and limitations of the reference interval within clinical chemistry and its reliability for disease detection. Br. J. Biomed. Sci. 81, 12339 (2024).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">38481978</ArticleId><ArticleId IdType=\"pmc\">10932992</ArticleId></ArticleIdList></Reference><Reference><Citation>Keshet, A. et al. CGMap: characterizing continuous glucose monitor data in thousands of non-diabetic individuals. Cell Metab. 35, 758&#x2013;769 (2023).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37080199</ArticleId></ArticleIdList></Reference><Reference><Citation>Diament, A. et al. A multimodal dataset of 21,412 recorded nights for sleep and respiratory research. Preprint at https://arxiv.org/abs/2311.08979 (2023).</Citation></Reference><Reference><Citation>Shapira, M. et al. Unveiling associations between retinal microvascular architecture and phenotypes across thousands of healthy subjects. Preprint at medRxiv https://doi.org/10.1101/2024.04.05.24305164 (2024).</Citation></Reference><Reference><Citation>Leviatan, S., Shoer, S., Rothschild, D., Gorodetski, M. &amp; Segal, E. An expanded reference map of the human gut microbiome reveals hundreds of previously unknown species. Nat. Commun. 13, 3863 (2022).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35790781</ArticleId><ArticleId IdType=\"pmc\">9256738</ArticleId></ArticleIdList></Reference><Reference><Citation>Mannarino, M. R., Di Filippo, F. &amp; Pirro, M. Obstructive sleep apnea syndrome. Eur. J. Intern. Med. 23, 586&#x2013;593 (2012).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22939801</ArticleId></ArticleIdList></Reference><Reference><Citation>American Diabetes Association Professional Practice Committee.Diagnosis and classification of diabetes: standards of care in diabetes&#x2014;2024. Diabetes Care 47, S20&#x2013;S42 (2024).</Citation></Reference><Reference><Citation>Shilo, S. et al. Continuous glucose monitoring and intrapersonal variability in fasting glucose. Nat. Med. 30, 1424&#x2013;1431 (2024).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">38589602</ArticleId></ArticleIdList></Reference><Reference><Citation>Reicher, L. et al. Phenome-wide associations of human aging uncover sex-specific dynamics. Nat. Aging 4, 1643&#x2013;1655 (2024).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">39501126</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian, Y. E. et al. Heterogeneous aging across multiple organ systems and prediction of chronic disease and mortality. Nat. Med. 29, 1221&#x2013;1231 (2023).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37024597</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh, H. S.-H. et al. Organ aging signatures in the plasma proteome track health and disease. Nature 624, 164&#x2013;172 (2023).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">38057571</ArticleId><ArticleId IdType=\"pmc\">10700136</ArticleId></ArticleIdList></Reference><Reference><Citation>Moqri, M. et al. Validation of biomarkers of aging. Nat. Med. 30, 360&#x2013;372 (2024).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">38355974</ArticleId><ArticleId IdType=\"pmc\">11090477</ArticleId></ArticleIdList></Reference><Reference><Citation>Bar, N. et al. A reference map of potential determinants for the human serum metabolome. Nature 588, 135&#x2013;140 (2020).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33177712</ArticleId></ArticleIdList></Reference><Reference><Citation>Talmor-Barkan, Y. et al. Metabolomic and microbiome profiling reveals personalized risk factors for coronary artery disease. Nat. Med. 28, 295&#x2013;302 (2022).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35177859</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohn, S. et al. Phenome-wide associations of sleep characteristics in the Human Phenotype Project. Nat. Med. 31, 1026&#x2013;1037 (2025).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">39870817</ArticleId></ArticleIdList></Reference><Reference><Citation>Rein, M., Elkan, M., Godneva, A., Dolev, N. C. &amp; Segal, E. Sex-specific dietary habits and their association with weight change in healthy adults. BMC Med. 22, 512 (2024).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">39501340</ArticleId><ArticleId IdType=\"pmc\">11539530</ArticleId></ArticleIdList></Reference><Reference><Citation>Neeland, I. J. et al. Metabolic syndrome. Nat. Rev. Dis. Prim. 10, 77 (2024).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">39420195</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickard, J. M., Zeng, M. Y., Caruso, R. &amp; N&#xfa;&#xf1;ez, G. Gut microbiota: role in pathogen colonization, immune responses, and inflammatory disease. Immunol. Rev. 279, 70&#x2013;89 (2017).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28856738</ArticleId><ArticleId IdType=\"pmc\">5657496</ArticleId></ArticleIdList></Reference><Reference><Citation>Bommasani, R. et al. On the opportunities and risks of foundation models. Preprint at https://arxiv.org/abs/2108.07258 (2021).</Citation></Reference><Reference><Citation>Lutsker, G., Rossman, H., Godneva, N. &amp; Segal, E. COMPRER: a multimodal multi-objective pretraining framework for enhanced medical image representation. Preprint at medRxiv https://doi.org/10.1101/2024.03.17.24304415 (2024).</Citation></Reference><Reference><Citation>Krishnan, R., Rajpurkar, P. &amp; Topol, E. J. Self-supervised learning in medicine and healthcare. Nat. Biomed. Eng. 6, 1346&#x2013;1352 (2022).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35953649</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, J. et al. RETFound-enhanced community-based fundus disease screening: real-world evidence and decision curve analysis. npj Digit. Med. 7, 108 (2024).</Citation></Reference><Reference><Citation>Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203&#x2013;209 (2018).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30305743</ArticleId><ArticleId IdType=\"pmc\">6786975</ArticleId></ArticleIdList></Reference><Reference><Citation>Lutsker, G. et al. From glucose patterns to health outcomes: a generalizable foundation model for continuous glucose monitor data analysis. Preprint at https://arxiv.org/abs/2408.11876 (2024).</Citation></Reference><Reference><Citation>Yurkovich, J. T. et al. The transition from genomics to phenomics in personalized population health. Nat. Rev. Genet. 25, 286&#x2013;302 (2024).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">38093095</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurdasani, D., Barroso, I., Zeggini, E. &amp; Sandhu, M. S. Genomics of disease risk in globally diverse populations. Nat. Rev. Genet. 20, 520&#x2013;535 (2019).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31235872</ArticleId></ArticleIdList></Reference><Reference><Citation>Teagle, W. L. et al. Comorbidities and ethnic health disparities in the UK Biobank. JAMIA Open 5, ooac057 (2022).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36313969</ArticleId><ArticleId IdType=\"pmc\">9272510</ArticleId></ArticleIdList></Reference><Reference><Citation>Mapes, B. M. et al. Diversity and inclusion for the All of Us research program: a scoping review. PLoS ONE 15, e0234962 (2020).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32609747</ArticleId><ArticleId IdType=\"pmc\">7329113</ArticleId></ArticleIdList></Reference><Reference><Citation>van Alten, S., Domingue, B. W., Galama, T. &amp; Marees, A. T. Reweighting the UK Biobank to reflect its underlying sampling population substantially reduces pervasive selection bias due to volunteering. Preprint at medRxiv https://doi.org/10.1101/2022.05.16.22275048 (2022).</Citation></Reference><Reference><Citation>Aasmets, O., Krigul, K. L., L&#xfc;ll, K., Metspalu, A. &amp; Org, E. Gut metagenome associations with extensive digital health data in a volunteer-based Estonian microbiome cohort. Nat. Commun. 13, 869 (2022).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35169130</ArticleId><ArticleId IdType=\"pmc\">8847343</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdi, S. et al. TwinsUK: the UK adult twin registry update. Twin Res. Hum. Genet. 22, 523&#x2013;529 (2019).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31526404</ArticleId></ArticleIdList></Reference><Reference><Citation>Rein, M. S. et al. Breast cancer personalised nutrition (BREACPNT): dietary intervention in breast cancer survivors treated with endocrine therapy&#x2014;a protocol for a randomised clinical trial. BMJ Open 12, e062498 (2022).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36410828</ArticleId><ArticleId IdType=\"pmc\">9680181</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang, K. P., Gourin, C. G. &amp; Terris, D. J. A comparison of polysomnography and the WatchPAT in the diagnosis of obstructive sleep apnea. Otolaryngol. Head. Neck Surg. 137, 665&#x2013;668 (2007).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17903588</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine, Z. et al. Genome-wide association studies and polygenic risk score phenome-wide association studies across complex phenotypes in the human phenotype project. MED 5, 90&#x2013;101 (2024).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">38157848</ArticleId></ArticleIdList></Reference><Reference><Citation>Seabold, S. &amp; Perktold, J. Statsmodels: econometric and statistical modeling with Python. In Proc. 9th Python in Science Conference 92&#x2013;96 (SciPy, 2010).</Citation></Reference><Reference><Citation>Lundberg, S. M., Erion, G. G. &amp; Lee, S.-I. Consistent individualized feature attribution for tree ensembles. Preprint at https://arxiv.org/abs/1802.03888 (2018).</Citation></Reference><Reference><Citation>Royston, P. &amp; Parmar, M. K. B. Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat. Med. 21, 2175&#x2013;2197 (2002).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12210632</ArticleId></ArticleIdList></Reference><Reference><Citation>Dosovitskiy, A. et al. An image is worth 16x16 words: transformers for image recognition at scale. Preprint at https://arxiv.org/abs/2010.11929 (2020).</Citation></Reference><Reference><Citation>Oquab, M. et al. DINOv2: learning robust visual features without supervision. Preprint at https://arxiv.org/abs/2304.07193 (2023).</Citation></Reference><Reference><Citation>Nastya. Nastyagodneva/HPP_resource_code: v1.0.0. Zenodo https://doi.org/10.5281/zenodo.14855715 (2025).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">40664887</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>15</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">1432-1076</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>184</Volume><Issue>8</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>16</Day></PubDate></JournalIssue><Title>European journal of pediatrics</Title><ISOAbbreviation>Eur J Pediatr</ISOAbbreviation></Journal><ArticleTitle>Mental health risks in children with food allergies: a population-based comparison of food allergies with other chronic conditions.</ArticleTitle><Pagination><StartPage>483</StartPage><MedlinePgn>483</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1007/s00431-025-06316-0</ELocationID><Abstract><AbstractText Label=\"UNLABELLED\">Children with chronic diseases face a&#xa0;higher risk of mental health disorders. However, the cognitive consequences of food allergies (FA), which are not classified as a chronic disease, remain insufficiently researched. The objective of this study is to examine the association between FA and mental health in children and adolescents, compared to children and adolescents without FA (controls) and those with other chronic conditions but no history of FA. This is a retrospective cohort study using IQVIA Medical Research Data from UK primary care practices. Five cohorts of children aged 0-18 between 2000 and 2021 were defined: FA, control, asthma, atopic dermatitis (AD), and type 1 diabetes (T1D). The study included 1,130,721 children without FA (control), 23,263 with FA, 136,453 with asthma, 207,575 with AD, and 4835 with T1D. Compared to control, FA patients had higher risks of eating disorders (hazard ratio (HR) 1.85, 95% CI 1.42-2.41), anxiety (HR 1.35, 95% CI 1.25-1.45), and depression (HR 1.24, 95% CI 1.11-1.39). FA patients had lower depression risk than asthma and T1D patients (HR 0.77, 95% CI 0.68-0.87, 0.64, 95% CI 0.54-0.76, respectively) and lower anxiety risk than asthma patients (HR 0.86, 95% CI 0.79-0.91). FA patients' risk of eating disorders was not significantly different from asthma and T1D patients (HR 1.17, 95% CI 0.88-1.55, 1.58, 95% CI 0.81-3.10, respectively) but was significantly higher than in the AD group (HR 1.43, 95% CI 1.07-1.90).</AbstractText><AbstractText Label=\"CONCLUSION\" NlmCategory=\"CONCLUSIONS\">This study indicates that children with FA face elevated risks of anxiety, depression, and eating disorders compared to children without FA, and that these risks vary when compared to children with other chronic conditions. These findings highlight the need for integrated mental health support in FA management and greater awareness of FA's psychological impact among healthcare providers.</AbstractText><AbstractText Label=\"WHAT IS KNOWN\" NlmCategory=\"BACKGROUND\">&#x2022; Children with chronic illnesses such as asthma&#xa0;and&#xa0;diabetes are known to have an elevated risk of mental health disorders. However, research on the mental health impact of food allergies remains limited.</AbstractText><AbstractText Label=\"WHAT IS NEW\" NlmCategory=\"BACKGROUND\">&#x2022; This study reveals that children with FA have significantly increased risks of anxiety, depression, and eating disorders compared to children without FA and provides comparative insights into the mental health risks of FA relative to other chronic conditions like asthma, atopic dermatitis, type 1 diabetes, and healthy controls.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\" EqualContrib=\"Y\"><LastName>Flaks-Manov</LastName><ForeName>Natalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>KI Research Institute, Kfar Malal, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\" EqualContrib=\"Y\"><LastName>Goldshtein</LastName><ForeName>Inbal</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>KI Research Institute, Kfar Malal, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Yanover</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>KI Research Institute, Kfar Malal, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lachover-Roth</LastName><ForeName>Idit</ForeName><Initials>I</Initials><Identifier Source=\"ORCID\">0000-0001-8968-4143</Identifier><AffiliationInfo><Affiliation>Allergy and Clinical Immunology Unit, Meir Medical Center, Kfar Saba, Israel. idit.lachover@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel. idit.lachover@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D003160\">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2025</Year><Month>07</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur J Pediatr</MedlineTA><NlmUniqueID>7603873</NlmUniqueID><ISSNLinking>0340-6199</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D005512\" MajorTopicYN=\"Y\">Food Hypersensitivity</DescriptorName><QualifierName UI=\"Q000523\" MajorTopicYN=\"N\">psychology</QualifierName><QualifierName UI=\"Q000453\" MajorTopicYN=\"N\">epidemiology</QualifierName><QualifierName UI=\"Q000150\" MajorTopicYN=\"N\">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D002648\" MajorTopicYN=\"N\">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008297\" MajorTopicYN=\"N\">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D005260\" MajorTopicYN=\"N\">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D012189\" MajorTopicYN=\"N\">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D002675\" MajorTopicYN=\"N\">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000293\" MajorTopicYN=\"N\">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D007223\" MajorTopicYN=\"N\">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D002908\" MajorTopicYN=\"N\">Chronic Disease</DescriptorName><QualifierName UI=\"Q000523\" MajorTopicYN=\"N\">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D006113\" MajorTopicYN=\"N\" Type=\"Geographic\">United Kingdom</DescriptorName><QualifierName UI=\"Q000453\" MajorTopicYN=\"N\">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D001249\" MajorTopicYN=\"N\">Asthma</DescriptorName><QualifierName UI=\"Q000523\" MajorTopicYN=\"N\">psychology</QualifierName><QualifierName UI=\"Q000453\" MajorTopicYN=\"N\">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D003876\" MajorTopicYN=\"N\">Dermatitis, Atopic</DescriptorName><QualifierName UI=\"Q000523\" MajorTopicYN=\"N\">psychology</QualifierName><QualifierName UI=\"Q000453\" MajorTopicYN=\"N\">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D007231\" MajorTopicYN=\"N\">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D012307\" MajorTopicYN=\"N\">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D003863\" MajorTopicYN=\"N\">Depression</DescriptorName><QualifierName UI=\"Q000453\" MajorTopicYN=\"N\">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D003922\" MajorTopicYN=\"N\">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI=\"Q000523\" MajorTopicYN=\"N\">psychology</QualifierName><QualifierName UI=\"Q000453\" MajorTopicYN=\"N\">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D008603\" MajorTopicYN=\"N\">Mental Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D001523\" MajorTopicYN=\"Y\">Mental Disorders</DescriptorName><QualifierName UI=\"Q000453\" MajorTopicYN=\"N\">epidemiology</QualifierName><QualifierName UI=\"Q000209\" MajorTopicYN=\"N\">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D001007\" MajorTopicYN=\"N\">Anxiety</DescriptorName><QualifierName UI=\"Q000453\" MajorTopicYN=\"N\">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Anxiety</Keyword><Keyword MajorTopicYN=\"N\">Depression</Keyword><Keyword MajorTopicYN=\"N\">Eating disorders</Keyword><Keyword MajorTopicYN=\"N\">Food allergy</Keyword></KeywordList><CoiStatement>Declarations. Ethical approval: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of IQVIA Scientific Review Committee (SRC Reference Number: 23SRC014). Competing interest: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2025</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2025</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2025</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>0</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2025</Year><Month>7</Month><Day>15</Day><Hour>23</Hour><Minute>29</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">40664887</ArticleId><ArticleId IdType=\"doi\">10.1007/s00431-025-06316-0</ArticleId><ArticleId IdType=\"pii\">10.1007/s00431-025-06316-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Torpy JM, Campbell A, Glass RM (2010) Chronic diseases of children. JAMA 303:682. https://doi.org/10.1001/jama.303.7.682</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jama.303.7.682</ArticleId><ArticleId IdType=\"pubmed\">20159879</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett S, Shafran R, Coughtrey A et al (2015) Psychological interventions for mental health disorders in children with chronic physical illness: a systematic review. Arch Dis Child 100:308&#x2013;316. https://doi.org/10.1136/archdischild-2014-307474</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/archdischild-2014-307474</ArticleId><ArticleId IdType=\"pubmed\">25784736</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodwin RD, Robinson M, Sly PD et al (2013) Severity and persistence of asthma and mental health: a birth cohort study. Psychol Med 43.&#xa0; https://doi.org/10.1017/S0033291712001754</Citation></Reference><Reference><Citation>Gupta RS, Warren CM, Smith BM et al (2019) Prevalence and severity of food allergies among US adults. JAMA Netw Open 2:e185630. https://doi.org/10.1001/jamanetworkopen.2018.5630</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/jamanetworkopen.2018.5630</ArticleId><ArticleId IdType=\"pubmed\">30646188</ArticleId><ArticleId IdType=\"pmc\">6324316</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta RS, Springston EE, Warrier MR et al (2011) The prevalence, severity, and distribution of childhood food allergy in the United States. Pediatrics 128:e9&#x2013;e17. https://doi.org/10.1542/peds.2011-0204</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1542/peds.2011-0204</ArticleId><ArticleId IdType=\"pubmed\">21690110</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang MLK, Mullins RJ (2017) Food allergy: is prevalence increasing? Intern Med J 47:256&#x2013;261. https://doi.org/10.1111/imj.13362</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/imj.13362</ArticleId><ArticleId IdType=\"pubmed\">28260260</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng C, Kim J-H (2019) Beyond avoidance: the psychosocial impact of food allergies. Clin Rev Allergy Immunol 57:74&#x2013;82. https://doi.org/10.1007/s12016-018-8708-x</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12016-018-8708-x</ArticleId><ArticleId IdType=\"pubmed\">30171460</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings AJ, Knibb RC, King RM, Lucas JS (2010) The psychosocial impact of food allergy and food hypersensitivity in children, adolescents and their families: a review. Allergy 65:933&#x2013;945. https://doi.org/10.1111/j.1398-9995.2010.02342.x</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1398-9995.2010.02342.x</ArticleId><ArticleId IdType=\"pubmed\">20180792</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferro MA, Van Lieshout RJ, Ohayon J, Scott JG (2016) Emotional and behavioral problems in adolescents and young adults with food allergy. Allergy 71:532&#x2013;540. https://doi.org/10.1111/all.12829</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/all.12829</ArticleId><ArticleId IdType=\"pubmed\">26715290</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanahan L, Zucker N, Copeland WE et al (2014) Are children and adolescents with food allergies at increased risk for psychopathology? J Psychosom Res 77:468&#x2013;473. https://doi.org/10.1016/j.jpsychores.2014.10.005</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jpsychores.2014.10.005</ArticleId><ArticleId IdType=\"pubmed\">25454290</ArticleId><ArticleId IdType=\"pmc\">4307934</ArticleId></ArticleIdList></Reference><Reference><Citation>Brew BK, Lundholm C, Gong T et al (2018) The familial aggregation of atopic diseases and depression or anxiety in children. Clin Exp Allergy 48:703&#x2013;711. https://doi.org/10.1111/cea.13127</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/cea.13127</ArticleId><ArticleId IdType=\"pubmed\">29513367</ArticleId><ArticleId IdType=\"pmc\">6001531</ArticleId></ArticleIdList></Reference><Reference><Citation>Nachshon L, Schwartz N, Goldberg MR et al (2021) Characteristics and associated morbidities of young adults with misconceived food allergy: a cross-sectional study. eClinicalMedicine 33. https://doi.org/10.1016/j.eclinm.2021.100766</Citation></Reference><Reference><Citation>Ciciulla D, Soriano VX, McWilliam V et al (2023) Systematic review of the incidence and/or prevalence of eating disorders in individuals with food allergies. J Allergy Clin Immunol Pract 11:2196&#x2013;2207.e13. https://doi.org/10.1016/j.jaip.2023.04.010</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jaip.2023.04.010</ArticleId><ArticleId IdType=\"pubmed\">37088367</ArticleId></ArticleIdList></Reference><Reference><Citation>Avery NJ, King RM, Knight S, Hourihane JO (2003) Assessment of quality of life in children with peanut allergy. Pediatr Allergy Immunol 14:378&#x2013;382. https://doi.org/10.1034/j.1399-3038.2003.00072.x</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1034/j.1399-3038.2003.00072.x</ArticleId><ArticleId IdType=\"pubmed\">14641608</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemet S, Mahlab&#x2010;Guri K, Elbirt D, et al (2023) Food allergy is associated with increased risk of developing psychological disorders: a nationwide study of 603,257 Israelis. | EBSCOhost. https://openurl.ebsco.com/contentitem/10.1111%2Fall.15775?sid=ebsco:plink:crawler&amp;id=ebsco:10.1111%2Fall.15775 . Accessed 14 Jan 2025</Citation></Reference><Reference><Citation>Wolf A, Dedman D, Campbell J et al (2019) Data resource profile: Clinical Practice Research Datalink (CPRD) Aurum. Int J Epidemiol 48:1740&#x2013;1740g. https://doi.org/10.1093/ije/dyz034</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/ije/dyz034</ArticleId><ArticleId IdType=\"pubmed\">30859197</ArticleId><ArticleId IdType=\"pmc\">6929522</ArticleId></ArticleIdList></Reference><Reference><Citation>Myland M, O&#x2019;Leary C, Bafadhal B et al (2021) IQVIA Medical Research Data (IMRD). In: Sturkenboom M, Schink T (eds) Databases for pharmacoepidemiological research. Springer International Publishing, Cham, pp 67&#x2013;76</Citation></Reference><Reference><Citation>Blak BT, Thompson M, Dattani H, Bourke A (2011) Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates. | EBSCOhost. https://openurl.ebsco.com/contentitem/10.14236%2Fjhi.v19i4.820?sid=ebsco:plink:crawler&amp;id=ebsco:10.14236%2Fjhi.v19i4.820 . Accessed 14 Jan 2025</Citation></Reference><Reference><Citation>Fleischer DM, Conover-Walker MK, Matsui EC, Wood RA (2005) The natural history of tree nut allergy. J Allergy Clin Immunol 116:1087&#x2013;1093. https://doi.org/10.1016/j.jaci.2005.09.002</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jaci.2005.09.002</ArticleId><ArticleId IdType=\"pubmed\">16275381</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters RL, Guarnieri I, Tang MLK et al (2022) The natural history of peanut and egg allergy in children up to age 6 years in the HealthNuts population-based longitudinal study. J Allergy Clin Immunol 150:657&#x2013;665.e13. https://doi.org/10.1016/j.jaci.2022.04.008</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jaci.2022.04.008</ArticleId><ArticleId IdType=\"pubmed\">35597613</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim M, Lee JY, Yang H et al (2019) The natural course of immediate-type cow&#x2019;s milk and egg allergies in children. Int Arch Allergy Immunol 181:103&#x2013;110. https://doi.org/10.1159/000503749</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1159/000503749</ArticleId><ArticleId IdType=\"pubmed\">31752004</ArticleId></ArticleIdList></Reference><Reference><Citation>Cobham VE, Hickling A, Kimball H et al (2020) Systematic review: anxiety in children and adolescents with chronic medical conditions. J Am Acad Child Adolesc Psychiatry 59:595&#x2013;618. https://doi.org/10.1016/j.jaac.2019.10.010</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jaac.2019.10.010</ArticleId><ArticleId IdType=\"pubmed\">31676391</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y, Lu J-W, Wang J-H et al (2023) Associations of atopic dermatitis with attention deficit/hyperactivity disorder and autism spectrum disorder: a systematic review and meta-analysis. Dermatology 240:13&#x2013;25. https://doi.org/10.1159/000533366</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1159/000533366</ArticleId><ArticleId IdType=\"pubmed\">37939694</ArticleId></ArticleIdList></Reference><Reference><Citation>Kauppi S, Jokelainen J, Timonen M et al (2022) Atopic dermatitis and the risk of eating disorders: a population-based cohort study. J Am Acad Dermatol 87:474&#x2013;476. https://doi.org/10.1016/j.jaad.2021.10.021</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jaad.2021.10.021</ArticleId><ArticleId IdType=\"pubmed\">34688824</ArticleId></ArticleIdList></Reference><Reference><Citation>Goebel-Fabbri A, Copeland P, Touyz S, Hay P (2019) EDITORIAL: Eating disorders in diabetes: discussion on issues relevant to type 1 diabetes and an overview of the Journal&#x2019;s special issue. J Eat Disord 7:27. https://doi.org/10.1186/s40337-019-0256-0</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s40337-019-0256-0</ArticleId><ArticleId IdType=\"pubmed\">31360517</ArticleId><ArticleId IdType=\"pmc\">6637645</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikniaz Z, Beheshti S, Abbasalizad Farhangi M, Nikniaz L (2021) A systematic review and meta-analysis of the prevalence and odds of eating disorders in patients with celiac disease and vice-versa. Int J Eat Disord 54:1563&#x2013;1574. https://doi.org/10.1002/eat.23561</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/eat.23561</ArticleId><ArticleId IdType=\"pubmed\">34042201</ArticleId></ArticleIdList></Reference><Reference><Citation>Duffus SH, Cooper KL, Agans RP, Jain N (2019) Mental health and behavioral screening in pediatric type 1 diabetes. Diabetes Spectr 32:171&#x2013;175. https://doi.org/10.2337/ds18-0053</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2337/ds18-0053</ArticleId><ArticleId IdType=\"pubmed\">31168290</ArticleId><ArticleId IdType=\"pmc\">6528398</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, Wang J, Carru C et al (2023) The prevalence of depression among parents of children/adolescents with type 1 diabetes: a systematic review and meta-analysis. Front Endocrinol 14. https://doi.org/10.3389/fendo.2023.1095729</Citation></Reference><Reference><Citation>Jurgen B, Baker CN, Kamps JL et al (2020) Associations between depressive symptoms, fear of hypoglycemia, adherence to management behaviors and metabolic control in children and adolescents with type 1 diabetes. J Clin Psychol Med Settings 27:385&#x2013;395. https://doi.org/10.1007/s10880-019-09676-6</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s10880-019-09676-6</ArticleId><ArticleId IdType=\"pubmed\">31728880</ArticleId><ArticleId IdType=\"pmc\">7220842</ArticleId></ArticleIdList></Reference><Reference><Citation>Soodhana Mohan D, HN V, Madegowda RK, Palany R (2024) Psychosocial factors and the role of family in children with type 1 diabetes mellitus. Dubai Diabetes Endocrinol J 29:171&#x2013;178. https://doi.org/10.1159/000535051</Citation></Reference><Reference><Citation>Nartey Y, Crooks C, West J et al (2023) The incidence and prevalence of coeliac disease in the United Kingdom. In: Big data. American Academy of Family Physicians, p 5051</Citation></Reference><Reference><Citation>Lebwohl B, Hagg&#xe5;rd L, Emilsson L et al (2021) Psychiatric disorders in patients with a diagnosis of celiac disease during childhood from 1973 to 2016. Clin Gastroenterol Hepatol 19:2093&#x2013;2101.e13. https://doi.org/10.1016/j.cgh.2020.08.018</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.cgh.2020.08.018</ArticleId><ArticleId IdType=\"pubmed\">32801012</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho WHJ, Atkinson EL, David AL (2023) Examining the psychosocial well-being of children and adolescents with coeliac disease: a systematic review. J Pediatr Gastroenterol Nutr 76:e1&#x2013;e14. https://doi.org/10.1097/MPG.0000000000003652</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/MPG.0000000000003652</ArticleId><ArticleId IdType=\"pubmed\">36573999</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">40664716</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>15</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">2045-2322</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>15</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Conducting the National Health and Morbidity Survey 2023 in Malaysia with focus on methodology and main findings on non-communicable diseases.</ArticleTitle><Pagination><StartPage>25531</StartPage><MedlinePgn>25531</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1038/s41598-025-08311-9</ELocationID><Abstract><AbstractText>The National Health and Morbidity Survey (NHMS), which focuses on non-communicable diseases (NCDs), their risk factors and healthcare demand, is a cross-sectional,&#xa0;nationwide, population-based survey conducted every four-year cycle since 2011. NHMS 2023 was the 7th cycle of NCDs, their risk factors and healthcare demand, which aimed to monitor trends in diseases and healthcare utilisation. This article outlines the methodology, sociodemographic characteristics, and overall findings from the population surveyed in 2023 regarding NCDs, their risk factors, and various health-related topics. This survey utilised a two-stage stratified random sampling design and encompassed fifteen main scopes, with sample sizes calculated to meet the specific requirements of each scope. Conducted from July to September 2023, it involved the random selection of 499 enumeration blocks(EBs) by the Department of Statistics Malaysia (DOSM) across all states and federal territories in Malaysia. The step resulted in the selection of 5,988 living quarters&#xa0;(LQs). Data collection methods included validated questionnaires administered through face-to-face interviews and self-administered questionnaires, alongside clinical assessments and blood investigations using calibrated devices. To ensure the high quality of the collected data, we implemented stringent quality control measures. Furthermore, we applied complex sampling analyses to ensure that the findings accurately represented the population in Malaysia. The survey received responses from 13,616 individuals out of the 5,006 LQs that were successfully visited, resulting in an overall response rate of the survey of 83.2%, which includes individuals aged 5 years and above. A substantial segment of the population lived in urban regions, comprising 77.6% of the total. About half of the population consisted of males (51.9%), Malay (54.6%), and individuals who had attained secondary education (54.2%). Additionally, 20.0% of the population were within the age range of 30 to 39 years. The weighted prevalence of diabetes was 15.6%, hypertension 29.2%, hypercholesterolaemia 33.3%, overweight and obesity 54.4%.&#xa0;Depression among adults was&#xa0;4.6%, while mental health problems among children were reported at 16.5%. The current tobacco smokers prevalence was 19.0%, and 29.9%&#xa0;of adults in Malaysia were physically inactive. The known asthma prevalence among adults was 6.2%, while the current asthma among children was 3.4%. Additionally, 37.7% of adults experienced sleep insufficiency.&#xa0;The results indicate that the higher proportion of diabetes, hypertension,&#xa0;and hypercholesterolaemia, particularly among the young age group, and the high prevalence of overweight and obesity, as well as mental health problems,&#xa0; are making the healthcare system deal with more non-communicable diseases, complications, and problems. The methodology of this survey is robust for a population-based study. We took comprehensive steps to ensure the validity and reliability of the findings. The findings indicate an urgent need for targeted public health interventions to address the escalating health issues. By focusing on prevention and early intervention strategies, we can mitigate the impact of NCDs on the healthcare system and improve overall population health.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Mat Rifin</LastName><ForeName>Halizah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute for Public Health, National Institutes of Health, Ministry of Health, Blok B5 &amp; B6,Kompleks NIH, No. 1, Jalan Setia Murni U13/52, Seksyen U13 Setia Alam, Shah Alam, 40170, Selangor, Malaysia. halizah.matrifin@moh.gov.my.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Mohd Yusoff</LastName><ForeName>Muhammad Fadhli</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Institute for Public Health, National Institutes of Health, Ministry of Health, Blok B5 &amp; B6,Kompleks NIH, No. 1, Jalan Setia Murni U13/52, Seksyen U13 Setia Alam, Shah Alam, 40170, Selangor, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Abd Hamid</LastName><ForeName>Hamizatul Akmal</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Institute for Public Health, National Institutes of Health, Ministry of Health, Blok B5 &amp; B6,Kompleks NIH, No. 1, Jalan Setia Murni U13/52, Seksyen U13 Setia Alam, Shah Alam, 40170, Selangor, Malaysia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>NMRR-22-00545-XAC</GrantID><Agency>Kementerian Kesihatan Malaysia</Agency><Country/></Grant><Grant><GrantID>NMRR-22-00545-XAC</GrantID><Agency>Kementerian Kesihatan Malaysia</Agency><Country/></Grant><Grant><GrantID>NMRR-22-00545-XAC</GrantID><Agency>Kementerian Kesihatan Malaysia</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2025</Year><Month>07</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000073296\" MajorTopicYN=\"Y\">Noncommunicable Diseases</DescriptorName><QualifierName UI=\"Q000453\" MajorTopicYN=\"N\">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D008296\" MajorTopicYN=\"N\" Type=\"Geographic\">Malaysia</DescriptorName><QualifierName UI=\"Q000453\" MajorTopicYN=\"N\">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D008297\" MajorTopicYN=\"N\">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D005260\" MajorTopicYN=\"N\">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008875\" MajorTopicYN=\"N\">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000328\" MajorTopicYN=\"N\">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006306\" MajorTopicYN=\"Y\">Health Surveys</DescriptorName><QualifierName UI=\"Q000379\" MajorTopicYN=\"N\">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000368\" MajorTopicYN=\"N\">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000293\" MajorTopicYN=\"N\">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D003430\" MajorTopicYN=\"N\">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D055815\" MajorTopicYN=\"N\">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D012307\" MajorTopicYN=\"N\">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D002648\" MajorTopicYN=\"N\">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D002675\" MajorTopicYN=\"N\">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D009017\" MajorTopicYN=\"N\">Morbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011795\" MajorTopicYN=\"N\">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Malaysia; National Health and Morbidity Survey (NHMS) 2023</Keyword><Keyword MajorTopicYN=\"N\">Methodology</Keyword><Keyword MajorTopicYN=\"N\">Non-communicable diseases</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: All respondents provided written informed consent prior to interviews. The survey protocol was approved by the Medical Research and Ethics Committee (MREC), Ministry of Health Malaysia (22-00545-XAC (2)). All methods adhered to the principles of the Declaration of Helsinki and the Malaysian Good Clinical Practice Guidelines. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2025</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2025</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>0</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2025</Year><Month>7</Month><Day>15</Day><Hour>23</Hour><Minute>18</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">40664716</ArticleId><ArticleId IdType=\"doi\">10.1038/s41598-025-08311-9</ArticleId><ArticleId IdType=\"pii\">10.1038/s41598-025-08311-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. Noncommunicable diseases, (2024). https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases</Citation></Reference><Reference><Citation>Khaw, W. F. et al. Malaysian burden of disease: years of life lost due to premature deaths. BMC Public. Health. 23, 1383 (2023).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12889-023-16309-z</ArticleId><ArticleId IdType=\"pubmed\">37464344</ArticleId><ArticleId IdType=\"pmc\">10355013</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x200c;Institute for Public Health (IKU). Malaysian Burden of Disease and Injury Study 2015&#x2013;2017. (2020).</Citation></Reference><Reference><Citation>Institute for Public Health (IKU). National Health and Morbidity Survey (NHMS) 2023: Non-Communicable Diseases and Healthcare Demand: Technical Report (2024).</Citation></Reference><Reference><Citation>World Health Organization. STEPS Instrument. Noncommunicable disease surveillance, monitoring, and reporting (2020). https://www.who.int/teams/noncommunicable-diseases/surveillance/systems-tools/steps/instrument</Citation></Reference><Reference><Citation>Disease Policy and Strategy Division, and Health Analytics Division, Ministry of Health Policy, Research &amp; Surveillance Group, Health Promotion Board, Singapore. National Population Health Survey 2023 (2024).</Citation></Reference><Reference><Citation>Rusyda, A. L. Exploring the Non-Communicable disease burden in Indonesia &#x2013; Findings from the 2023 health survey. Indonesian J. Public. Health Nutr. (IJPHN) (2025).</Citation></Reference><Reference><Citation>Ministry of Health. National Strategic Plan for Non-Communicable Disease (NSP-NCD) 2016&#x2013;2025 (2016).</Citation></Reference><Reference><Citation>Jaspan, V. N. et al. The role of sleep in cardiovascular disease. Curr. Atheroscler. Rep. 26, 249&#x2013;262 (2024).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11883-024-01207-5</ArticleId><ArticleId IdType=\"pubmed\">38795275</ArticleId><ArticleId IdType=\"pmc\">11192677</ArticleId></ArticleIdList></Reference><Reference><Citation>Knutson, K. L. &amp; Van Cauter, E. Associations between sleep loss and increased risk of obesity and diabetes. Ann. N. Y. Acad. Sci. 1129, 287&#x2013;304 (2008).</Citation></Reference><Reference><Citation>Institute for Public Health (IKU). National Heatlh and Morbidity Survey 1996: Volume 1: The scope and methodology of the survey. (1997).</Citation></Reference><Reference><Citation>World Health Organization. Global physical activity questionnaire analysis guide.</Citation></Reference><Reference><Citation>Washington Group on Disability Statistics (WG). WG Short Set on Functioning (WG-SS), https://www.washingtongroup-disability.com/question-sets/wg-short-set-on-functioning-wg-ss/ .</Citation></Reference><Reference><Citation>European Community Respiratory Health Survey. European Community Respiratory Health Survey (ECRHS) III Main Questionnaire. https://www.ecrhs.org/_files/ugd/4aa474_034ead4589224fe2a6623cf955b15820.pdf (2011).</Citation></Reference><Reference><Citation>The International Study of Asthma and Allergies in Childhood. Phase Three Core Questionnaire (ISAAC) both ages. https://isaac.auckland.ac.nz/phases/phasethree/corequestionnaire.pdf .</Citation></Reference><Reference><Citation>World Health Organization. World Health Organization Programme of Nutrition, Family and Reproductive Health. Obesity: preventing and managing the global epidemic: report of a WHO consultation on obesity. (1998).</Citation></Reference><Reference><Citation>Ministry of Health. The Clinical Practice Guideline: Management of Obesity (2nd edition). https://www.moh.gov.my/moh/resources/Penerbitan/CPG/Endocrine/CPG_Management_of_Obesity_(Second_Edition)_2023.pdf (2023).</Citation></Reference><Reference><Citation>Malaysian Psychiatric Association. PHQ-9 For Major Depressive Disorder. (2018). https://psychiatry-malaysia.com/public/public-education/screening-tools/phq-9-for-major-depressive-disorder/</Citation></Reference><Reference><Citation>youthinmind. What is the SDQ? (2022). https://www.sdqinfo.org/a0.html</Citation></Reference><Reference><Citation>Saunders, J. B. AUDIT (Alcohol Use Disorders Identification Test) https://auditscreen.org/ .</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention. Sleep and sleep disorders. (2022). https://www.cdc.gov/sleep/index.html</Citation></Reference><Reference><Citation>Institute for Public Health (IKU). National Health and Morbidity Survey (NHMS) 2019: Vol. I: NCDs &#x2013; Non-Communicable Diseases: Risk Factors and other Health Problems. (2020).</Citation></Reference><Reference><Citation>Department of Statistics Malaysia. Department of Statistics Malaysia. Frequently asked questions: Population and housing census: What is the definition of urban areas used by the Department?. (2022).</Citation></Reference><Reference><Citation>Fadhli, Y., Noor Ani, O. A. A., Balkish, M. N., Ahmad, K. &amp; Jessree A tahir,. Approaches in methodology of a Population-Based study in malaysia: the National health and morbidity survey 2011 (NHMS 2011). Malaysian J. Med. Health Sci. 9, 25&#x2013;33 (2013).</Citation></Reference><Reference><Citation>An International Network for the Continuous Demographic Evaluation of Populations and Their Health in Developing Countries. Field quality control, (2008). https://www.indepth-network.org/Resource%20Kit/INDEPTH%20DSS%20Resource%20Kit/Fieldqualitycontrol.htm</Citation></Reference><Reference><Citation>Bedirhan &#xdc;stun, T., Mechbal, S. C. A., Christopher, J. L. &amp; Murray Household Sample Surveys in Developing and Transition Countries, https://unstats.un.org/unsd/hhsurveys/pdf/Chapter_10.pdf .</Citation></Reference><Reference><Citation>Department of Statistics Malaysia. Household Income Survey Report 2022 Technical Notes. (2022).</Citation></Reference><Reference><Citation>Carletto, G., Tiberti, M. &amp; Zezza, A. Measure for measure: comparing survey based estimates of income and consumption for rural households. World Bank Res. Obs. 37, 1&#x2013;38. https://doi.org/10.1093/wbro/lkab009 (2021).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1093/wbro/lkab009</ArticleId></ArticleIdList></Reference><Reference><Citation>Luiten, A., Hox, J. &amp; de Leeuw, E. Survey nonresponse trends and fieldwork effort in the 21st century: results of an international study across countries and surveys. J. Official Stat. 36, 469&#x2013;487&#xa0;(2020).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2478/jos-2020-0025</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC). National Health and Nutrition Examination Survey (NHANES): Response Rates and Population Totals, (2021). https://www.cdc.gov/nchs/nhanes/index.htm</Citation></Reference><Reference><Citation>Epidemiology &amp; Disease Control Division and Policy, Research &amp; Surveillance Group Ministry of Health and Health Promotion Board, Singapore, National Population Health Survey 2020. (2021).</Citation></Reference><Reference><Citation>Borneo Bulletin. Preliminary results of health survey show nation on right track, (2024). https://borneobulletin.com.bn/preliminary-results-of-health-survey-show-nation-on-right-track/</Citation></Reference><Reference><Citation>Epidemiology &amp; Disease Control Division and Policy, Research &amp; Surveillance Group Ministry of Health and Health Promotion Board, Singapore. National Population Health Survey 2022. (2023).</Citation></Reference><Reference><Citation>Chan, C.M.H. et al. Prevalence of insufficient sleep and its associated factors among working adults in Malaysia. Nat. Sci. Sleep 13, 1109&#x2013;1116 (2021).</Citation></Reference><Reference><Citation>Ministry of Health. Majlis Pelancaran Hasil Penyelidikan Tinjauan Kebangsaan Kesihatan Dan Morbiditi (NHMS) 2023: Penyakit Tidak Berjangkit (NCD) dan Permintaan Jagaan Kesihatan(2024). https://www.moh.gov.my/index.php/pages/view/9993</Citation></Reference><Reference><Citation>Sooryanarayana, R. et al. An overview of the methodology and general findings from the National health and morbidity survey (NHMS) 2018: older persons&#x2019; health in Malaysia. Geriatr. Gerontol. Int. 20 (Suppl 2), 7&#x2013;15 (2020).</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/ggi.14094</ArticleId><ArticleId IdType=\"pubmed\">33370855</ArticleId></ArticleIdList></Reference><Reference><Citation>Tee, E. S. &amp; Voon, S. H. Combating obesity in Southeast Asia countries: current status and the way forward. Glob. Health J. 8, 147&#x2013;151 (2024).</Citation></Reference><Reference><Citation>World Health Organization. Growth reference data for 5&#x2013;19 years &#x2013; indicators. https://www.who.int/tools/growth-reference-data-for-5to19years/indicators</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">40664706</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>15</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">2045-2322</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>15</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Disinfection of medical devices with a steam machine that operates at atmospheric pressure and is suitable for home usage.</ArticleTitle><Pagination><StartPage>25486</StartPage><MedlinePgn>25486</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1038/s41598-025-11509-6</ELocationID><Abstract><AbstractText>Medical devices that come in direct contact with human skin or the oral cavity will inevitably be contaminated with microorganisms, including potential pathogens. Ensuring the microbiological safety of such devices is therefore crucial to prevent infections. Healthcare institutions usually have the facilities needed for effective sterilization of reusable medical devices. However, effective sterilization or disinfection of medical devices for usage at home has remained challenging both in terms of pathogen elimination and user safety. Preferably, this involves easy-to-operate equipment that works at relatively low temperatures and atmospheric pressure. In principle this need can be met by disinfection with steam. Therefore, the objective of the present study was to examine the efficacy of a simple electronic steam machine designed for home usage. Our results show that exposure to steam at 100&#xa0;&#xb0;C for 60&#xa0;s resulted in complete eradication (100% reduction) of bacterial contaminants, including Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus (MRSA). Significant bacterial reductions (ranging from ~&#x2009;90-100%) were also observed within shorter exposure times (10-30&#xa0;s), depending on the strain. Importantly, the applied steam disinfection approach is effective even against biofilm-embedded bacteria, or bacteria applied to a medical device for home usage, as exemplified with a nebulizer that is used by patients with asthma or chronic obstructive pulmonary disease (COPD). In conclusion, our results provide quantitative proof-of-concept evidence that portable steam-generating devices that operate at atmospheric pressure can be used for effective disinfection of reusable medical devices in home settings.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Wang</LastName><ForeName>Shiyi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, Groningen, 9700 RB, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>van Dijl</LastName><ForeName>Jan Maarten</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, Groningen, 9700 RB, The Netherlands. j.m.van.dijl01@umcg.nl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2025</Year><Month>07</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D013227\">Steam</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D013227\" MajorTopicYN=\"Y\">Steam</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D004203\" MajorTopicYN=\"Y\">Disinfection</DescriptorName><QualifierName UI=\"Q000379\" MajorTopicYN=\"N\">methods</QualifierName><QualifierName UI=\"Q000295\" MajorTopicYN=\"N\">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D001274\" MajorTopicYN=\"N\">Atmospheric Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D004864\" MajorTopicYN=\"Y\">Equipment and Supplies</DescriptorName><QualifierName UI=\"Q000382\" MajorTopicYN=\"N\">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D055624\" MajorTopicYN=\"N\">Methicillin-Resistant Staphylococcus aureus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011550\" MajorTopicYN=\"N\">Pseudomonas aeruginosa</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D040981\" MajorTopicYN=\"N\">Acinetobacter baumannii</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D001419\" MajorTopicYN=\"N\">Bacteria</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D018441\" MajorTopicYN=\"N\">Biofilms</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Decontamination</Keyword><Keyword MajorTopicYN=\"N\">Disinfection</Keyword><Keyword MajorTopicYN=\"N\">Healthcare-associated infection</Keyword><Keyword MajorTopicYN=\"N\">Home disinfection</Keyword><Keyword MajorTopicYN=\"N\">Microbial</Keyword><Keyword MajorTopicYN=\"N\">Nebulizer</Keyword><Keyword MajorTopicYN=\"N\">Portable steam machine</Keyword><Keyword MajorTopicYN=\"N\">Steam sterilization</Keyword></KeywordList><CoiStatement>Declarations. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2024</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2025</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>0</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2025</Year><Month>7</Month><Day>15</Day><Hour>23</Hour><Minute>17</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">40664706</ArticleId><ArticleId IdType=\"doi\">10.1038/s41598-025-11509-6</ArticleId><ArticleId IdType=\"pii\">10.1038/s41598-025-11509-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rowan, N. J., Kremer, T. &amp; McDonnell, G. A review of spaulding&#x2019;s classification system for effective cleaning, disinfection and sterilization of reusable medical devices: viewed through a modern-day lens that will inform and enable future sustainability. Sci. Total Environ. 878, 162976 (2023).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36963674</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohapatra, S. Sterilization and Disinfection. Essentials of Neuroanesthesia. 929&#x2009;&#x2013;&#x2009;44. (2017).</Citation></Reference><Reference><Citation>, E. H. &amp;, C. (eds) BS,., Preserv. Philadelphia Lea Febige Chemical disinfection of medical and surgical materials. Disinfect sterilization. 517&#x2013;31. (1968).</Citation></Reference><Reference><Citation>Wells-Bennik, M. H. J. et al. Heat resistance of spores of 18 strains of Geobacillus stearothermophilus and impact of culturing conditions. Int. J. Food Microbiol. 291, 161&#x2013;172 (2019).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30504002</ArticleId></ArticleIdList></Reference><Reference><Citation>de Sousa Iwamoto, L. A., Duailibi, M. T., Iwamoto, G. Y., de Oliveira, D. C. &amp; Duailibi, S. E. Evaluation of ethylene oxide, gamma radiation, dry heat and autoclave sterilization processes on extracellular matrix of biomaterial dental scaffolds. Sci. Rep. 12 (1), 4299 (2022).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35277556</ArticleId><ArticleId IdType=\"pmc\">8916068</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutala, W. A. &amp; Weber, D. J. New disinfection and sterilization methods. Emerg. Infect. Dis. 7 (2), 348&#x2013;353 (2001).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11294738</ArticleId><ArticleId IdType=\"pmc\">2631727</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhaliwal, J. S. et al. Microbial biofilm decontamination on dental implant surfaces: A Mini review. Front. Cell. Infect. Microbiol. 11, 736186 (2021).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34692562</ArticleId><ArticleId IdType=\"pmc\">8531646</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutala, W. A. &amp; Weber, D. J. Disinfection and sterilization in health care facilities: an overview and current issues. Infect. Dis. Clin. North. Am. 35 (3), 575&#x2013;607 (2021).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34362535</ArticleId></ArticleIdList></Reference><Reference><Citation>van Doornmalen, J. &amp; Kopinga, K. Review of surface steam sterilization for validation purposes. Am. J. Infect. Control.. 36 (2), 86&#x2013;92 (2008).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18313509</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabatabaii, S. A. et al. Microbial contamination of home nebulizers in children with cystic fibrosis and clinical implication on the number of pulmonary exacerbations. BMC Pulm. Med. 20 (1), 33 (2020).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32028925</ArticleId><ArticleId IdType=\"pmc\">7006379</ArticleId></ArticleIdList></Reference><Reference><Citation>Tangpothitham, S., Pongprueksa, P., Inokoshi, M. &amp; Mitrirattanakul, S. Effect of post-polymerization with autoclaving treatment on monomer elution and mechanical properties of 3D-printing acrylic resin for splint fabrication. J. Mech. Behav. Biomed. Mater. 126, 105015 (2022).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34896766</ArticleId></ArticleIdList></Reference><Reference><Citation>Panta, G., Richardson, A. K. &amp; Shaw, I. C. Effectiveness of autoclaving in sterilizing reusable medical devices in healthcare facilities. J. Infect. Dev. Ctries. 13 (10), 858&#x2013;864 (2019).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32084015</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabnis, R. B., Bhattu, A. &amp; Vijaykumar, M. Sterilization of endoscopic instruments. Curr. Opin. Urol. 24 (2), 195&#x2013;202 (2014).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24451088</ArticleId></ArticleIdList></Reference><Reference><Citation>Brydon, N. Endotoxin is inactivated by ethylene oxide, gamma, Electron beam, and steam sterilization. Biomed. Instrum. Technol. 57 (3), 98&#x2013;105 (2023).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37624937</ArticleId><ArticleId IdType=\"pmc\">10512995</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadr, S. J., Fayyaz, A., Mahshid, M., Saboury, A. &amp; Ansari, G. Steam sterilization effect on the accuracy of friction-style mechanical torque limiting devices. Indian J. Dent. Res. 25 (3), 352&#x2013;356 (2014).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25098994</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiessner, R. et al. Alterations in the mechanical, chemical and biocompatibility properties of low-cost polyethylene and polyester meshes after steam sterilization. Hernia 24 (6), 1345&#x2013;1359 (2020).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32975699</ArticleId><ArticleId IdType=\"pmc\">7701087</ArticleId></ArticleIdList></Reference><Reference><Citation>Tesini, B. L. &amp; Dumyati, G. Health Care-Associated infections in older adults: epidemiology and prevention. Infect. Dis. Clin. North. Am. 37 (1), 65&#x2013;86 (2023).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36805015</ArticleId></ArticleIdList></Reference><Reference><Citation>Dix, L. M. L., de Goeij, I., Manintveld, O. C., Severin, J. A. &amp; Verkaik, N. J. Pseudomonas aeruginosa left ventricular assist device (LVAD) driveline infection acquired from the bathroom at home. Am. J. Infect. Control. 50 (12), 1392&#x2013;1394 (2022).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35569615</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavallo, F. M., Kommers, R., Friedrich, A. W., Glasner, C. &amp; van Dijl, J. M. Exploration of oxygen-mediated disinfection of medical devices reveals a high sensitivity of Pseudomonas aeruginosa to elevated oxygen levels. Sci. Rep. 12 (1), 18243 (2022).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36309557</ArticleId><ArticleId IdType=\"pmc\">9617943</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres, A., Blasi, F., Dartois, N. &amp; Akova, M. Which individuals are at increased risk of Pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive Pneumococcal disease. Thorax 70 (10), 984&#x2013;989 (2015).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26219979</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouhrour, N., Nibbering, P. H. &amp; Bendali, F. Medical Device-Associated biofilm infections and Multidrug-Resistant pathogens. Pathogens ;13(5). (2024).</Citation></Reference><Reference><Citation>Harris, J. C. et al. Bacterial surface detachment during nebulization with contaminated reusable home nebulizers. Microbiol. Spectr. 10 (1), e0253521 (2022).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35107362</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanson, C. S. et al. Microbiome-scale analysis of aerosol facemask contamination during nebulization therapy in hospital. J. Hosp. Infect. 134, 80&#x2013;88 (2023).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36690253</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei, Q. &amp; Ma, L. Z. Biofilm matrix and its regulation in Pseudomonas aeruginosa. Int. J. Mol. Sci. 14 (10), 20983&#x2013;21005 (2013).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24145749</ArticleId><ArticleId IdType=\"pmc\">3821654</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasrollahian, S., Graham, J. P. &amp; Halaji, M. A review of the mechanisms that confer antibiotic resistance in pathotypes of E. coli. Front. Cell. Infect. Microbiol. 14, 1387497 (2024).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">38638826</ArticleId><ArticleId IdType=\"pmc\">11024256</ArticleId></ArticleIdList></Reference><Reference><Citation>Podschun, R. &amp; Ullmann, U. Klebsiella spp. As nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin. Microbiol. Rev. 11 (4), 589&#x2013;603 (1998).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9767057</ArticleId><ArticleId IdType=\"pmc\">88898</ArticleId></ArticleIdList></Reference><Reference><Citation>Naehrig, S., Chao, C. M. &amp; Naehrlich, L. Cystic fibrosis. Dtsch. Arztebl Int. 114 (33&#x2013;34), 564&#x2013;574 (2017).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28855057</ArticleId><ArticleId IdType=\"pmc\">5596161</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulcahy, L. R., Isabella, V. M. &amp; Lewis, K. Pseudomonas aeruginosa biofilms in disease. Microb. Ecol. 68 (1), 1&#x2013;12 (2014).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">24096885</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibrahim, S., Al-Saryi, N., Al-Kadmy, I. M. S. &amp; Aziz, S. N. Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitals. Mol. Biol. Rep. 48 (10), 6987&#x2013;6998 (2021).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34460060</ArticleId><ArticleId IdType=\"pmc\">8403534</ArticleId></ArticleIdList></Reference><Reference><Citation>Raineri, E. J. M., Altulea, D. &amp; van Dijl, J. M. Staphylococcal trafficking and infection-from &#x2018;nose to gut&#x2019; and back. FEMS Microbiol. Rev. ;46(1). (2022).</Citation></Reference><Reference><Citation>Burke, &#xd3;., Zeden, M. S. &amp; O&#x2019;Gara, J. P. The pathogenicity and virulence of the opportunistic pathogen Staphylococcus epidermidis. Virulence 15 (1), 2359483 (2024).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">38868991</ArticleId><ArticleId IdType=\"pmc\">11178275</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao, C. M. &amp; Fritz, S. A. Infection prevention-how can we prevent transmission of community-onset methicillin-resistant Staphylococcus aureus? Clin. Microbiol. Infect. 31 (2), 166&#x2013;172 (2025).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">38218373</ArticleId></ArticleIdList></Reference><Reference><Citation>Sibila, O. et al. Risk factors and antibiotic therapy in P. aeruginosa community-acquired pneumonia. Respirology 20 (4), 660&#x2013;666 (2015).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25776134</ArticleId></ArticleIdList></Reference><Reference><Citation>de Goffau, M. C., van Dijl, J. M. &amp; Harmsen, H. J. Microbial growth on the edge of desiccation. Environ. Microbiol. 13 (8), 2328&#x2013;2335 (2011).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21554517</ArticleId></ArticleIdList></Reference><Reference><Citation>de Goffau, M. C., Yang, X., van Dijl, J. M. &amp; Harmsen, H. J. Bacterial pleomorphism and competition in a relative humidity gradient. Environ. Microbiol. 11 (4), 809&#x2013;822 (2009).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19040453</ArticleId></ArticleIdList></Reference><Reference><Citation>Maillard, J. Y. &amp; Centeleghe, I. How biofilm changes our Understanding of cleaning and disinfection. Antimicrob. Resist. Infect. Control. 12 (1), 95 (2023).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37679831</ArticleId><ArticleId IdType=\"pmc\">10483709</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, C. &amp; Xin, W. Different disinfection strategies in bacterial and biofilm contamination on dental unit waterlines: A systematic review. Int. J. Dent. Hyg. (2025).</Citation></Reference><Reference><Citation>Talsma, S. S. Biofilms on medical devices. Home Healthc. Nurse. 25 (9), 589&#x2013;594 (2007).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18049256</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha, A. K., L&#xf8;bner-Olesen, A. &amp; Riber, L. Bacterial chromosome replication and DNA repair during the stringent response. Front. Microbiol. 11, 582113 (2020).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32983079</ArticleId><ArticleId IdType=\"pmc\">7483579</ArticleId></ArticleIdList></Reference><Reference><Citation>Nerandzic, M. M., Cadnum, J. L., Eckart, K. E. &amp; Donskey, C. J. Evaluation of a hand-held far-ultraviolet radiation device for decontamination of Clostridium difficile and other healthcare-associated pathogens. BMC Infect. Dis. 12, 120 (2012).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22591268</ArticleId><ArticleId IdType=\"pmc\">3419611</ArticleId></ArticleIdList></Reference><Reference><Citation>Raeiszadeh, M. &amp; Adeli, B. A critical review on ultraviolet disinfection systems against COVID-19 outbreak: applicability, validation, and safety considerations. ACS Photonics. 7 (11), 2941&#x2013;2951 (2020).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">37556269</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos, C. C. R. et al. Use of ultraviolet-C in environmental sterilization in hospitals: A systematic review on efficacy and safety. Int. J. Health Sci. (Qassim). 14 (6), 52&#x2013;65 (2020).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33192232</ArticleId></ArticleIdList></Reference><Reference><Citation>Vignali, V. et al. An efficient UV-C disinfection approach and biological assessment strategy for microphones. Appl. Sci. 12 (14), 7239 (2022).</Citation></Reference><Reference><Citation>Li, D. F. et al. Steam treatment for rapid decontamination of N95 respirators and medical face masks. Am. J. Infect. Control. 48 (7), 855&#x2013;857 (2020).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32417321</ArticleId><ArticleId IdType=\"pmc\">7227495</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizwan, M., Chan, S. W., Comeau, P. A., Willett, T. L. &amp; Yim, E. K. F. Effect of sterilization treatment on mechanical properties, biodegradation, bioactivity and printability of GelMA hydrogels. Biomed. Mater. 15 (6), 065017 (2020).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">32640427</ArticleId><ArticleId IdType=\"pmc\">7733554</ArticleId></ArticleIdList></Reference><Reference><Citation>Komolprasert, V., McNeal, T. P. &amp; Begley, T. H. Effects of gamma- and electron-beam irradiation on semi-rigid amorphous polyethylene terephthalate copolymers. Food Addit. Contam. 20 (5), 505&#x2013;517 (2003).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12775470</ArticleId></ArticleIdList></Reference><Reference><Citation>Bharti, B., Li, H., Ren, Z., Zhu, R. &amp; Zhu, Z. Recent advances in sterilization and disinfection technology: A review. Chemosphere 308 (Pt 3), 136404 (2022).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">36165840</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarvis, S. et al. Microbial contamination of domiciliary nebulisers and clinical implications in chronic obstructive pulmonary disease. BMJ Open. Respir Res. 1 (1), e000018 (2014).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25478172</ArticleId><ArticleId IdType=\"pmc\">4212782</ArticleId></ArticleIdList></Reference><Reference><Citation>Tipnis, N. P. &amp; Burgess, D. J. Sterilization of implantable polymer-based medical devices: A review. Int. J. Pharm. 544 (2), 455&#x2013;460 (2018).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29274370</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkhardt, F. et al. Dimensional accuracy and simulation-based optimization of polyolefins and biocopolyesters for extrusion-based additive manufacturing and steam sterilization. J. Mech. Behav. Biomed. Mater. 153, 106507 (2024).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">38503082</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernie, K., Hamilton, S. &amp; Somerville, R. A. Limited efficacy of steam sterilization to inactivate vCJD infectivity. J. Hosp. Infect. 80 (1), 46&#x2013;51 (2012).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22099953</ArticleId></ArticleIdList></Reference><Reference><Citation>Czuba, L. Application of plastics in medical devices and equipment. Handb. Polym. Appl. Med. Med. Devices :9&#x2013;19. (2014).</Citation></Reference><Reference><Citation>Vienken, J. &amp; Boccato, C. Do medical devices contribute to sustainability? The role of innovative polymers and device design. Int. J. Artif. Organs. 47 (4), 240&#x2013;250 (2024).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">38618975</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin, S. et al. Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics. Signal. Transduct. Target. Ther. 7 (1), 199 (2022).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35752612</ArticleId><ArticleId IdType=\"pmc\">9233671</ArticleId></ArticleIdList></Reference><Reference><Citation>Garvey, M. Medical Device-Associated healthcare infections: sterilization and the potential of novel biological approaches to ensure patient safety. Int. J. Mol. Sci. ;25(1). (2023).</Citation></Reference><Reference><Citation>Riquena, B. et al. Microbiological contamination of nebulizers used by cystic fibrosis patients: an underestimated problem. J. Bras. Pneumol.. 45 (3), e20170351 (2019).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31166553</ArticleId><ArticleId IdType=\"pmc\">6715035</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranjan, N., Singla, N., Guglani, V., Randev, S. &amp; Kumar, P. Bacterial colonization of home nebulizers used by children with recurrent wheeze. Indian Pediatr. 59 (5), 377&#x2013;379 (2022).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35348123</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra, A., Aggarwal, A. &amp; Khan, F. Medical Device-Associated infections caused by Biofilm-Forming microbial pathogens and controlling strategies. Antibiot. (Basel). 13, 7 (2024).</Citation></Reference><Reference><Citation>Sagripanti, J. L. &amp; Bonifacino, A. Bacterial spores survive treatment with commercial sterilants and disinfectants. Appl. Environ. Microbiol. 65 (9), 4255&#x2013;4260 (1999).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10473448</ArticleId><ArticleId IdType=\"pmc\">99773</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavari, Y. et al. Healthcare workers mobile phone usage: A potential risk for viral contamination. Surveillance pilot study. Infect. Dis. (Lond). 48 (6), 432&#x2013;435 (2016).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27030915</ArticleId></ArticleIdList></Reference><Reference><Citation>Glasner, C. et al. Rapid and high-resolution distinction of community-acquired and nosocomial Staphylococcus aureus isolates with identical pulsed-field gel electrophoresis patterns and spa types. Int. J. Med. Microbiol. 303 (2), 70&#x2013;75 (2013).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23369304</ArticleId></ArticleIdList></Reference><Reference><Citation>Herbert, S. et al. Repair of global regulators in Staphylococcus aureus 8325 and comparative analysis with other clinical isolates. Infect. Immun. 78 (6), 2877&#x2013;2889 (2010).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20212089</ArticleId><ArticleId IdType=\"pmc\">2876537</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-P&#xe9;rez, A. N. et al. From the wound to the bench: exoproteome interplay between wound-colonizing Staphylococcus aureus strains and co-existing bacteria. Virulence 9 (1), 363&#x2013;378 (2018).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29233035</ArticleId><ArticleId IdType=\"pmc\">5955179</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin, A. R. &amp; Finlay, W. H. Nebulizers for drug delivery to the lungs. Expert Opin. Drug Deliv. 12 (6), 889&#x2013;900 (2015).</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25534396</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">40664435</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>15</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">2052-4439</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>15</Day></PubDate></JournalIssue><Title>BMJ open respiratory research</Title><ISOAbbreviation>BMJ Open Respir Res</ISOAbbreviation></Journal><ArticleTitle>Screening tools for work-related asthma and their diagnostic accuracy: a systematic review.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">e003251</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1136/bmjresp-2025-003251</ELocationID><Abstract><AbstractText Label=\"INTRODUCTION\" NlmCategory=\"BACKGROUND\">One in four cases of asthma in adults is caused or worsened by work (work-related asthma: WRA). Early detection of WRA could prevent poor health and employment outcomes, but clinical diagnosis is often missed or delayed. The standardisation and effectiveness of screening tools have not been well established. We aimed to summarise and compare the performance of screening tools for identifying WRA in both clinical settings and workplaces.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"METHODS\">We searched for studies that used structured questionnaires or prediction models (with/without physiological tests) to identify WRA in clinical settings or workplaces with individuals aged&#x2265;16&#x2009;years in MEDLINE, Embase, other bibliographic databases and grey literature between 1975 and 2024. Two reviewers independently screened titles, abstracts and full texts for inclusion, extracted data and assessed risk of bias using QUADAS-2 tool (Quality Assessment of Diagnostic Test Accuracy 2) or PROBAST (Prediction Model Risk of Bias Assessment Tool). Screening tools and their indices of accuracy were summarised with paired forest plots of sensitivities and specificities.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">Of 17&#x2009;504 identified studies, 7 were included. All were implemented in tertiary hospitals (n=5) and specialist centres (n=2). The screening tools comprised questionnaires alone (individual questions n=3 and multiple questions n=2), questionnaire with methacholine challenge test (n=1) and diagnostic models (n=4). The question 'improvement off work' had sensitivity=74-87%&#x2009;and specificity=15-58% for identifying WRA. Multiple questions had sensitivity=80-100% and specificity=8-55%. Addition of the methacholine challenge test to one questionnaire improved specificity to 75% with sensitivity=65%. Diagnostic models reported area under the curve (AUC) between 0.69 and 0.89, and AUC was improved when adding demographic variables or objective tests.</AbstractText><AbstractText Label=\"DISCUSSION\" NlmCategory=\"CONCLUSIONS\">A single item 'improvement off work' and multiple questions have high sensitivity but low specificity for WRA, which are sufficient for screening purposes to enhance WRA diagnosis. Adding demographic variables and objective tests can improve specificity or AUC. However, studies on screening tools for WRA are limited and inadequately reported; further evaluations of performance are needed in primary care populations and workplaces.</AbstractText><AbstractText Label=\"PROSPERO REGISTRATION NUMBER\" NlmCategory=\"UNASSIGNED\">CRD42021246031.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Kongsupon</LastName><ForeName>Ngamjit</ForeName><Initials>N</Initials><Identifier Source=\"ORCID\">0000-0001-6975-9646</Identifier><AffiliationInfo><Affiliation>Department of Applied Health Sciences, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Community Medicine and Family Medicine, Thammasat University Faculty of Medicine, Khlong Nueng, Pathum Thani, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Adab</LastName><ForeName>Peymane</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Applied Health Sciences, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Jordan</LastName><ForeName>Rachel E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Department of Applied Health Sciences, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Huntley</LastName><ForeName>Christopher C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Applied Health Sciences, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Occupational and Interstitial Lung Disease Services, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Rattanakanokchai</LastName><ForeName>Siwanon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Applied Health Sciences, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, Khon Kaen University, Nai Mueang, Khon Kaen, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Wallbanks</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Occupational and Interstitial Lung Disease Services, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Li</LastName><ForeName>Shiyao</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Applied Health Sciences, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Walters</LastName><ForeName>Gareth I</ForeName><Initials>GI</Initials><AffiliationInfo><Affiliation>Department of Applied Health Sciences, University of Birmingham, Birmingham, UK g.i.walters@bham.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Occupational and Interstitial Lung Disease Services, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D000078182\">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2025</Year><Month>07</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open Respir Res</MedlineTA><NlmUniqueID>101638061</NlmUniqueID><ISSNLinking>2052-4439</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D059366\" MajorTopicYN=\"Y\">Asthma, Occupational</DescriptorName><QualifierName UI=\"Q000175\" MajorTopicYN=\"N\">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D011795\" MajorTopicYN=\"N\">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008403\" MajorTopicYN=\"Y\">Mass Screening</DescriptorName><QualifierName UI=\"Q000379\" MajorTopicYN=\"N\">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D012680\" MajorTopicYN=\"N\">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000328\" MajorTopicYN=\"N\">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D001249\" MajorTopicYN=\"Y\">Asthma</DescriptorName><QualifierName UI=\"Q000175\" MajorTopicYN=\"N\">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D017132\" MajorTopicYN=\"N\">Workplace</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Asthma</Keyword><Keyword MajorTopicYN=\"N\">Occupational Lung Disease</Keyword><Keyword MajorTopicYN=\"N\">Sensitivity and Specificity</Keyword><Keyword MajorTopicYN=\"N\">Surveys and Questionnaires</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2025</Year><Month>2</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2025</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>0</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2025</Year><Month>7</Month><Day>15</Day><Hour>20</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">40664435</ArticleId><ArticleId IdType=\"doi\">10.1136/bmjresp-2025-003251</ArticleId><ArticleId IdType=\"pii\">12/1/e003251</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"Publisher\" Owner=\"NLM\"><PMID Version=\"1\">40664333</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>15</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1534-4436</ISSN><JournalIssue CitedMedium=\"Internet\"><PubDate><Year>2025</Year><Month>Jul</Month><Day>13</Day></PubDate></JournalIssue><Title>Annals of allergy, asthma &amp; immunology : official publication of the American College of Allergy, Asthma, &amp; Immunology</Title><ISOAbbreviation>Ann Allergy Asthma Immunol</ISOAbbreviation></Journal><ArticleTitle>A Case of Ichthyosis Prematurity Syndrome Mimicking Hyper-IgE Syndrome.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">S1081-1206(25)00349-7</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.anai.2025.07.009</ELocationID><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Yilmaz</LastName><ForeName>Saniye Yasemin</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Pediatric Immunology and Allergy, Selcuk University Faculty of Medicine, Konya, Turkey. Electronic address: drsaniyeyaseminyilmaz@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>&#xc7;elik</LastName><ForeName>&#x130;lknur K&#xfc;lha&#x15f;</ForeName><Initials>&#x130;K</Initials><AffiliationInfo><Affiliation>Department of Pediatric Immunology and Allergy, Selcuk University Faculty of Medicine, Konya, Turkey. Electronic address: celikilknur46@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Arta&#xe7;</LastName><ForeName>Hasibe</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pediatric Immunology and Allergy, Selcuk University Faculty of Medicine, Konya, Turkey. Electronic address: artachasibe@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2025</Year><Month>07</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Allergy Asthma Immunol</MedlineTA><NlmUniqueID>9503580</NlmUniqueID><ISSNLinking>1081-1206</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Hyper immunoglobulin E syndrome</Keyword><Keyword MajorTopicYN=\"N\">elevated serum IgE</Keyword><Keyword MajorTopicYN=\"N\">eosinophilia</Keyword><Keyword MajorTopicYN=\"N\">ichthyosis prematurity syndrome</Keyword></KeywordList><CoiStatement>Declaration of competing interest None</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2025</Year><Month>6</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2025</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2025</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>0</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>0</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2025</Year><Month>7</Month><Day>15</Day><Hour>19</Hour><Minute>28</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">40664333</ArticleId><ArticleId IdType=\"doi\">10.1016/j.anai.2025.07.009</ArticleId><ArticleId IdType=\"pii\">S1081-1206(25)00349-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>\n"
     ]
    }
   ],
   "source": [
    "pmids = \",\".join(pmid_list)\n",
    "efetch_url = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi\"\n",
    "params = {\n",
    "    \"db\": \"pubmed\",\n",
    "    \"id\": pmids,\n",
    "    \"retmode\": \"xml\"\n",
    "}\n",
    "\n",
    "efetch_response = requests.get(efetch_url, params=params)\n",
    "print(efetch_response.text)  # XML  xml.etree.ElementTree "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "7b067d59",
   "metadata": {},
   "outputs": [],
   "source": [
    "import xml.etree.ElementTree as ET\n",
    "root = ET.fromstring(efetch_response.text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "fe56a367",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "DOI: https://doi.org/10.1126/sciadv.ads8033\n",
      "DOI: https://doi.org/10.1007/s40266-016-0426-6\n",
      "DOI: https://doi.org/10.1097/00000542-200106000-00008\n",
      "DOI: https://doi.org/10.1177/21501319251353599\n",
      "DOI: https://doi.org/10.1093/infdis/jiaf226\n",
      "DOI: https://doi.org/10.62675/2965-2774.20250296\n",
      "DOI: https://doi.org/10.1002/2211-5463.70090\n",
      "DOI: https://doi.org/10.2196/23154\n",
      "DOI: https://doi.org/10.1101/2025.06.13.659090\n",
      "DOI: https://doi.org/10.1186/s12967-025-06646-5\n",
      "DOI: https://doi.org/10.2215/CJN.10161011\n",
      "DOI: https://doi.org/10.1186/s12969-025-01126-y\n",
      "DOI: https://doi.org/10.2500/aap.2019.40.4274\n",
      "DOI: https://doi.org/10.1038/s41598-025-09150-4\n",
      "DOI: https://doi.org/10.1038/s41591-025-03790-9\n",
      "DOI: https://doi.org/10.1097/MPG.0000000000003652\n",
      "DOI: https://doi.org/10.1111/ggi.14094\n",
      "DOI: https://doi.org/10.1038/s41598-025-11509-6\n",
      "DOI: https://doi.org/10.1136/bmjresp-2025-003251\n",
      "DOI: https://doi.org/10.1016/j.anai.2025.07.009\n"
     ]
    }
   ],
   "source": [
    "for article in root.findall(\".//PubmedArticle\"):\n",
    "    doi = None\n",
    "    for id_elem in article.findall(\".//ArticleId\"):\n",
    "        if id_elem.attrib.get(\"IdType\") == \"doi\":\n",
    "            doi = id_elem.text\n",
    "    if doi:\n",
    "        doi_url = f\"https://doi.org/{doi}\"\n",
    "        print(\"DOI:\", doi_url)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "a4ad8415",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "base",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.21"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
